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ABSTRACT 
Jacqueline Grace Wallenborn:  The Role of Metals in Particulate Matter-Induced Toxicity: 
Cardiovascular Effects of Zinc 
(Under the direction of Dr. Urmila Kodavanti) 
    Cardiovascular health effects following exposure to particulate matter (PM) are well 
recognized.  One potential mechanism behind this is the direct translocation of water soluble 
PM components, including metals, from the lungs into the circulation, whereby they exert 
extrapulmonary effects directly.  Zinc is a common PM-associated metal proposed to be a 
causative component in PM-induced injury.  To further investigate this, three approaches 
have been taken.  First, to assess the relative toxicity of zinc compared to other PM-
associated metals, male Wistar Kyoto (WKY) rats (15 wks, 300-350 g) were exposed via a 
single intratracheal instillation (IT) to 1 µmol/kg body weight of saline or zinc, nickel, 
vanadium, iron or copper, all in soluble sulfate forms.  Zinc induced specific pulmonary and 
cardiac effects, both in timing and degree of response.  Second, to prove that zinc directly 
translocates from the lungs into systemic circulation following IT, we used high resolution 
magnetic sector field inductively coupled plasma mass spectrometry to measure levels of a 
stable isotope of zinc (70Zn) in lungs, plasma, heart, liver, spleen, and kidney of male WKY 
rats (13 wks, 250-300 g), 1, 4, 24, and 48 h following a single IT or oral gavage of saline or 
0.7 µmol/rat 70Zn, using a solution enriched with 76.6% 70Zn.  Natural abundance of 70Zn is 
0.62%, making it an easily detectable tracer following exposure.  Gavage group was included 
to distinguish between kinetics following pulmonary and oral exposure to zinc, as this dose is 
nontoxic when taken orally.  70Zn translocated to all extrapulmonary organs, with 
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levels higher following IT than following gavage.  Third, to ascertain whether cardiac 
changes occur following exposure to environmentally relevant levels of zinc, male WKY rats 
(12 wks age) were exposed via nose only inhalation to filtered air or 10, 30 or 100 µg/m3 of 
aerosolized zinc sulfate 5 h/d, 3 d/wk for 16 wks. No significant changes were observed in 
lung injury or inflammation markers, indicating minimal pulmonary effect; however in the 
heart, small but significant changes were detected.  We have shown that soluble zinc directly 
moves from lungs into extrapulmonary systems, possibly in part causing PM-induced 
cardiovascular injury.   
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CHAPTER 1.  INTRODUCTION 
    Although it is generally accepted that exposure to air pollution causes numerous adverse 
health effects, air pollution levels remain elevated in both developed and developing 
countries.  In 2003 in the United States alone, more than 62 million people lived in counties 
in which the level of pollution exceeded the contemporaneous National Ambient Air Quality 
Standards (NAAQS) set by the Environmental Protection Agency (EPA) (EPA 2004).  The 
EPA monitors air quality by measuring six criteria pollutants: ozone, carbon monoxide, 
sulfur dioxide, nitrogen dioxide, lead and particulate matter (PM).  Many epidemiological 
studies have linked increased levels of PM to increases in adverse health effects, including 
myocardial infarction (Zanobetti and Schwartz, 2006), hypertension (Brook, 2005) and 
stroke (Wellenius et al., 2005).  However, the PM issue is complex, owing to many factors, 
including the wide range of sizes and composition of ambient particles.  Exposures to 
particles of a single size or composed of a single element are rare; and this makes the 
attribution of injury to certain particle characteristics extremely complicated.  PM-induced 
injury to the lungs, as well as cardiovascular and other extrapulmonary systems is well 
documented epidemiologically; however what specifically about particles is causing this 
injury remains unclear.  Literature in the epidemiology provides only a partial link between 
PM exposure and cardiovascular risk; however investigating the underlying biological 
plausibility of this is best carried out in animal models.  Toxicology and mechanistic studies 
are needed to support epidemiological findings, and provide the biological plausibility to 
assume a causal relationship between PM exposure and adverse cardiovascular health effects.
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    There are several different hypotheses about the mechanism of extrapulmonary injury 
following a pulmonary insult.  Lung inflammation occurring from PM exposure may induce 
a systemic inflammatory response, causing injury to the cardiovascular and other 
extrapulmonary systems secondarily to pulmonary injury (Dubowsky et al., 2006).  
Autonomic control of the heart may also be altered, causing PM-induced changes in heart 
rate and heart rate variability (Park et al., 2005), especially important in the case of pre-
existing heart conditions or disease.  In addition to these two hypotheses, translocation of PM 
components, especially the water soluble fraction, to organs outside of the lung may be 
causing a direct effect on the heart and other extrapulmonary organs (Elder et al., 2006; 
Wallenborn et al., 2007a).  Following inhalation, the water soluble fraction of PM is easily 
dissolved in the lung lining fluid, and is likely to be translocated to the vasculature of the 
lungs, as well as to the heart before dilution in the systemic circulation and hepatic clearance.  
Furthermore, the highly acidic environment provided by activated alveolar macrophages 
yields eventual translocation of the acid leachable fraction of PM.   
    PM is by no means homogenous, which makes studying mechanisms of its toxicity 
difficult.  PM differs in size, and is usually reported in terms of mass median aerodynamic 
diameter (MMAD).  The aerodynamic diameter describes the diameter of a sphere having the 
same unit density as the particle in question, no matter its shape or size.  Aerodynamic 
diameter is used to describe settling velocity, which can be used to predict how deep into the 
respiratory tract the particle will settle.  The MMAD describes the median of the 
aerodynamic diameters, where 50% of the particles mass will fall above this size range, and 
50% of the particles mass will fall below.  Particles over 10 µm MMAD will generally not be 
respirable.  PM10 describes particles with a MMAD of 10 µm or less.  PM2.5 describes 
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particles with a MMAD of 2.5 µm or less. Ultrafine particles have a geometric diameter of 
0.1 µm or less.  Ultrafine particles are not classified by MMAD, as this measurement relies 
on impaction for size measurement, and ultrafine particles are so small they generally do not 
settle or impact.  Instead, their electrical mobility is measured after all particles are given 
equal charges.  In addition to size, the chemical composition of PM is extremely diverse.   
    Because PM composition varies greatly depending on factors such as source and 
geographical location, several constituents of PM have been speculated to play a role in 
pulmonary and cardiovascular injury causation.  In particular, the amount of metals in PM is 
thought to be one of the primary components mediating toxicity (Costa and Dreher, 1997; 
Kodavanti et al., 1998).  The extrapulmonary toxicity of PM probably depends upon the 
amount and type of water soluble, and therefore bioavailable, metals present (Kodavanti et 
al., 2003; Gilmour et al., 2006b).  Translocation of intratracheally instilled vanadium to 
systemic circulation has been documented (Sharma et al., 1987; Wallenborn et al., 2007a), 
and the solubility of the element has been suggested to mediate translocation from pulmonary 
exposure (Rhoads and Sanders, 1985).  We have shown that translocation of several different 
PM-associated metals occurs following a single IT instillation of a metal containing PM, and 
that residence time in the lung is related to the water solubility of each specific metal 
(Wallenborn et al., 2007a).  The amount and type of water soluble metals present in PM has 
been suggested to modulate the generation of free radicals, and therefore oxidative stress and 
toxicity (Valavanidis et al., 2005), and in an in vivo study, increases in oxidative stress in the 
lung as well as the heart have been observed following inhalation of metal rich concentrated 
ambient particles (Gurgueira et al., 2002).     
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    Table 1.1 represents a summary of several different studies reporting the composition of 
metals in ambient air.  All values listed in Table 1.1 are in µg/m3.  Table 1.2 is also a 
summary of several different studies; however lists metal composition in µg/g sample 
collected.  Values in these two tables represent total amounts of each specific metal, and do 
not delineate between total, water soluble and acid soluble fractions of each one.  In addition 
to the total amount of specific metals present in PM, water and acid solubility may play a 
major role in the bioavailability, and therefore potentially the toxicity, of each metal.   
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Various 
California Various US      
  countiesa urban areasb Detroit, MIc Chicago ILc 
  µg/m3 µg/m3 µg/m3 µg/m3 
Zinc 0.012 1.4-8.3 0.025 0.023 
Copper 0.007 0.5-6.8 0.006 0.004 
Vanadium 0.002 0.07-1.4 0.002 0.001 
Nickel 0.005 0.15-1.4 0.002 0.001 
Iron 0.124 5.4-32 0.12 0.091 
aOstro et al., 2007 
bSchroeder et al., 1987 
cChen and Lippmann, 2009 
 
Table 1.1  Summary of composition of selected metals in various ambient settings, in µg/m3.  
Values adapted from cited studies.   
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Provo, Utah Valley Saint Louis Ottawa, CA
Utaha 1986 sampleb NIST no. 1648c EHC-93d
µg/g µg/g µg/g µg/g
Zinc 1010 74 3560 10,400
Copper 1370 55.2 370 845
Vanadium 10 0.72 110 90.4
Nickel 40 4.3 110 69.6
Iron 2220 26.4 8910 14,900
 
aKennedy et al., 1998 
bDye et al., 2001 
cCosta and Dreher, 1997 
dVincent et al., 1997 
 
Table 1.2  Summary of composition of selected metals in various ambient settings, in µg/g 
particle collected.  Values adapted from cited studies.   
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    Specific PM sources contribute to specific metals in the air.  Zinc is associated with tire 
wear, while brake dust is very rich in copper.  In order to determine if a specific source may 
be driving cardiovascular effects of PM exposure, it is necessary to examine effects of each 
metal individually.  Therefore, within the focus of PM associated metals, the question 
becomes which specific metal, or combination of metals, is mediating which specific effect.  
Several epidemiological studies have implicated several individual specific metals are linked 
to specific effects.  For example, exposure to PM-associated nickel and vanadium have been 
linked to increases in all cause mortality (Lippman et al., 2006), and several different metals, 
including iron, copper and zinc, have been linked to respiratory and cardiovascular mortality 
(Ostro et al., 2007).  These associations of specific PM components to specific endpoints are 
usually small, and therefore toxicology studies in the laboratory aim to investigate 
mechanisms behind each of these, to give these correlations biological plausibility.  The role 
of various individual metals, as well as their combined effects has been investigated.  For 
example, a synergistic relationship between inhaled vanadium and nickel has been proposed 
(Campen et al., 2001), and in this study iron seemed to attenuate the toxic response to inhaled 
vanadium or vanadium and nickel (Campen et al., 2002).  IT instillation of iron, nickel and 
vanadium in differing amounts induced changes in BALF measures of oxidative stress 
(Madden et al., 1999), as well as cardiac physiological parameters (Campen et al., 2002).  IT 
instillation of equimolar amounts of nickel and vanadium revealed differences in lung injury 
and inflammatory response, both in specific endpoints and time course of injury (Kodavanti 
et al., 2001).  Increased heart rate and decreased heart rate variability induced in ApoE-/- 
mice exposed to concentrated ambient particles was linked to the nickel content (Lippman et 
al., 2006).  Nickel has actually been shown to decrease activity of iron containing enzymes, 
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including succinate dehydrogenase (Chen and Costa, 2006), implying that nickel may 
decrease mitochondrial ATP production, and possibly inducing cardiac effects.  Vanadium 
has been shown to increase mitochondrial reactive oxygen species (ROS) production, but not 
apoptosis, in cultured alveolar macrophages (Huang et al., 2003).  In vivo, the PM-associated 
water soluble nickel and vanadium has been correlated with vascular leakage and 
neutrophilic influx, respectively, into the lung (Kodavanti et al., 1998).   
    Nickel and vanadium are not the only suggested drivers of PM induced toxicity.  When 
exposed to concentrations of metals found in a PM sample collected in Provo, Utah, copper 
was found to be the only metal found to induce IL-8 production in bronchial epithelial cells, 
though iron and lead were more abundant (Kennedy et al., 1998).  The lung injury and 
inflammation potential of PM has been linked to copper content (Gerlofs-Nijland et al., 
2007) and following IT instillation of 0.5 µmol / kg body weight of copper, we observed 
changes in BALF parameters of lung injury and inflammation, as well as cardiac enzyme 
activity levels (Gottipolu et al., 2008).  Zinc is commonly found in ambient PM, especially in 
urban areas (Dye et al., 2001) and near roadways (Schauer et al., 2006), and was shown to be 
the pulmonary injury causing metal in a well studied particle collected in Ottawa, Canada 
(Adamson et al., 2000).  Many subsequent studies have shown zinc effects in vitro in airway 
epithelial cells (Tal et al., 2006; Kim et al., 2006).  Lang et al (2007) suggest a protective role 
of zinc with respect to allergen induced airway inflammation; however, this follows zinc 
supplementation via ip injection rather than inhalation, as would be the case following 
exposure to PM.  Because it is the most abundant metal in ambient air, and therefore the most 
relevant to public health, much work has been done in recent years investigating the 
mechanisms of PM associated zinc toxicity.   
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    PM-induced toxicity may occur via different mechanisms, depending on the composition 
of the PM in the air, specifically which metals are present and at what concentration.  
Therefore, investigations of their specific mechanisms of injury are necessary.  However, 
although pulmonary and cardiac responses of many different PM associated metals have been 
described, no study has evaluated the toxicity and potency of zinc relative to other PM 
associated metals.   
    In a previous study, exposure to a single IT instillation of a zinc containing PM induced a 
subtle cardiac effect in three strains of rats, including healthy male WKY rats (Wallenborn et 
al., 2007b).  Furthermore, we detected nonessential metals found in high amounts in the 
water soluble fraction of the PM in the plasma, heart and liver of exposed rats only, 
signifying that direct translocation of metals is occurring (Wallenborn et al., 2007a).  
Changes in zinc levels in organs outside of the lung were also induced; however because zinc 
is found in high amounts in thousands of different proteins and enzymes in the normal 
cellular environment, it is not possible to attribute increases to the direct translocation of PM 
associated zinc rather than induction of zinc containing proteins or enzymes or possibly 
sequestration from zinc pools in other organs.  The fact that zinc is essential means that the 
body may deal with zinc exposure in different ways than nonessential metals, which may 
lead to differences in kinetics.  The detection of nickel and vanadium outside of the lung 
following pulmonary exposure suggests that zinc is also able to translocate; however this 
assumption should not be made based on the ability of other metals to translocate.   
    It is clear that zinc is playing a role in injury causation following pulmonary exposure to 
metal rich PM; however zinc effects on extrapulmonary systems, including cardiovascular, 
are less well investigated.  Following zinc oxide inhalation, levels of plasma IL-6 were 
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elevated over controls (Fine et al., 1997), suggesting possible involvement of a systemic 
inflammatory response.  However, unlike the response following IT instillation of zinc, 
neutrophilic influx was not observed following inhalation of lower levels of zinc containing 
PM for 13 weeks (Kodavanti et al., 2002), suggesting a direct effect of zinc on cardiac tissue.  
Changes in expression of blood coagulation factors (Gilmour et al., 2006a), metallothionein, 
and zinc transporter-2 (Gilmour et al., 2006b) were observed in the hearts of rats following 
pulmonary exposure to zinc sulfate.  It has also been found that zinc alters expression of 
calcium and potassium channels in rat cardiomyocytes following exposure in vitro (Graff et 
al., 2004) and also pulmonary exposure in vivo (Gilmour et al., 2006b).  Following 
pulmonary zinc exposure, changes in expression of genes involved in mitochondrial 
respiration have been shown (Gilmour et al., 2006b; Kodavanti et al., 2008).  Cardiac 
mitochondrial DNA damage was induced by repeated IT instillation of zinc (Kodavanti et al., 
2008).  In addition, inhibition of cardiac mitochondrial aconitase activity following 
pulmonary zinc exposure has also been observed (Gottipolu et al., 2008).  It must be noted 
that all of these studies used single or multiple IT instillations of high concentrations of zinc 
as a route of exposure.    
    In vitro studies in several different cell types show that PM, and specifically zinc exposure 
has an effect on mitochondrial function (Nel et al., 2005; Ye et al., 2001; Dineley et al., 
2005).  Our previous microarray results support this contention, even in vivo (Gilmour et al., 
2006b).  Because of their high energy demand, cardiomyocytes are rich in mitochondria 
(Benard et al., 2006), therefore making them a potential target of zinc exposure.  Zinc 
transport from extracellular space into the cell, and specifically, to the mitochondria, has 
been studied in several cell types (Sensi et al., 2003; Wiseman et al., 2006), including 
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cardiomyocytes (Ayaz and Turan, 2006).  Several zinc transporters, including the Zrt/IRT-
like proteins (ZIP proteins) and zinc transporter family (Zn-T), on the outer plasma 
membrane of the cell aid in zinc influx and efflux from the extracellular matrix into the cell 
(Rutherford and Bird, 2004).  Within the cell, metallothionein is a cysteine rich protein 
involved in the transport and regulation of metals, including cadmium, copper and zinc.  
Several studies have implicated the involvement of metallothionein in intracellular transport 
of zinc to mitochondria (Feng et al., 2005; Costello et al., 2004).  Metallothionein import into 
the mitochondria from the cytosol is then facilitated by a family of translocases on the 
mitochondria (Ye et al., 2001).  Zinc-induced inhibition of mitochondrial pathways which are 
essential for normal cellular function, such as electron transport, glycolysis, and the 
tricarboxylic acid cycle, has been speculated (Brown et al., 2000; Link and von Jagow, 
1995).  In hepatic mitochondria, zinc exposure inhibited activity of Fe-S cluster-containing 
enzymes such as aconitase, succinate dehydrogenase, and cytochrome C oxidase (Lemire et 
al., 2008).  These authors speculate that zinc may be displacing iron in Fe-S clusters, making 
these enzymes inactive.  A link between zinc specific transporter ZnT-1 and L-type calcium 
channels is known, indicating a close link between cellular transport of several metal cations, 
including zinc and calcium (Ohana et al., 2006).  Furthermore, exposure to zinc has been 
shown to disturb intracellular calcium homeostasis (Hershfinkel et al., 2001), suggesting that 
the soluble fraction of zinc found in PM may also have a direct effect on calcium 
homeostasis in the heart (Bagate et al., 2006; Gilmour et al., 2006b).  Because mitochondria, 
ion channel activity, and calcium homeostasis are important in proper cardiac functioning, 
demonstrated effects of zinc on these parameters support epidemiological studies citing a 
cardiovascular effect of PM exposure (Dockery, 2001). 
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    Most in vivo studies investigating the effects of pulmonary zinc exposure are designed as 
acute exposures to high concentrations of zinc.  Toxicology studies addressing the effects of 
a “real world” situation, i.e., subchronic or chronic exposures to concentrations of zinc which 
are more environmentally relevant, and have been found in industrial polluted settings are 
relatively infrequent.  Longer term studies that have been carried out have demonstrated a 
cardiac effect (Kodavanti et al., 2002; 2003) following inhalation of combustion PM that 
contained zinc.  Although these studies employed inhalation rather than IT instillation as a 
method of exposure, the concentrations used were far above what may be found in an 
environmental setting.  Whether inhalation exposure to environmentally relevant levels of 
zinc causes pulmonary or cardiac changes remains to be tested.   
    IT instillation as a means of pulmonary exposure has been well established as a method to 
investigate mechanisms of toxicity, or as a method to screen a large number of potentially 
toxic substances.  An exact known amount of test agent (PM, metal, etc.) can be administered 
as a large bolus into the lung, and this is not dependent on factors that may change from 
subject to subject, such as deposition fraction and breathing rate.  However, IT instillation is 
by no means representative of environmental exposures.  Inhalation exposure obviously is 
best when designing studies to more closely mimic environmental or occupational exposures; 
however are more costly and time consuming, use more test substance, and further, the exact 
dose to each animal is not known and must be estimated.  Several studies have been 
conducted to investigate differences between these two routes of exposure, with regards to 
toxicity, as well as lung deposition, distribution and clearance patterns.  These issues will be 
further discussed in Chapter 5.  For the upcoming experiments, means of pulmonary 
exposure (IT vs. inhalation) were chosen with specific hypothesis to be tested in mind.  
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Experiments in Chapter 2 were designed as a screening study, to understand which specific 
metal may be more potent than others.  For these studies, it is crucial that a known and 
constant amount of metal be delivered to the lungs of each rat, so IT instillation was chosen.  
For experiments carried out in Chapter 3, it was also crucial that a known amount of 70Zn be 
delivered to the lungs or gut of each animal, in order to compare kinetics via these two 
separate routes so therefore, IT instillation was also chosen as a means of pulmonary 
exposure.  For the experiments described in Chapter 4, the goal was to assess the 
cardiovascular effects of zinc exposure via more environmentally relevant conditions, so 
inhalation exposure was chosen.   
    Based on these previous results and review of the literature, it is probable that the metal 
content, and specifically the zinc content, of PM is in part driving cardiovascular toxicity.  
Following pulmonary exposure to zinc, it is likely that the soluble portion of this element 
binds to lung lining proteins and directly translocates via the pulmonary capillaries into 
systemic circulation, and therefore has a direct effect on cardiac tissue, and specifically, 
cardiac mitochondria.  This is likely the case even during exposure to low levels of zinc for 
long periods of time.  This research project more clearly defines the mechanisms of cardiac 
effects of pulmonary exposure to metals.  Because zinc is commonly the most abundant 
metal in ambient air and therefore most relevant to public health, the research presented here 
more clearly defines the role of PM-associated zinc in PM-induced cardiovascular toxicity.  
Characterization of cardiac effects following a single IT instillation of equimolar amounts of 
zinc or other PM associated metals (nickel, vanadium, iron, copper) shows that the effects of 
pulmonary exposure to zinc are specific to zinc.  This experiment is also helpful in linking 
specific cardiovascular effects of PM exposure with specific metal composition of PM.  IT 
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instillation or oral gavage of a stable isotope of zinc found in extremely low abundance 
naturally demonstrates the kinetics of zinc, and ascertains that direct translocation from the 
lungs into the heart is occurring, possibly explaining differences in response to zinc exposure 
via inhalation versus ingestion.  Lastly, a long term inhalation exposure to zinc sulfate 
provides evidence that exposure to environmentally relevant concentrations of zinc over a 
relatively long period of time induces cardiac effects in vivo.  As most environmental 
exposures to zinc are to lower levels over a long period of time, these results highlight the 
relevance of studying zinc exposure from a public health perspective.   
    In summary, it appears that metals associated with PM are playing a role in pulmonary and 
cardiovascular injury causation; however, the mechanisms are poorly understood.  The 
overarching aim of this project is to determine whether zinc present in PM is causing distinct 
pulmonary and cardiac effects, and whether zinc has a direct effect on the heart.  A better 
description of the exact changes occurring following pulmonary zinc exposure will help to 
support existing epidemiological studies showing an association between cardiac effects and 
exposure to zinc containing PM, and aid in demonstrating a causal relationship between zinc 
exposure and adverse cardiac effects.  Furthermore, this work aids in source allocation, 
whereby specific PM components from specific sources may be mediating cardiovascular 
injury causation. 
    Zinc specifically as a mediator of systemic and cardiac injury has been proposed, and 
several toxicological studies have linked the adverse health effects of PM exposure to the 
zinc present in the particle sample (Kodavanti et al., 2003; Adamson et al., 2000).  However, 
there is also a multitude of other studies linking other PM associated metals with pulmonary 
and cardiac toxicity (Samet et al., 1997; Kennedy et al., 1998; Kodavanti et al., 1998; 
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Campen et al., 2002; 2003; Gerlofs-Nijland, 2007).  Before this, no study has been carried 
out investigating the comparative cardiac toxicity of common metals found in PM.  Results 
presented in Chapter 2 illustrate that pulmonary and cardiac effects are metal specific.   
    In Chapter 3, the use of a stable isotope of zinc to monitor the kinetics following 
pulmonary exposure proves that zinc is translocating directly into the circulation.  This will 
help to further prove our hypothesis that the systemic effects of zinc exposure are the result 
of a direct effect of zinc rather than stemming entirely from the pulmonary inflammatory 
response.  Additionally, because exogenous zinc kinetics differ in the heart between 
pulmonary and oral exposures, work presented in Chapter 3 demonstrates the heart as a 
specific target for exposures to inhaled soluble components of PM.   
    Compared to most toxicological studies addressing mechanisms of injury, environmental 
exposures to PM are chronic and at relatively low concentrations.  Effects of an acute 
exposure to a large dose of PM may be very different than a chronic exposure to lower 
concentrations.  Work presented in Chapter 4 addresses this issue.  The concentrations 
chosen for this subchronic exposure (0, 10, 30 and 100 µg/m3 of aerosolized zinc sulfate) 
reflect concentrations of zinc that have been measured near roadways or in industrial polluted 
settings (Schroeder et al., 1987; Matczak and Gromiec, 2002).    
    Chapter 2 ties together much previous work done on many different metals at many 
different time points.  Chapter 3 proves that PM-associated zinc is reaching extrapulmonary 
organs, at a higher concentration than following ingestion.  Chapter 4 addresses both the 
environmental relevance and mechanisms of zinc induced injury.  Collected, the components 
of this project help to better define PM-induced injury, elucidate the mechanisms, and prove 
that PM-associated metals, particularly zinc, are in part responsible for cardiac injury.
CHAPTER 2.  DIFFERENTIAL PULMONARY AND CARDIAC EFFECTS OF 
PULMONARY EXPOSURE TO A PANEL OF PM-ASSOCIATED METALS 
 
2.1 Introduction 
    Exposure to particulate matter (PM) has been linked to increases in not only respiratory 
health effects, but cardiovascular morbidity and mortality as well (Pope et al., 2004).  There 
are several different hypotheses regarding the mechanism of this linkage, one being that 
following inhalation, soluble components associated with PM, including metals, move 
directly through the pulmonary vasculature and reach systemic circulation (Wallenborn et al., 
2007; 2009), and therefore have a direct effect on systems outside of the lung, including the 
heart.  Ambient PM is a complex mixture of chemicals, and composition differs depending 
on source and location.  PM-associated metals exist in varying chemical forms, concentration 
and may be in water soluble, loosely bound or undetachable forms.  Aside from iron, metals 
associated with PM are primarily anthropogenic in origin (Birmili et al., 2006; Mazzei et al., 
2008) and therefore, PM found in industrial areas (Dye et al., 2001) and near roadsides is 
particularly metal-rich (Schauer et al., 2006) .    
    There are a multitude of studies supporting the hypothesis that metals are playing a role in 
PM induced cardiovascular toxicity.  Several epidemiological studies link the total metal 
content of PM to increased morbidity (Ghio, 2004; Ostro et al., 2007), while in the 
laboratory, numerous animal toxicology studies have corroborated this.  In 1998, Kodavanti 
et al. compared responses to IT instillation or in vitro exposure of macrophages to 10 
different PM samples, all with differing total metal and individual metal amounts.  Findings
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 from this study suggest the soluble metal content of the PM mediates lung injury and 
inflammation.  By comparing results from instillation of equal amounts of total particle or 
total metals, Costa and Dreher (1997) suggest that it is the metal content, rather than the total 
mass of particle, that mediates respiratory damage.  Studies resulting from a steel mill in the 
Utah Valley closing in 1987 provide a unique setting for comparative studies using ambient 
PM samples collected in 1986, 1987, and 1988.  As is the case with most studies comparing 
responses to many PM samples, PM collected during these three periods differ in both their 
total metal content as well as amounts of specific metals.  Dye et al. (2001) showed that the 
PM sample collected during the year when the mill was closed produced less of an 
inflammatory response than PM collected in flanking years.  Furthermore, instilling at similar 
metal contents seemed to show that PM samples collected in 1986 and 1988 were more toxic, 
suggesting that differences in specific metal content, rather than total metal content, may be 
mediating toxicity of PM.  In rodent airway epithelial cells, exposure to the metal content 
alone reproduced toxicity produced by exposure to the soluble fraction of Utah Valley PM 
extracts, suggesting that within the soluble fraction it is the metals that cause toxicity (Pagan 
et al., 2003).  Furthermore, these authors showed that exposure of cells to Zn and Cu resulted 
in a response greater than to exposure to each of these metals alone, suggesting a potential 
interaction (Pagan et al., 2003).  Removal of the metals from the Utah Valley PM sample 
resulted in decreased toxicity (Mollinelli et al., 2002).  In vitro studies using human epithelial 
cells have shown that many metals, including Zn, Ni and V, can cause a range of effects, 
including inhibition of phosphatases (Samet et al., 1999) and induction of inflammatory 
signaling pathways (Kim et al., 2007).  In rat cardiomyocytes, decreased beat frequency as 
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well as changes in expression of ion channels has been observed following equimolar 
exposure to Zn or V (Graff et al., 2004).  
    Although numerous studies have shown in many different ways that the metal content of 
PM is at least in part responsible for its toxicity, there have been relatively fewer that attempt 
to elucidate which specific metal, or combination of metals, may be driving the toxicity.  
Ambient air contains many different metals, in differing amounts dependent on factors such 
as geographic location and surrounding sources, including both point and mobile.  Among 
the top most commonly found metals in ambient PM are copper, zinc and iron (Valavanidis 
et al., 2006; Rungratanaubon et al., 2008).  Copper is used in brake pads and is found to be 
enriched in roadside ambient air, whereas zinc is used to galvanize tires, and therefore like 
copper, can be found in relatively high amounts near roads (Salma and Maenhaut, 2006).  
Vanadium and nickel can usually be attributed to specific industrial activities, such as oil 
combustion (Hedberg et al., 2006) or smelting (Lippman et al., 2006).  Vanadium and nickel 
have also been purported to underlie PM toxicity (Campen et al., 2002); however, they are 
found in small amounts relative to other metals like iron and zinc in most ambient PM 
samples.  Differences in redox potential, solubility, and bioavailability may all play a role in 
determining which metal or combination of metals may mediate the toxicity of PM 
(Wallenborn et al., 2007a; Valavanidis et al., 2005; Smith and Aust, 1997; Lewis et al., 
2003).  Furthermore, metals that are essential in biological functions (such as zinc and 
copper) may induce effects that are different from metals which are not essential (such as 
vanadium).  Different metals may cause injury through distinct mechanisms.  For example, 
regression analysis following exposure of rats to several different residual oil fly ash (ROFA) 
samples containing varying amounts of metals suggested that lung injury is associated with 
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amount of soluble nickel and neutrophilic influx into the lung is associated with amount of 
soluble vanadium in the PM (Kodavanti et al., 1998).  Because of differences in PM metal 
composition, only part of the question is addressed when total metal content is used to assess 
PM toxicity.    
    Residual oil fly ash (ROFA) is a particle type rich in metals such as vanadium, nickel and 
iron, and has been used extensively as a prototypical metal-rich particle.  Many studies have 
used different ROFAs, collected at different times and at different locations, to study PM-
induced toxicity.  There are a variety of different ROFAs available for use at the EPA, many 
of which were collected in Boston, Massachusetts from different locations within a coal 
burning power plant, and have been extensively characterized, both chemically and 
biologically (Kodavanti et al., 1998).  These contain different relative amounts of specific 
metals, such as nickel, vanadium, iron, and zinc; however are all metal rich relative to 
ambient PM.  Exposure to ROFA, as well as individual metals found in ROFA, induces 
pulmonary (Kodavanti et al., 1998; Pritchard et al., 1996) and cardiac effects (Campen et al., 
2001 and 2002).  However, metals other than nickel, vanadium and iron are commonly found 
in PM of ambient air, and usually in greater amounts.  Studies investigating toxicity of 
ROFA may not be applicable to toxicity of ambient air because effects most likely differ with 
respect to metal content, both in degree and timing of effect.  Zinc is commonly the most 
abundant ambient PM metal found in soluble form, and many studies have suggested that it 
also plays a role in toxicity of PM (Adamson et al., 2000; Kodavanti et al., 2003 and 2008; 
Wallenborn et al., 2008).  Copper is also commonly associated with PM, and has been 
purported to be the causative agent in PM induced effects (Kennedy et al., 1998; Gavett et 
al., 2003).    
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    Most studies investigating the role of individual PM associated metals employ the amount 
of metal found in a PM sample as a guide to the dose or concentration used (Adamson et al., 
2000; Campen et al., 2001 and 2002).  Because of this, it is hard to ascertain from current 
literature whether PM-induced toxicity is driven by the most common metal in the PM, 
regardless of specific metal, or whether specific metal composition plays a role.  Some 
studies, in both the epidemiology and toxicology literature, have attempted to link a certain 
effect with a level of certain metal in soluble form (Kodavanti et al., 1998; Ostro et al., 2007; 
Lippmann et al., 2006).  However, many of the toxicology studies make use of different 
exposure regimens and PM samples, with differing amounts of specific metals and solubility, 
and different endpoints measured.  This means that one is unable to ascertain which specific 
metal is causing the most toxicity to either the pulmonary or cardiovascular system.  Zinc has 
been singled out in many studies by several different groups as a metal that is mediating 
respiratory and cardiac adverse effects; however, this may just be the result of the 
concentration of zinc.  A 2002 study addresses the comparative pulmonary toxicity of PM 
associated metals in equal amounts according to mass.  Their results show that at equal 
masses, zinc and copper seem to cause relatively more pulmonary toxicity than vanadium, 
nickel, iron or lead (Prieditis and Adamson, 2002).  However, no study has systematically 
investigated cardiac effects of pulmonary exposure to individual soluble metals or further 
more, the temporality of both pulmonary and cardiac effects.  Knowledge of the comparative 
toxic effects of different metals is necessary in studying the mechanisms underlying PM-
induced cardiopulmonary effects.  
    With this study we sought to assess the relative effects, and kinetics of both pulmonary and 
cardiovascular, of pulmonary exposure to equal concentrations of several metals commonly 
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associated with PM.  Each of these metals has been suggested to mediate PM toxicity; 
however the potency of exposure to each of these metals relative to each other has not been 
investigated.  Our results indicate differential kinetics and degree of pulmonary toxicities of 
different metals commonly associated with PM (zinc, copper, nickel, vanadium and iron).  
Further, at 1 µmol/kg body weight, only zinc and nickel induce systemic and cardiac 
responses.  Zinc is commonly one of the most abundant metals in ambient air.  This, taken 
with the results of the current investigation, suggests that zinc content may be the most 
important monitor and regulate in order to reduce PM exposure-induced cardiovascular 
disease.   
 
2.2 Materials and Methods 
Animals.  Healthy male Wistar Kyoto (WKY) rats, 14 weeks old, were purchased from 
Charles River Laboratories Inc., Raleigh, NC.  Animals were double housed in polycarbonate 
cages with beta chips bedding and acclimatized for at least one week in an AAALAC-
approved animal facility (21 ± 1OC, 50 ± 5% relative humidity, 12-h light-dark cycle) prior to 
the experimental period. All animals received standard Purina rat chow (Brentwood, MO) 
and water ad libitum except during exposures.   
 
Selection of metals and concentration.  Zinc, copper and iron are commonly found to be 
associated with ambient PM (Adamson et al., 2000; Valavanidis et al., 2006).  Pulmonary 
and cardiac effects of vanadium and nickel have been well studied in previous studies in 
which pulmonary and cardiac toxicity of exposure to ROFA is described (Costa and Dreher, 
1997; Campen et al., 2001 and 2002).  All five of these metals have been suggested in 
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different studies and by different investigators to mediate toxicity of PM (Adamson et al., 
2000; Kennedy et al., 1998; Campen et al., 2002; Smith and Aust, 1997; Lippman et al., 
2006).  We therefore chose to expose rats to equimolar amounts of these five metals to assess 
their relative pulmonary and cardiac toxicities.  Each of these metals was used in the water 
soluble sulfate form.  We chose 1 µmol/kg body weight to be comparable to many of our 
previous studies (Gottipolu et al., 2008; Kodavanti et al., 2008).   
 
Intratracheal instillations.  Rats were randomly assigned to different groups (n = 6) based on 
body weight.  Individual metals were weighed, and suspended in sterile saline at 1 µmolp/mL 
and shaken for at least 2 hours prior to instillation.  Rats were anesthetized under isofluorane 
and IT instilled at a volume of 1 ml/kg (Costa et al., 1986).  Control rats received 1 ml/kg of 
sterile saline.   
 
Necropsy and sample collection.  We hypothesized that responses would differ in timing, 
depending on the metal rats were exposed to.  Vanadium has been shown to have more acute 
effects, whereas effects of nickel exposure are more delayed (Campen et al., 2002).  We 
therefore chose four time points following a single IT instillation for analysis of pulmonary 
and cardiac endpoints. At 4, 24, 48 or 96 hrs after exposure, rats were weighed and 
anesthetized with an overdose of sodium pentobarbital (50-100 mg/kg, ip).  Blood was 
collected through an abdominal aortic puncture directly into vaccutainers containing either 
EDTA (for complete blood counts) or citrate for plasma analysis.  A piece of liver was 
quickly excised, quick frozen in liquid nitrogen, and stored at -80ºC for polymerase chain 
reaction (PCR) analysis.  The diaphragm was cut, and the heart quickly excised.  The right 
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ventricle was quickly removed, and a piece of left ventricle was quick frozen in liquid 
nitrogen, and stored at -80ºC for PCR analysis.  The remaining left ventricle was used for 
isolation of mitochondrial and cytosolic fractions, described further below.   
    The trachea was cannulated and the left lung was tied off.  The right lung was lavaged 
using a volume of Ca2+/Mg2+ free phosphate buffered saline (pH 7.4) equal to 35 ml/kg body 
weight (total lung capacity) X 0.6 (right lung is 60% of total lung volume).  Three washes 
were performed with the same buffer aliquot.  Bronchoalveolar lavage fluid (BALF) was 
stored in 15 ml sterile tubes on ice.  The left lung was inflated with 10% formalin and 
processed for histopathology as described below.  Right lung lobes were excised, quick 
frozen in liquid nitrogen, and stored at -80ºC for PCR analysis.   
 
Blood/plasma/serum analysis.  Complete blood counts (red blood cells, total white blood 
cells, lymphocytes, hemoglobin, hematocrit) were performed on the Beckman Coulter AcT 
blood analyzer (Beckman-Coulter Inc., Fullerton, CA).  Using commercially available kits 
from Thermo Electron Corporation (Victoria, Australia), serum was analyzed for total 
cholesterol, low density lipoprotein, high density lipoprotein, and triglycerides.  Likewise, 
using commercially available kits, plasma was analyzed for fibrinogen (DiaSorin, Stillwater, 
MN) and angiontensin converting enzyme (Thermo Electron Corporation, Victoria, 
Australia).  Assays were adapted for use on the Konelab clinical chemistry analyzer (Thermo 
Clinical Labsystems, Espoo, Finland). 
 
Cell differential and bronchoalveolar lavage fluid (BALF) analysis.  Aliquots of BALF were 
used to determine total cell counts with a Z1 Coulter Counter (Coulter, Inc., Miami, FL).  A 
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second aliquot was centrifuged (Shandon 3 Cytospin, Shandon, Pittsburg, PA) to prepare cell 
differential slides.  Slides were dried at room temperature and stained with Leukostat (Fisher 
Scientific Co., Pittsburg, PA).  Macrophages, neutrophils, eosinophils and lymphocytes were 
counted using light microscopy.  At least 300 cells were counted on each slide.  The 
remaining BALF was centrifuged at 1500 x g to remove cells, and the supernatant fluid was 
analyzed for markers of lung injury. Total protein (µg/ml BALF) was analyzed using 
Coomassie Plus Protein Assay Kit (Pierce Rockford IL). BALF albumin (µg/ml BALF) was 
analyzed using a commercially available kit (DiaSorin, Stillwater, MN).  Lactate 
dehydrogenase (LDH) activity (U/L BALF) was determined using a Kit 228 from Sigma 
Chemical Co. (St. Louis, MO). N-Acetyl glucosaminidase (NAG) activity (U/L BALF) was 
measured using a kit and standards from Roche Diagnostics (Indianapolis IN).  γ-glutamyl 
transferase (GGT) activity (U/L BALF) was measured using a kit from Thermo Trace Ltd 
(Melbourne, Australia).  These assays were modified and adapted for use on the Konelab 
clinical chemistry analyzer (Thermo Clinical Labsystems, Espoo, Finland). 
 
RNA isolation.  Total lung, heart and liver RNA was isolated from tissue frozen at -80ºC, 
with a commercially available RNeasy mini kit (Qiagen, Valencia, CA) using silica gel 
membrane purification.  Total RNA from ~20mg tissue was isolated, and resuspended in 
40µl RNAse free water.  RNAse inhibitor was added and RNA yield was determined 
spectrophotometrically on the NanoDrop 1000 (Thermo Scientific, Wilmington, DE).  Each 
RNA sample was diluted to a uniform concentration of 20ng/µl and stored until PCR reaction 
was carried out.   
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Real time reverse transcriptase PCR.  One-step real-time reverse transcription polymerase 
chain reaction (RT-PCR) was carried out using the SuperScript III One-step RT-qPCR kit 
from Invitrogen.  All reactions were run in duplicate using 100ng total RNA.  18S ribosomal 
RNA was run as an endogenous control for each sample separately.  Real time PCR was 
conducted on an ABI Prism 7900 HT sequence detection system (Applied Biosystems, Foster 
City, CA).  RT-PCR conditions were as follows:  20 minutes at 53ºC for reverse 
transcription, 2 minutes at 95ºC for inactivation of reverse transcriptase, followed by 40 
cycles of 15 seconds at 95ºC and 45 seconds at 60ºC.  Inventoried TaqMan Gene Expression 
Assays for metallothionein-1 (Assay ID Rn01536930_g1), zinc transporter-1 (Assay ID 
Rn00575737_m1) and 18S ribosomal RNA (Assay ID Hs99999901_s1) were purchased from 
ABI, each containing a 6-carboxy-fluorescein (FAM dye) label at the 5’ end.  Data were 
analyzed using ABI sequence detection software (SDS), version 2.2.  For each plate, cycle 
threshold (cT) was set to an order of magnitude above background.  For each individual 
sample, target gene cT was normalized to control (18S) cT to account for variability in 
starting RNA amount.  Expression of each exposure group was quantified relative to increase 
over saline control, at the corresponding time point.    
 
Preparation of cytosolic and mitochondrial fractions from heart.  Immediately following 
excision, a portion of the left ventricle was minced in ice cold buffer containing 210mM 
mannitol, 5.0mM MOPS, 70mM sucrose, 1.0mM EDTA, at pH 7.4.  The tissue was 
homogenized in 10 ml of this buffer using a Dounce homogenizer with a Teflon pestle.  This 
homogenate was centrifuged at 1200rpm at 4ºC for 10 minutes to remove unhomogenized 
cells and nuclear debris.  The supernatant was transferred to another tube, and centrifuged at 
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10,000rpm at 4ºC for 20 minutes.  This supernatant was used as the cytosolic fraction.  The 
pellet was resuspended in 1 ml of the homogenizing buffer, with added protease inhibitors 
(1:200 dilution, Calbiochem Catalog #593134, San Diego, CA), and used as the 
mitochondrial fraction.  Both of these fractions were stored at -80ºC until analysis.   
 
Analysis of cytosol and mitochondria.  We have previously shown changes in several 
different enzymes in cardiac mitochondria and cytosol following pulmonary exposure to 
ROFA (Wallenborn et al., 2007b) or its constituent metals (Wallenborn et al., 2008; 
Gottipolu et al., 2008).  In each of the cardiac mitochondrial and cytosolic fractions, we 
measured the activity of aconitase, succinate dehydrogenase (SDH), isocitrate dehydrogenase 
(ICDH), superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione 
transferase (GTr), as well as ferritin levels.  Aconitase activity, based on the formation of 
NADPH from NADP+, was measured using the Bioxytech Aconitase-340 Assay (Oxis 
International Inc., Foster City, CA).  Citrate is converted to isocitrate (catalyzed by 
aconitase), which then undergoes oxidative decarboxylation (catalyzed by isocitrate 
dehydrogenase) and becomes α-ketoglutarate.  Concomitantly during this last reaction, 
NADP+ is reduced to NADPH.  NADPH formation is measured spectrophotometrically at 
340nm absorbance, and is proportional to aconitase activity. SDH was measured according to 
the methods described by Trounce et al. (1996).  ICDH activity was assessed by measuring 
reduced NADPH following the ICDH catalyzed oxidative decarboxylation of L-isocitrate to 
2-oxoglutarate, similar to the method for measuring aconitase activity. SOD activity was 
measured using a kit from RANSOD (Randox Laboratories, Oceanside, CA).  SOD catalyzes 
the reaction of superoxide radicals to oxygen and hydrogen peroxide.  In this assay, xanthine 
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and xanthine oxidase are used to form superoxide radicals, which react with 2-(4-
iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium (INT) to form a red dye.  SOD activity is 
measured by the degree to which this reaction is inhibited.  Glutathione peroxidase activity 
was measured indirectly by a coupled reaction with glutathione reductase, as the oxidation of 
NADPH by glutathione reductase during the oxidation of glutathione (GSH) to GSSG (Jaskot 
et al., 1983).  Glutathione transferase (GTR) activity was measured as the amount of amount 
of GSH conjugate of the GTR substrate 1-chloro-2, 4-dinitrobenzene, described further by 
Jaskot et al. (1983).  Ferritin levels were measured using the K-Assay Ferritin from the 
Kamiya Biomedical Company (Seattle, WA).  This is an antibody based assay using latex 
beads coated in ferritin antibody.  When these antibodies recognize ferritin, the particles 
agglomerate, and this is detected as an absorbance change, which is proportional to the 
amount of ferritin in the sample.  A standard curve is used to determine the quantity of 
ferritin present.   
 
Statistical analysis.  The data set from each metal was analyzed individually with two way 
analysis of variance (ANOVA), with exposure and time as factors, using SigmaStat software, 
version 3.5 (Systat Software, Inc., Point Richmond, CA).  Pairwise comparisons between 
groups were made using the Holm-Sidak method.  Statistical significance was stated when a 
minimum p-value of 0.05 or less was reached. 
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2.3  Results 
2.3.1  BALF markers of pulmonary inflammation and injury 
    To assess the kinetics and relative pulmonary toxicities of each of the metals, BALF 
markers of inflammation (total cells, neutrophils, macrophages) and injury (protein and 
albumin levels, enzyme activity levels) were measured.  A single IT instillation of 1 µmol/kg 
of metal in soluble sulfate form caused significant increases in total cells, macrophages, and 
neutrophils in the lungs, compared to rats IT instilled with saline as a control (Figure 2.1 A, 
B, C).  Zinc caused increases in total cells, macrophages, and neutrophils starting at 24h post 
IT, and these endpoints remained elevated over controls at 48 and 96 h.  In accord with 
previous studies, nickel caused more delayed increases in lung inflammation.  Total BALF 
cells and BALF macrophage levels were highest 96 h post IT of nickel, whereas BALF 
neutrophils peaked at 48 h post nickel IT.  Copper induced lung inflammation was highest at 
4 and 24 h but decreased following 24 h.  Vanadium and iron caused minimal lung 
inflammation relative to zinc, nickel and copper; however vanadium and iron induced small 
increases in BALF neutrophils readily apparent at 24 h (Figure 2.1 C).   
    These trends were evident in the BALF markers of lung injury as well.  Temporal trends in 
lung inflammatory markers were mirrored in BALF lung injury markers.  BALF levels of 
protein and albumin, as well as lactate dehydrogenase activity, were highest 24-48 h post IT 
of zinc, 48-96 h post IT of nickel, and earliest, 4h post IT, of copper (Figure 2.2 A, B, C).  
Effects of IT of vanadium or iron on these markers were minimal, with only significant 
increases in protein and LDH activity 24 h post IT of iron (Figure 2.2 A, C).  γ-glutamyl 
transferase (GGT) activity in the BALF fluid is indicative of an oxidant response (Takahashi 
et al., 1997).  IT of nickel caused the largest increase in BALF GGT activity, with a peak 48h 
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post IT (Figure 2.2 D).  Similar to other pulmonary injury/inflammation markers, IT of 
copper caused an earlier increase at 4 h post IT, whereas IT of zinc caused a later increase in 
GGT activity (Figure 2.2 D).  These increases were much smaller than what is observed with 
nickel. N-acetyl-glucosaminidase (NAG) is a lysozymal enzyme secreted by activated 
macrophages (McMillan et al., 1980).  BALF NAG activity increased the most 4h post IT of 
copper (Figure 2.2 E), concordant with the increase in BALF macrophages following copper 
IT (Figure 2.1 B).  IT of nickel caused a later increase in BALF NAG activity (Figure 2.2 D), 
also exemplified in the number of BALF macrophages (Figure 2.1 B).  Furthermore, IT of 
zinc caused increased NAG activity in the BALF 24 and 48h post exposure, similar to the 
temporality in the increases in macrophages in the BALF following IT of zinc (Figure 2.1 B). 
 
2.3.2  Systemic effects of pulmonary exposure to metals 
    Previously, changes in systemic endpoints have been induced by pulmonary exposure to 
metal (Gilmour et al., 2006a), possibly explaining the increased risk of cardiovascular 
morbidity and mortality with increased PM exposure.  Therefore, we chose to measure 
systemic markers such as serum levels of total cholesterol, high density lipoprotein (HDL), 
low density lipoprotein (LDL), glucose, and triglycerides, as well as in the plasma, 
fibrinogen and angiotensin converting enzyme (ACE).  Out of the serum and plasma 
markers, metal IT exposure-induced changes were observed in serum total cholesterol only 
(Figure 2.3 A).  IT of 1 µmol/kg of zinc induced an increase in total cholesterol at 24 and 48h 
post exposure.  Cholesterol levels returned to baseline by 96h post IT of zinc.  IT of 1 
µmol/kg nickel induced an increase in serum cholesterol levels 96h post exposure, matching 
the temporality of other markers of nickel exposure.  IT of iron also caused a delayed 
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increase in serum total cholesterol levels, at 96 h post exposure only.  We have also 
previously observed zinc IT-induced changes in CBC measures hematocrit and hemoglobin 
(Gilmour et al., 2006a).  In the current study, we observed a zinc IT-induced increase in red 
blood cells at 24, 48 and 96 h post exposure (Figure 2.3 B).  Similar patterns were noted in 
hemoglobin and hematocrit (Figure 2.4 A, B).  Nickel was the only other metal which 
induced a change in these measures, and an increase at 96 h post IT was observed in red 
blood cells (Figure 2.3 B), hematocrit (Figure 2.4 A) and hemoglobin (Figure 2.4 B).  There 
were no significant metal exposure-induced changes in white blood cells (WBC) at any 
individual time point; however, when combined, there was a copper-induced increase in 
circulating total WBC (Figure 2.3 C).  This was also the case with the number of 
lymphocytes (as a subset of the total WBC) (Figure 2.3 D).    
 
2.3.3  Real time PCR 
    Real time reverse transcriptase PCR (RTPCR) was used to assess the effect of pulmonary 
metal exposure on transcript levels of several genes in lung, heart and liver at each time point 
post exposure.  We have previously noted changes in transcript levels of zinc transporter-2 
(ZnT-2) and metallothionein 1 (MT-1) in these organs following IT of 2 µmol/kg zinc 
(Gilmour et al., 2006b).  In the current study, we chose to measure MT-1 and zinc transporter 
1 (ZnT-1), as it is expressed more ubiquitously than ZnT-2 (Liuzzi et al., 2001).  Lung 
mRNA levels of MT-1 were increased following pulmonary exposure to all metals tested; 
however degree and timing of increase varied in a metal-specific manner (Figure 2.5 A).  
Zinc IT induced the most immediate increase in lung MT-1, by 4 h post exposure; however 
levels returned to near baseline levels by 24 h post exposure.  IT of both iron and copper 
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induced immediate increases in lung MT-1, which remained elevated until 24h post IT.  IT of 
nickel induced the greatest increase in lung MT-1 expression, but at a later time point, with 
highest levels at 24 and 48 h post IT.  To an extent, cardiac MT-1 levels also mirrored the 
metal specific temporal trend (Figure 2.5 C).  Following IT of zinc, levels of MT-1 transcript 
in the heart increased at 4 and 24 h post exposure, whereas MT-1 transcript levels rose 24 
and 48 h following IT of nickel (Figure 2.5 C).  It should be noted here that levels did not 
reach significance; however these results are consistent with small changes in heart MT 
levels we saw following IT of double the amount of zinc (Gilmour et al., 2006b).  Liver MT-
1 levels increased 24 h post IT of every metal except nickel.  MT-1 was further induced 96 h 
following zinc exposure.  Hepatic MT-1 was increased 24 and 48 h following IT of nickel 
(Figure 2.5 E).   
    ZnT-1 is a member of the solute linked carrier 30 family, which function in zinc efflux 
from the cell (Liuzzi and Cousins, 2004).  We hypothesized that if zinc does directly reach 
extrapulmonary organs, ZnT-1 would be upregulated to compensate.  IT of zinc induced a 
trend towards increase in lung ZnT-1 levels.  There was significantly more ZnT-1 transcript 
in the lungs of rats exposed to zinc at 24 h than 4 h; however this was attenuated by 48 and 
96 h post exposure (Figure 2.5 B).  There were no other significant metal-induced changes in 
lung ZnT-1 levels, suggesting a small but significant zinc specific effect on ZnT-1.  Further 
supporting this, cardiac ZnT-1 levels were changed significantly following zinc exposure 
only (Figure 2.5 D).  Cardiac ZnT-1 transcript levels rose at 4 and 24 h following zinc IT, 
with levels significantly higher than saline control at 24 h.  Similar to the lung, cardiac ZnT-1 
levels of zinc exposed rats had fallen back to control levels by 48 and 96 h post IT.  There 
were no other significant changes following exposure to any other metal (Figure 2.5 D).  
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Hepatic ZnT-1 transcript levels were not changed significantly following exposure to any 
metal (Figure 2.5 F).   
 
2.3.4  Cardiac mitochondrial and cytosolic changes 
    We have previously shown increases in mitochondrial ferritin in the heart following 
subchronic inhalation of zinc sulfate (Wallenborn et al., 2008).  This increase was measured 
48 h after the end of the last exposure.  In the current study, we report a trend towards 
increase (however statistically insignificant) in cytosolic and mitochondrial ferritin 48 h 
following a single IT instillation of zinc sulfate, and further, mitochondrial ferritin levels 
remained elevated 96 h post exposure (Figure 2.6).  However, mitochondrial ferritin was 
most significantly elevated 96 h following IT of nickel sulfate.  Levels of cytosolic ferritin 
followed these patterns as well; with levels significantly increased 48 and 96 h post IT of 
zinc, and to the highest extent 96h following IT of nickel (Figure 2.6).    
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Figure 2.1 
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Figure 2.1.  Pulmonary inflammatory response to intratracheal instillation of saline or 1 
µmol/kg body weight of zinc, nickel, vanadium, iron or copper, as determined by analysis of 
bronchoalveolar lavage fluid (BALF) total cells, macrophages and neutrophils in WKY rats 
4, 24, 48 or 96 h after the single exposure.  Each bar represents the mean ± SEM for 6 
animals.  * indicate significantly different from saline control at that time point (p ≤ 0.05).   
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Figure 2.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2.  Pulmonary injury response to intratracheal instillation of saline or 1 µmol/kg 
body weight of zinc, nickel, vanadium, iron or copper, as determined by analysis of 
bronchoalveolar lavage fluid (BALF) levels of protein, albumin, and activities of n-acetyl 
glucosaminidase (NAG), lactate dehydrogenase (LDH), and γ-glutamyl transferase (GGT) in 
WKY rats 4, 24, 48 or 96 h after the single exposure.  Each bar represents the mean ± SEM 
for 6 animals.  * indicate significantly different from saline control at that time point (p ≤ 
0.05).   
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Figure 2.3 
 
 
 
 
 
 
 
 
 
Figure 2.3.  Systemic response to intratracheal instillation of saline or 1 µmol/kg body weight 
of zinc, nickel, vanadium, iron or copper, as determined by analysis of serum levels of total 
cholesterol or complete blood counts of red blood cells, white blood cells, and lymphocytes 
in WKY rats 4, 24, 48 or 96 h after the single exposure.  Each bar represents the mean ± 
SEM for 6 animals.  * indicate significantly different from saline control at that time point (p 
≤ 0.05).  For white blood cells and lymphocytes, when time points are combined within an 
exposure group, saline is significantly different than copper (p ≤ 0.05).   
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Figure 2.4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4.  Systemic response to intratracheal instillation of saline or 1 µmol/kg body weight 
of zinc, nickel, vanadium, iron or copper, as determined by analysis of complete blood count 
levels of hematocrit or hemoglobin in WKY rats 4, 24, 48 or 96 h after the single exposure.  
Each bar represents the mean ± SEM for 6 animals.  * indicate significantly different from 
saline control at that time point (p ≤ 0.05).   
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Figure 2.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.  Expression of metallothionein-1 (MT-1) and zinc transporter-1 (ZnT-1) in lung, 
heart and liver of WKY rats following a single intratracheal instillation of saline or 1 
µmol/kg body weight of zinc, nickel, vanadium, iron or copper.  MT-1 and ZnT-1 transcript 
levels were analyzed using reverse transcriptase real time PCR at 4, 24, 48 or 96 h after the 
single exposure.  Each bar represents the mean ± SEM for 4 animals.  * indicate significantly 
different from saline control at that time point (p ≤ 0.05).   
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Figure 2.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.  Cardiac levels of cytosolic ferritin and mitochondrial ferritin in WKY rats 
following a single intratracheal instillation of saline or 1 µmol/kg body weight of zinc, 
nickel, vanadium, iron or copper.  Levels were measured 4, 24, 48 or 96 h after the single 
exposure.  Each bar represents the mean ± SEM for 6 animals.  * indicate significantly 
different from air control (p ≤ 0.05).   
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2.4  Discussion 
    In investigating mechanisms of PM toxicity, metals are frequently suggested to be 
mediating effects seen both in epidemiological studies, as well as human and animal 
toxicology studies.  Effects of exposure to PM-associated metals has been previously 
reported and discussed by many investigators; however many papers are focused on the 
effects of only one or two specific metals in a study (Adamson et al., 2000; Campen et al., 
2001; Kennedy et al., 1998; Gottipolu et al., 2008).  With the current study we show for the 
first time temporal effects of in vivo pulmonary exposure to a panel of metals in a single 
experiment.  We report here the relative pulmonary and systemic toxicities of pulmonary 
exposure to equal amounts of zinc, nickel, vanadium, copper and iron, all commonly 
associated with PM.  Although much of the data presented here has been previously reported, 
our inclusion of many different metals and times makes this a valuable data set in evaluating 
toxic mechanisms of PM from various sources.  Our goal for this study was to create a 
comprehensive report of the relative toxicity of several different PM-associated metals, all of 
which have been suggested to be involved in PM toxicity.   
    Many studies have been carried out investigating the toxicity of different ROFA samples 
(as a model metal-rich particle) and their individual metal constituents (Pritchard et al., 1995; 
Costa and Dreher, 1997; Kodavanti et al., 1998).  Individual ROFA samples may vary in 
their total and specific metal content, depending on source, composition of the oil burned, 
and sampling method.  ROFA samples used in the cited studies are especially rich in 
vanadium and nickel, so it seems logical that these individual metals may be contributing to 
ROFA toxicity.  Furthermore, airborne vanadium and nickel have been singled out as 
potential toxicity mediators following exposure of ApoE-/- mice to concentrated ambient 
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particles (CAPS) (Lippman et al., 2006).  In the present study, we did not observe as marked 
of an increase in pulmonary injury or inflammation following vanadium instillation 
compared to other metals, which at first glance may be surprising.  However, a closer look at 
differences in exposure concentration and time course analyzed in different studies explains 
these different results, further highlighting the need for a comprehensive panel study.  
Campen et al. (2002) instilled rats with 263 µg of NiSO4·6H20, 245 µg of VSO4, each per rat.  
Per kilogram body weight, this is about 3 µmol Ni/kg or 5 µmol V/kg, compared to the 
present study concentrations of 1 µmol metal/kg.  Therefore, we exposed rats to 5 and 3 fold 
less metal than Campen et al. (2002).  Campen et al also measured BAL parameters 96h post 
exposure.  When all of these variables are taken into account, results from these two studies 
are comparable.  Exposure concentration should be carefully scrutinized in any study, as 
many investigations implicating vanadium as a potent lung toxicant are employing relatively 
larger amounts of vanadium than other metals.  Our current results refute this, and show that 
relative to nickel and zinc, vanadium is actually not as toxic to the lung.  These results are 
further supported by Prieditis and Adamson (2002) who showed this also by instilling Swiss 
mice with equal amounts of metal by mass, using the amount of zinc in the well studied 
EHC-93 particle as a guide, and found that vanadium did not induce any significant increases 
in lung injury or inflammatory measures.  However, exposure to a single metal rarely occurs, 
and as vanadium has the potential to redox cycle, it may interact with other metals present in 
PM to enhance PM toxicity (Campen et al., 2001).  The presence of even small amounts of 
vanadium in PM should not be discounted.     
    Our inclusion of iron in ferric sulfate form was based on its relative prevalence in ambient 
air in most areas.  As with vanadium, we observed no marked increase in lung toxicity 
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following IT of 1 µmol/kg body weight.  However, this was not as initially surprising, the 
respiratory system of mammals is much better equipped to deal with iron exposure, through 
iron specific receptors and chaperone proteins such as transferrin and ferritin.  Because 
humans may be exposed to as much as 10µg of iron daily, ways of isolating exogenous iron 
to make it chemically less active may have evolved (Ghio et al., 2006), whereas this may not 
be the case with other metals such as zinc, nickel or vanadium.   
    We have previously observed systemic effects following pulmonary zinc exposure 
(Gilmour et al., 2006a; Gottipolu et al., 2008; Kodavanti et al., 2008; Wallenborn et al., 
2008) and this seems to be from the direct action of zinc (Wallenborn et al., 2009).  
Hypercholesterolemia in the serum has been shown to be induced by dietary zinc intake, and 
this likely is due to an increase in zinc:copper ratio, leading to a state of copper deficiency 
and impaired oxidative defense (Klevay, 1973).  Our current observation of this occurrence 
following pulmonary exposure to zinc may be reflective of this phenomenon.  However, we 
also observed a more delayed increase in serum cholesterol following IT of nickel, 
suggesting that it may be possible that this response is not due to the direct action of the 
metal outside of the lungs, but to the systemic inflammatory response from instillation, as 
nickel effects in the lung are more delayed than zinc.  Acute phase response in rodents 
induced by endotoxin exposure has been shown to cause hypercholesterolemia (Hardardottir 
et al., 1995); however this is not true in humans (Khovidhunkit et al., 2004).  On the other 
hand, IT of iron also induced a delayed increase in cholesterol without significant lung 
inflammation, which may be indicative that this is in fact a direct metal effect, and nickel and 
iron may be translocating from the lungs more slowly.  We also saw increases in circulating 
red blood cells, hematocrit and hemoglobin levels in rats exposed to zinc or nickel.  The 
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temporality of these changes matches the temporality of the effect of zinc and nickel on lung 
inflammation and injury.  As lung edema is the result of increased plasma being shunted to 
the lungs, it may be that an increase in these blood measures is a result of lowered systemic 
plasma volume.  The trend towards increase in circulating WBC and lymphocytes most likely 
reflects the early lung inflammatory response, and therefore systemic inflammatory response, 
of copper.  Although many mechanistic possibilities exist, our results show clear differential 
systemic responses of instillation of metals commonly associated with PM.   
    A systemic response to different PM associated metals is further reflected in the amount of 
MT-1 and ZnT-1 transcript levels in the lung, and extrapulmonary tissue as well.  We report 
here a 4-5 fold increase in MT-1 expression in the lung following IT instillation of 1 µmol/kg 
of zinc, nickel or copper, but not vanadium or iron.  Lung inflammation was also increased 
the most following exposure to zinc, nickel, or copper.  IT instillation of 2 µmol/kg zinc 
induced a 24 fold increase in lung MT-1 transcript levels (Gilmour et al., 2006b).  We 
believe that the reason for this discrepancy is that greater levels of lung inflammation 
following exposure to a greater amount of zinc augment lung MT-1 induction.  
Metallothionein acts as a free radical scavenger in the lung, and has been shown to be 
induced following ozone exposure (Johnston et al., 1999).  Furthermore, MT-/- mice are 
more susceptible to ozone-induced lung inflammation (Inoue et al., 2008), suggesting that its 
induction in response to pulmonary inflammation is not fully metal-specific.  In the heart, 
levels of MT-1 were not significantly changed following IT of any metal.  Although MT-1 is 
associated with resistance to oxidative stress, cardiac MT does not seem to be induced 
following a variety of cardiotoxic insults, perhaps due to the lower relative levels of MT in 
the heart compared to other organs such as the liver (Nath et al., 2000).  Cardiac ZnT-1 
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transcript levels were slightly, but significantly higher 24h after exposure to zinc.  In the 
heart, L-type calcium channels are involved in action potential stability and duration (Ohana 
et al., 2006), and interestingly, ZnT-1 has been shown to interact with L-type calcium 
channels (Beharier et al., 2007).  These results, taken with our observation of increased 
cardiac ZnT-1 following exposure to zinc but not other PM-associated metals, supports the 
association between exposure to zinc rich PM and adverse cardiac effects.  In the liver, 
similar to the lung, we observed a much less pronounced induction of MT-1 than we have 
previously observed following IT of 2 µmol/kg zinc.  Hepatic metallothionein induction has 
been shown to be induced following inhalation of endotoxin (Hur et al., 1999), suggesting 
that non-metal specific pulmonary insults cause this as well.  A larger insult to the lung 
following IT of 2 µmol/kg, compared to the current level of 1 µmol/kg, may be the reason for 
the enhancement of hepatic MT-1 expression increase, in addition to any metal specific 
response.  Liver ZnT-2 transcript levels were only modestly increased following IT of double 
the amount of zinc (Gilmour et al., 2006), so the fact that we did not observe any significant 
changes in ZnT-1 transcript levels here is not surprising.  Furthermore, dietary zinc does not 
induce an increase in ZnT-1 (Liuzzi et al., 2001), so this may not be a major mechanism of 
zinc homeostasis in the liver.  Whether the systemic effects we have observed are from a 
direct effect of metal on extrapulmonary systems or not remains to be proven.   
    Iron-sulfur cluster containing enzymes, such as aconitase and succinate dehydrogenase, are 
known to be inhibited by zinc exposure (Lemire et al., 2007).  We have observed pulmonary 
zinc exposure-induced inhibition of both of these in the heart (Wallenborn et al., 2008; 
Kodavanti et al., 2008), suggesting a direct zinc effect.  One proposed mechanism of this 
inhibition is the displacement of iron from the catalytic site, and accordingly, following 
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subchronic inhalation of zinc we observed an increase in the iron binding protein ferritin.  In 
the current experiment we saw no significant exposure related changes in aconitase activity, 
succinate dehydrogenase activity, or ferritin levels; however it is possible that longer 
exposure times are needed for this to occur.  Exogenous zinc accumulates in the heart 
following pulmonary exposure (Wallenborn et al., 2009), so longer or repeated exposures 
would likely lead to enhancement of this, and eventual enzyme inhibition.  Likewise, nickel 
has been proposed to inhibit iron-containing enzymes, but through displacement of iron from 
a catalytic domain separate from an iron-sulfur cluster (Chen and Costa, 2006).  Nickel 
induced aconitase inhibition has been documented in vitro, but only at nickel concentrations 
much above what would be expected to be found in the plasma following IT of 1 µmol/kg 
(Chen and Costa, 2006).  We did see nickel induced increases in cardiac ferritin levels, both 
in the mitochondria and the cytosol.  Exposure to A549 cells in vitro to nickel causes 
decreased ferritin levels (Kang et al., 2006).  The discrepancy between our observations and 
these is unclear; however differences between in vitro and in vivo situations may be playing 
a role, as Kang et al. found differences in ferritin induction depending on the media used.  
Another possibility is that this increase in ferritin is somehow related to the pulmonary 
inflammatory response seen, as the delayed increase in cardiac ferritin following nickel IT 
mirrors the delayed induction of pulmonary inflammation from nickel IT.   
    We have previously shown that the soluble fraction of PM associated metals is able to 
reach the plasma, heart and liver following IT (Wallenborn et al., 2007a; Wallenborn et al., 
2009); however we also observe in our current study that in general, metals which seem to 
induce the greatest pulmonary effects are also the ones which induce systemic effects, i.e., 
nickel and zinc.  Overall, nickel caused the most effects (both pulmonary and 
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extrapulmonary), followed by zinc.  Nickel has been implicated as a mediator of 
cardiovascular toxicity of PM, especially in areas in which the air is particularly rich in 
nickel (Lippmann et al., 2006; Peltier et al., 2008).  However, while nickel seems to be more 
potent on an equimolar basis, zinc is more common in most ambient settings (US EPA, 2004) 
and so may present more of a public health concern regarding cardiovascular effects of PM 
exposure.  Source apportionment studies that attempt to correlate specific metals linked to 
health effects are conflicting.  With this study we have demonstrated differential potencies of 
various PM-associated metals, illustrating the importance of careful analysis of animal 
toxicology studies supporting epidemiological literature about PM toxicity.   
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3.  SYSTEMIC TRANSLOCATION OF 70ZINC:  KINETICS 
FOLLOWING INTRATRACHEAL INSTILLATION IN RATS 
 
3.1 Introduction 
    Adverse pulmonary, cardiovascular and other systemic health effects arising from 
exposure to particulate matter (PM) are widely reported in the epidemiological literature 
(Pope et al., 2004).  Increased exposure to air pollution has been linked to hypertension 
(Brook, 2005), stroke (Wellenius et al., 2005), accelerated development of atherosclerosis 
(Sun et al., 2005), and myocardial infarction (Zanobetti and Schwartz, 2007), among other 
ailments.  Direct translocation of PM associated components, such as metals, from the lung 
into systemic circulation is one probable mechanism being investigated.  The metal content 
of PM has been suggested as a mediator of cardiovascular injury by several investigators 
(Costa and Dreher, 1997; Kodavanti et al., 1998; Adamson et al., 2000).  The water soluble 
metals present in PM have been shown to mediate the generation of free radicals 
(Valavanidis et al., 2005) and so it is possible that metals increase the amount of oxidative 
stress and inflammation in the lung, indirectly causing cardiovascular effects.  However, 
translocation of metals from the lungs into the extrapulmonary circulation has been reported.  
Intratracheally instilled vanadium was detected in several extrapulmonary organs, including 
kidney, liver and spleen (Sharma et al., 1987).  Cigarette smoke contains a relatively high 
amount of cadmium, and smokers have 4-5 times more cadmium in their blood and 2-3 times 
more cadmium in their kidneys than nonsmokers (Satarug and Moore, 2004).  Following 
inhalation of metal containing fly ash, increases in lung, liver and kidney levels of various 
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metals were reported (Mani et al., 2007).  We have demonstrated the direct translocation of 
the water soluble fraction of PM associated metals from lung into systemic circulation, 
accumulating in extrapulmonary organs such as the heart and liver, following a single IT 
instillation (Wallenborn et al., 2007a).  These reports suggest that PM-associated metals 
could have a direct role in extrapulmonary injury causation.  Results presented in Chapter 2 
highlight the importance of knowing not just the total metal content, but perhaps more 
importantly the amount of specific metals associated with PM, when beginning to assess the 
potential health risks of PM exposure.   
    As discussed in more detail the previous chapter, the amount and variety of water soluble 
metals associated with PM varies geographically and by source, and zinc is among the most 
common metals present in ambient and indoor air.  Zinc is used for the galvanization of tires 
and in steel manufacturing, and is one of the most abundant metals found in ambient air 
(Ostro et al., 2007), especially around roadways and in industrial areas.  The Donora Smog of 
1948 occurred because of a temperature inversion over the town of Donora, Pennsylvania, a 
small town in which a zinc product plant was present, suggesting that PM during this time 
was rich in zinc (Townsend, 1950).  A high level of water soluble zinc was also associated 
with the London smog of 1952 (Hunt et al., 2003).  Zinc is also a component of indoor air 
pollution (Brauner et al., 2008).  Epidemiological studies have linked the zinc content in 
ambient air to cardiovascular effects (Ostro et al., 2007).  Although it is an essential element, 
inhalation of zinc has been suggested to cause both respiratory and cardiovascular toxicity 
(Adamson et al., 2000; Gilmour et al., 2006b; Kodavanti et al., 2008).  In vitro, zinc exposure 
induces changes in cell signaling pathways, including inhibition of phosphatases in lung 
epithelial cells (Samet et al., 1999), and in cardiomyocytes, changes in ion channel 
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expression (Graff et al., 2004).  In vivo pulmonary exposure to zinc causes increased lung 
inflammation (Adamson et al., 2000), increases in plasma IL-6 (Fine et al., 1997), increased 
blood coagulability (Gilmour et al., 2006a), disruption of copper homeostasis in several 
extrapulmonary tissue types (Gilmour et al., 2006b), and changes in cardiac expression of 
genes involved in ion channels, mitochondrial function, and cell signaling (Gilmour et al., 
2006b; Kodavanti et al., 2008).  Patterns of cardiac gene expression changes following 
exposure to zinc versus exposure to a metal free particle are distinct, suggesting that zinc 
plays a direct role in cardiovascular injury causation, outside of pulmonary inflammation 
(Kodavanti et al., 2008).  Estimations of the cellular free zinc pool are in the picomolar range 
(Maret, 2001).  Zinc is tightly regulated by a variety of metal binding proteins, including 
metallothionein and a family of zinc specific transporters.  A slight increase in free zinc can 
produce a variety of toxic responses.   
    Zinc is an essential element needed for the proper functioning of over one thousand 
different proteins in a cell.  The total zinc content of cells varies between tissue types but is 
usually in the micromolar range.  This is in contrast to the amount of free zinc, which is 
estimated to be in the picomolar range (Maret and Krezel, 2007).  Increases in nonessential 
metals, such as vanadium and nickel, in extrapulmonary organs following pulmonary 
exposure has been reported (Wallenborn et al., 2007a); however because the body may have 
different ways of dealing with different metals in excess, these increases cannot be used as a 
surrogate to assume that zinc translocation also occurs.  We have reported PM-induced 
increases in zinc levels in several organs; however, we are unable to discern whether this 
increase is due to direct translocation of PM associated zinc to these organs, or changes in 
levels of endogenous zinc.  There are 5 major stable isotopes of zinc (64Zn, 66Zn, 67Zn, 68Zn, 
 50 
70Zn), all with varying natural abundances.  Since 70Zn has a relatively low natural abundance 
(0.6%), it has been used as a stable isotopic tracer to study kinetics of zinc (Janghorbani et 
al., 1981; Serfass et al., 1989; Krebs and Hambidge, 2001).  In this experiment, we take 
advantage of this low natural abundance and expose rats to a solution of zinc sulfate enriched 
with 70Zn to describe the direct translocation of pulmonary delivered zinc outside of the 
lungs.   
    The daily recommended intake of zinc is 10-15 mg for a 70 kg human (Samman, 2007).  
Inhalation exposure to 15 mg of zinc is very unlikely; however when taken orally, 15 mg is 
nontoxic.  Route of exposure to zinc may therefore be critical in the degree of zinc absorption 
and kinetics of systemic translocation.  More specifically, the amount of zinc that is absorbed 
and subsequently reaches each tissue type may differ with route of exposure, and this may be 
what is mediating effects of zinc.  To investigate this hypothesis, in addition to IT instillation, 
we exposed a separate group of animals to an equal amount of 70Zn via oral gavage.  Our 
results demonstrate that water soluble zinc is readily translocated from the lungs to the 
circulation, reaching the heart and other organs, causing disruption of essential metal 
homeostasis.  This supports the hypothesis that if soluble zinc concentrations in PM are high, 
the zinc component of PM could induce direct cardiovascular effects.   
 
3.2 Materials and Methods 
Animals.  Healthy male 13 week old Wistar Kyoto (WKY) rats were purchased from Charles 
River Laboratories Inc., Raleigh, NC.  Animals were double housed in polycarbonate cages 
with beta chips bedding and acclimatized for 1 week in an AAALAC-approved animal 
facility (21 ± 1ºC, 50% ± 5% relative humidity, 12/12 hour light/dark cycle) prior to and 
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during the experimental period.  All animals received standard Purina rat chow (Brentwood, 
MO) and water ad libitum.  The protocol for animal use in this study was approved by the 
Institutional Animal Care and Use Committee (NHEERL, USEPA).   
Zinc sulfate.  ZnSO4 with an isotopic enrichment for 70Zn was purchased from Cambridge 
Isotopes Inc (Andover, MA).  The daily recommended intake of dietary zinc is 10-15 mg for 
a 70 kg human (Samman, 2007).  Scaled down by body weight, this is equivalent to a daily 
intake of ~40-60 µg for a 300 g rat, or about 0.7 µmol 70Zn/rat.  This is equivalent to ~2.4 
µmol/kg body weight.  The study described in Chapter 2 utilized a dose less than half of this, 
1 µmol/kg body weight.  Although this is a much higher dose of zinc than Chapter 2 or our 
previous studies employing intratracheal (IT) instillation as a route of exposure (Gilmour et 
al., 2006b; Kodavanti et al., 2008), our goal was to compare kinetics of 70Zn following 
pulmonary exposure with kinetics following oral gavage.  Because this dietary dose is 
nontoxic, and we wanted to ensure that we would be able to detect increases in tissue levels 
of 70Zn, we chose 0.7 µmol 70Zn/rat as the dose.   
 
Intratracheal instillations.  Rats were randomly assigned to different groups (n = 6 for zinc 
exposed per time point to be analyzed, n = 2 for saline controls per time point to be analyzed) 
based on body weight (Table 3.1).  Average body weight at time of instillation or gavage was 
292 g.  Enriched ZnSO4 was weighed and suspended in sterile saline at a concentration of 2.4 
µmoles 70Zn / ml (~0.7 µmole/rat).  Solutions were shaken overnight prior to IT instillation 
or oral gavage.  Rats were anesthetized under light halothane and single IT instillations or 
oral gavages were given at a volume of 1 ml/kg (Costa et al., 1986).  Control rats received 1 
ml/kg of the sterile saline.  It should be noted that levels of lung 70Zn for two animals in the 
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group receiving 70Zn via IT instillation were similar to control values, and therefore it was 
assumed that these animals were not exposed via the lung to 70Zn, and were left out of all 
subsequent analyses.  Also, one animal from the 48 h 70Zn IT group died between 24 h and 
48 h, and so was left out of all subsequent analyses.   
 
Necropsy and tissue collection.  We chose a time course similar to previous studies (Gilmour 
et al., 2006b; Wallenborn et al., 2007a).  At 1, 4, 24 or 48 h post exposure, rats were weighed 
and anesthetized with sodium pentobarbital (50-100 mg/kg, ip).  Blood was collected through 
abdominal aortic puncture directly into a vaccutainer containing sodium heparin.  One ml 
whole blood was transferred into a 1.5 ml Eppendorf tube, and stored at -80ºC.  The 
remaining volume in the vaccutainer was centrifuged at 3000 X g at 4ºC for 10 min.  An 
aliquot of this plasma was stored at -80ºC.  Following exsanguination, the heart was quickly 
excised and blotted with gauze, and the right ventricle removed.  A portion of the left 
ventricle (0.1-0.2 g) was quick frozen in liquid nitrogen and then stored at -80ºC until 
analysis.  Similarly, the accessory lobe of the right lung (0.1-0.2 g), a portion of the liver 
(0.2-0.5 g), kidney (0.1-0.3 g), and spleen (0.1-0.2 g) were removed, blotted in gauze, quick 
frozen in liquid nitrogen, and stored at -80ºC until analysis.    
 
Sample preparation.  Prior to elemental analysis we digested all samples with tetramethyl 
ammonium hydroxide/nitric acid using US EPA Method 200.11 (Martin et al., 1991).  
Method 200.11 was originally developed for analysis of fish tissue using inductively coupled 
plasma-atomic emission spectroscopy (ICP-AES), but the digestion method is robust and 
used to solubilize all types of biological fluids and tissues.  We used dogfish liver Standard 
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Reference Material (SRM) DOLT-3 obtained from the National Research Council of Canada 
(NRCC, Ottawa, Ontario) as a method check for the sample digestion and analytical method.   
Elemental/isotope analysis.  All samples were analyzed on a Thermo Finnigan (Waltham, 
MA) Element2 Magnetic Sector Field High Resolution Inductively Coupled Plasma Mass 
Spectrometer (HR-ICPMS) located in a Class100 Clean Room (US EPA, RTP, NC) utilizing 
a quartz cyclonic spray chamber fitted with an Elemental Scientific (Omaha, NE) 100 µl/min 
low-flow nebulizer.  Individual elemental standards were purchased from High-Purity 
Standards (Charleston, SC) and used to create multi-element calibration standards a mixed 
ultrapure HNO3, 0.2% volume/volume, (SEASTAR Chemicals) and ultrapure HCl Optima 
Grade, 0.1% volume/volume, (Fisher Scientific) with >18.2 MΩ deionized water.  Standard 
Reference Materials 1640 and 1643e were obtained from NIST (Gaithersburg, MD) and used 
as calibration performance checks.  The following isotopes were quantified in high resolution 
mode (R>10,000):  63Cu, 64Zn, 66Zn, 67Zn, 68Zn, 70Zn.  Other isotopes were monitored for 
possible isobaric interferences including 72Ge (70Ge/70Zn) and 64Ni; however, no corrections 
were necessary.  An 115In internal standard was utilized for quantitative determinations.   
 
Statistical analysis.  A two way analysis of variance (ANOVA) test was performed, with 
time and exposure as factors, separately for IT groups and gavage groups.  One way ANOVA 
tests were performed to determine statistically significant differences between routes of 
exposure (IT versus gavage) and exposure (zinc versus saline), using Sigma Stat software, 
version 3.5 (Systat Software, Inc., Point Richmond, CA).  Pairwise comparisons were made 
using the Holm-Sidak method.  Statistical significance was stated when a minimum p-value 
of 0.05 or less was reached.   
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3.3 Results 
3.3.1 Quality controls 
    Zinc and copper values determined for duplicate samples of SRM DOLT-3 agreed within 
7% with the certified values (CV), indicating the sample preparation and analytical methods 
were performed correctly. Likewise, elemental content values of all sample types were within 
the ranges of previous studies (Schmit et al., 1991; Gelinas and Schmit, 1994; Gilmour et al., 
2006b; Wallenborn et al., 2007a). 
    NIST 1643e Trace Elements in Water CV and NIST 1640 Trace Elements in Natural 
Water reference values were used to ensure day to day instrument precision.  The NIST 
1643e Trace Elements in Water CV for copper and zinc were < 10% and 10-12.5% (22% for 
70Zn), respectively.  The measured percent difference in the certified value was <1% for 
copper and 3.7-9.4% for all zinc isotopes.  The NIST 1640 Trace Elements in Natural Water 
provides reference values for zinc and copper.  The day to day precision for copper was 
approximately 3.9%, while zinc was 3.3-4.7% (13.3% for 70Zn).  The percent difference in 
the measured values to the reference values was approximately 8% for copper and 6.8-9.2% 
for zinc (14% for 70Zn).  The average precision for isotope measurements of the digested 
tissue samples was 3.4-5.4% for all zinc isotopes and 3.9% for copper. 
 
3.3.2 Dosing solution analysis  
    The solution used to instill or gavage was analyzed to confirm isotopic enrichment, as well 
as relative amounts of the four other isotopes (Figure 3.1, Table 3.2).  The first column lists 
the reported natural abundance of each respective isotope, whereas the second column lists 
the percent total of each isotope measured in the solution used for instillations or gavages.  
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The third column represents the estimated amount, in nanograms, of each isotope of zinc 
instilled or gavaged.  These numbers were calculated based on our dose of 0.7 µmol 70Zn per 
rat, or 50 µg 70Zn per rat.  Table 3.3 represents a summary of the amount of 70Zn measured in 
each organ at each time point and route of exposure.  In the subsequent figures, values are 
expressed as ng metal per g tissue weight, whereas in Table 3.3, measured values were 
multiplied by whole organ weights to attain absolute amount of 70Zn, instead of per g tissue.  
Organ weights were taken at time of necropsy except for kidney and spleen.  These values 
are listed in Table 3.3, with estimated values for kidney and spleen from the National 
Bioresource Project (www.nbrp.jp) and whole blood and plasma volume based on published 
literature (Trippodo et al., 1981).  Values of 70Zn from saline exposed rats have been 
subtracted from each value, so values reported represent the amount of exogenous 70Zn 
reaching each tissue.  Rats were instilled or gavaged with 50 µg of 70Zn.  The last two 
columns in Table 3.3 lists a sum of all 70Zn amounts from all organs measured at that time 
point, and the percent of administered dose that can be accounted for at each time point.  At 1 
h post IT, the total body burden of 70Zn measured was slightly more than instilled, likely due 
to small errors in dosing and measurements.  However, because most of the 70Zn measured at 
this time point is found in the lung, this also indicates that zinc may take more than 1 hr to be 
absorbed to the pulmonary capillaries.  This is supported by our previous studies in which we 
reported delayed effects following pulmonary zinc exposure, compared to effects following 
pulmonary copper exposure (Gottipolu et al., 2008).  At later time points, the zinc that is 
unaccounted for may have translocated to other organs not assayed, or was excreted.  The 
significantly lower level of 70Zn accounted for 1 h post gavage (~3 µg) may be suggestive 
that absorption through the gut is not as high as absorption through the lungs, or that more 
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rapid redistribution through the liver may have occurred following oral exposure than 
pulmonary exposure.  It is also possible that zinc given via gavage may be under the process 
of absorption through the gut, for which 70Zn levels were not measured.   
 
3.3.3 Lung levels of zinc 
    As expected, a significantly higher amount of 70Zn was detected in the lungs of IT instilled 
rats, with levels decreasing over time at a rate in accordance with our previous studies which 
utilized a more similar dose of 2 µmol/kg body weight (Gilmour et al., 2006b) (Figure 3.2A).  
Because the amount of 70Zn in the lungs of rats instilled with zinc is so much larger than the 
amount of 70Zn in the lungs of control animals or animals gavaged with zinc, we have shown 
the same graph in Figure 3.2B, with a smaller ranging y-axis so that small changes in 70Zn 
can be visualized.  70Zn accumulated to levels almost twice the control values in the lungs of 
rats following gavage (Figure 3.2A).   
    Because 70Zn occurs at such a low abundance naturally, most of the 70Zn measured is 
exogenous.  By subtracting 70Zn from the measured amount of total zinc, one can visualize 
patterns of change in endogenous levels of zinc in response to exposure to exogenous zinc.  
This calculation was performed for all tissues measured.  The lungs (Figure 3.2D) and liver 
(Figure 3.4B) were the only tissue types in which zinc exposure significantly affected this 
measure.  Figure 3.2C shows the measured amount of total zinc in the lungs.  By 24 h post 
IT, the level of total zinc in the lungs of rats IT instilled with zinc matched control values.  
Figure 3.2D shows the amount of zinc following subtraction of 70Zn. From Table 3.2, it is 
estimated that ~15 µg of zinc, aside from the 70Zn, is instilled.  Thus, at 1 h post IT, the 
increase in isotopes of zinc other than 70Zn can be accounted for by the instilled amount.  By 
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4 h post IT, endogenous zinc is similar to control levels.  At 24 and 48 h post IT, levels of all 
other isotopes of zinc aside from 70Zn are lower than control values (Figure 3.2D).  This may 
be the result of lung edema from instillation.  Figure 3.2 zinc levels are reported by amount 
of zinc per gram tissue, and because plasma zinc levels are relatively smaller than lung zinc 
levels, the plasma influx is most likely diluting the zinc levels in the lung.   
 
3.3.4 Kinetics of zinc and 70Zn in extrapulmonary organs 
    As expected from previous studies, 70Zn was detected outside of the lung in all tissue types 
measured.  70Zn was higher in all organs following IT than following oral gavage.  In the 
plasma, 70Zn peaked at 1 h post IT or post gavage, with levels more than double following IT 
than following gavage.  Levels of 70Zn in the lungs of IT rats declined significantly from 
each time point to the next, with the exception of 24 h to 48 h, where the decline did not 
reach significance.   Levels of 70Zn were still significantly elevated over saline controls in 
both groups 48 h post exposure (Figure 3.3A).   
    In the heart, levels of 70Zn were elevated in IT rats by 1 h post exposure, and these levels 
continued to rise significantly with no apparent plateau, even at 48 h post exposure (Figure 
3.3B).  Levels of 70Zn in the hearts of gavage rats were not significantly higher than those of 
controls until 4 h post exposure, and furthermore, seemed to reach a plateau by this time 
point.  By 48 h post exposure, the difference over saline controls in rats instilled with 70Zn 
was over 200 ng/g (150 ng/g in saline controls vs. 400 ng/g in IT rats), whereas in rats 
gavaged with 70Zn, this difference was 50 ng/g (150 ng/g in saline controls vs. 200 ng/g in 
gavage rats).  Thus, the increase of 70Zn in IT rats was four times higher than in the gavaged 
rats (Figure 3.3B).  The level of 70Zn over control at 48 h post IT represents about 1% of total 
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zinc in the heart (total zinc data not shown).  Endogenous levels of zinc in the heart (amount 
of 70Zn measured subtracted from amount of total zinc measured) were not significantly 
changed in any animals exposed to 70Zn (Figure 3.4). 
    The pattern of kinetics of 70Zn in the spleen (Figure 3.3C), kidney (Figure 3.3D), and liver 
(Figure 3.5A) was similar.  Levels of 70Zn peak 24 h post IT, whereas following oral gavage, 
levels of 70Zn are highest earlier, at the 4 h post exposure time point (Figure 3.3C, 3.3D, 
Figure 3.5A).  In the liver, exposure via IT instillation, but not oral gavage, induced increases 
in levels of endogenous zinc 24 h and 48 h post exposure (Figure 3.5B).  70Zn does reach the 
liver; however, the increase in total endogenous zinc is much larger than the relative increase 
in 70Zn.   
 
3.3.5 Zinc exposure-induced changes in copper homeostasis 
    IT instillation, but not oral gavage, of 0.7 µmol / rat 70Zn induced changes in endogenous 
copper levels (Figure 3.6).  In the lungs, plasma, spleen and liver, increases in total copper 
were noted (Figure 3.6A, B, C, and E).  Conversely, in the kidney, IT of zinc induced a 
decrease in total copper (Figure 3.6D), possibly reflective of different zinc 
metabolism/homeostatic mechanisms of this organ.  1 h post zinc exposure via both IT and 
gavage induced slight but significant decreases in cardiac copper levels; however levels 
reached control by 4 h post exposure (Figure 3.7).   Copper levels were increased in one rat 
gavaged with zinc 48 h post exposure, which leads to a large increase, along with a large 
variability in this group, owing to the fact that n = 2 for saline controls of gavage or IT.  
Values of zinc isotopes were also abnormal in this animal; however because only two rats 
were used for each saline control group, it was left in the analysis.  
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Time 70Zn, IT, 
0.7µmol/rat 
(n*) 
Saline, IT 
(n*) 
70Zn Gavage, 
0.7µmol/rat 
(n*) 
Saline, Gavage 
(n*) 
1 hour 4 2 6 2 
4 hours 6 2 6 2 
24 hours 6 2 6 2 
48 hours 5 2 6 2 
*The number in each cell represents total number of rats/group. 
Table 3.1.  Experimental design table showing exposure groups, time course, and group 
sizes.   
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Figure 3.1.  Natural and dosing solution abundances of five stable zinc isotopes.  Black bars 
indicate relative abundances of isotopes in nature.  White bars indicate relative abundances 
found in solution used to IT or gavage.  This data is represented in tabular form in Table 3.2.   
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 Natural Abundance 
(%) 
Dosing Solution 
Abundance 
(%) 
Dosed / Rat 
(ng Zn) 
64Zn 48.89 7.17 4678 
66Zn 27.81 7.09 4626 
67Zn 4.11 1.73 1129 
68Zn 18.56 7.38 4815 
70Zn 0.62 76.63 50000 
Totals: 100 100 65249 
 
Table 3.2.  Analysis of solution used for dosing of rats, depicting amounts of each of five 
stable isotopes of zinc present naturally, in the dosing solution, and estimated absolute 
amount in nanograms given per rat.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ng 70Zn / 
whole 
lungs over 
control 
ng 70Zn / 
all 
plasma 
over 
control 
ng 70Zn / 
whole 
heart over 
control 
ng 70Zn / 
all blood 
over 
control 
ng 70Zn / 
whole 
liver over 
control 
ng 70Zn / 
whole 
spleen 
over 
control 
ng 70Zn / 
whole 
kidney 
over 
control 
Sum (ng 
70Zn over 
control) 
% Administered 
dose accounted 
for 
Whole Organ 
Weight 
1 g 11 ga 1 g 18 ga 10 g 0.4 gb 1.8 gb   
IT Zn, 1 h 47293 1027 37 806 2970 39 365 51511 103 
IT Zn, 4 h 28210 1026 120 1534 7158 117 1149 38287 76.6 
IT Zn, 24 h 6394 349 243 1257 13366 170 1372 22802 45.6 
IT Zn, 48 h 4342 227 267 1315 11645 156 1068 18794 37.6 
Gavage Zn, 1 h 46 448 17 475 2165 21 265 2989 6.0 
Gavage Zn, 4 h 119 299 70 565 3818 64 606 5242 10.5 
Gavage Zn, 24 h 105 95 75 395 2210 46 333 3164 6.3 
Gavage Zn, 48 h 115 55 61 392 1322 33 221 2144 4.3 
a
 Total plasma and blood volumes taken from Trippodo et al. (1981).   
b
 Spleen and kidney weights taken from National Bioresource Project (www.nbrp.jp).  
Table 3.3.  Mass balance of 70Zn at four time points following a single exposure via intratracheal instillation or oral gavage.  Values 
represent means of groups (n = 4-6 per group), measured in each tissue type per gram of tissue, and then multiplied by whole organ 
weight taken at necropsy or from published values (in the case of kidney and spleen).  Total sum does not include plasma levels of 
70Zn, as this is already accounted for in whole blood measurements. 
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Figure 3.2 
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Figure 3.2.  Lung levels of 70Zn, total zinc, or endogenous zinc 1, 4, 24 and 48 h following a 
single intratracheal instillation or oral gavage of ZnSO4 (76% of zinc as 70Zn) in rats.  A and 
B indicate levels of 70Zn, with B having a different y-axis scale to show smaller scale 
changes.  C depicts the amount of total zinc in lungs, and D depicts changes in endogenous 
zinc levels in the lungs, as calculated by subtracting the amount of 70Zn from total zinc.  All 
values represent mean ± standard error of the mean (n = 2 for control groups and n = 6 for 
70Zn groups).  (*) indicate significantly different from saline control within the same time 
point.  (#) indicate significant differences between IT and gavage of zinc, within the same 
time point.  A: Within IT zinc groups, all time points are significantly different from each 
other except between 24 and 48 h.  B: Within gavage zinc groups, 4, 24, and 48 h are all 
different from 1 h, but not each other.  C: Within IT zinc groups, all time points are 
significantly different from each other except between 24 and 48 h.  D:  Within IT zinc 
groups, all time points are significantly different from each other except between 24 and 48 
h. 
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Figure 3.3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasma
0
20
40
60
80
100
120
1hr 4hr 24hr 48hr
n
g 
70
Zn
 
/ g
 
tis
su
e
IT Zinc
Gavage Zinc
IT Saline
Gavage Saline
A
* *
*
*
*
*
*
*
# #
#
#
1h                              24h             48h
70Zn, pl
Heart
0
100
200
300
400
500
1hr 4hr 24hr 48hr
n
g 
70
Zn
 
/ g
 
tis
su
e
IT Zinc
Gavage Zinc
IT Saline
Gavage Saline
B
*
*
*
*
*
*
*#
#
#
#
1h               4h               24h             48h
70Zn, heart
Spleen
0
100
200
300
400
500
600
1hr 4hr 24hr 48hr
n
g 
70
Zn
 
/ g
 
tis
su
e
IT Zinc
Gavage Zinc
IT Saline
Gavage Saline
C
*
*
*
*
*
*
*
*
#
#
# #
                              24h             
70Zn, spleen
  66 
 
 
 
 
 
 
 
 
Figure 3.3.  Levels of 70Zn in plasma, heart, spleen and kidney, 1, 4, 24 and 48 h following a 
single intratracheal instillation or oral gavage of ZnSO4 (76% of zinc as 70Zn) in rats.  All 
values represent mean ± standard error of the mean (n = 2 for control groups and n = 6 for 
70Zn groups).  (*) indicate significantly different from saline control within the same time 
point.  (#) indicate significant differences between IT and gavage of zinc, within the same 
time point.  A:  Within IT zinc groups, all time points are significantly different from each 
other except between 1 and 4 h and between 24 and 48 h.  Within gavage zinc groups, all 
time points are significantly different from each other except between 24 and 48 h.  B:  
Within IT zinc groups, all time points are significantly different from each other.  Within 
gavage zinc groups, 4, 24, and 48 h are all different from 1 h, but not each other.  C:  Within 
IT zinc groups, all time points are different from each other except between 24 and 48 h.  
Within gavage zinc groups, all time points are different from each other except between 4 
and 24 h, and between 24 and 48 h.  D:  Within IT zinc groups, all time points are different 
from each other except between 4 and 48 h.  Within gavage zinc groups, 1, 24, and 48 h are 
all different from 4 h, but not each other.   
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Figure 3.4  
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Figure 3.4.  Heart levels of endogenous zinc (total 70Zn subtracted from total measured Zn) 1, 
4, 24 and 48 h following a single intratracheal instillation or oral gavage of ZnSO4 (76% of 
zinc as 70Zn) in rats.  All values represent mean ± standard error of the mean (n = 2 for 
control groups and n = 6 for 70Zn groups). 
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Figure 3.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5.  Levels of 70Zn and endogenous zinc in the liver 1, 4, 24 and 48 h following a 
single intratracheal instillation or oral gavage of ZnSO4 (76% of zinc as 70Zn) in rats.  
Endogenous zinc levels were calculated by subtracting the amount of 70Zn from total zinc.  
All values represent mean ± standard error of the mean (n = 2 for control groups and n = 6 
for 70Zn groups).  (*) indicate significantly different from saline control within the same time 
point.  (#) indicate significant differences between IT and gavage of zinc, within the same 
time point.  A:  Within IT zinc groups, all time points are different from each other.  Within 
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gavage zinc groups, 1, 24, and 48 h are all different from 4 h, but not each other.  B:  Within 
IT zinc groups, all time points are different from each other except between 1 and 4 h, and 
between 24 and 48 h.  Within gavage zinc groups, there are no differences between time 
points.   
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Figure 3.6 
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Figure 3.6. Levels of copper in the lungs, plasma, spleen, kidney and liver 1, 4, 24 and 48 h 
following a single intratracheal instillation or oral gavage of ZnSO4 (76% of zinc as 70Zn) in 
rats.  All values represent mean ± standard error of the mean (n = 2 for control groups and n 
= 6 for 70Zn groups).  (*) indicate significantly different from saline control within the same 
time point.  (#) indicate significant differences between IT and gavage of zinc, within the 
same time point.  A:  Within IT zinc groups, all time points are different from each other 
except between 1 and 4 h and between 24 and 48 h.  There are no significant differences 
between time points within gavage zinc groups.  B:  There are no significant differences in 
time points within IT or gavage of zinc.  C:  There are no significant differences in time 
points within IT or gavage of zinc.  D:  Within IT zinc groups, there are no significant 
differences in time points, except between 1 and 48 h, which are significantly different from 
each other.  Within gavage zinc groups, there are no significant differences in time points.  E:  
Within IT zinc groups, there is no significant difference between 1 and 4 h, between 24 and 
48 h, or between 4 and 24 h, all other time points are significantly different from each other.  
There are no significant differences in time points within gavage zinc groups. 
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Figure 3.7  
 
 
 
 
 
 
 
Figure 3.7.  Levels of copper in the heart 1, 4, 24 and 48 h following a single intratracheal 
instillation or oral gavage of ZnSO4 (76% of zinc as 70Zn) in rats.  All values represent mean 
± standard error of the mean (n = 2 for control groups and n = 6 for 70Zn groups).  (*) 
indicate significantly different from saline control within the same time point.   
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3.4 Discussion 
    We have proven here that pulmonary delivered zinc directly translocates outside of the 
lung, and reaches extrapulmonary organs in higher amounts than following ingestion of the 
same amount of zinc.  As zinc is commonly the most abundant water soluble metal in 
ambient air, several researchers have implicated its involvement in increased respiratory and 
cardiovascular disease risk associated with PM exposure.  Although other mechanisms, such 
as a general systemic inflammatory response (Frampton, 2001) or direct alteration of 
autonomic control of the heart (Pope et al., 1999) may also contribute to cardiotoxicity, with 
this study we have investigated the possibility that soluble PM components (including metals 
such as zinc), may be able to translocate outside of the lung and have a direct effect on the 
heart.  We have demonstrated here that soluble zinc introduced through the lungs not only 
reaches, but accumulates in the heart following pulmonary exposure. 
    The direct effect of zinc in the heart has been indicated previously by many groups.  
Similarities in cardiac responses to IT instillation or inhalation of zinc (Gilmour et al., 2006b; 
Kodavanti et al., 2008; Wallenborn et al., 2008) to in vitro zinc exposure of rat 
cardiomyocytes suggest that following pulmonary exposure, zinc does reach the heart, 
possibly exerting a direct effect.  Changes in expression of ion channels (Graff et al., 2004), 
mitochondrial effects (Ye et al., 2001), as well as an imbalance of phosphatase/kinase 
signaling at the protein level (Samet et al., 1999) are all known zinc effects in many cell 
types, and interestingly, many of these same “zinc specific” effects are seen in the heart 
following pulmonary exposure.  Zinc-induced effects on mitochondria have been 
demonstrated in neurons (Dineley et al., 2005) and hepatocytes (Ye et al., 2001), particularly 
via inhibition of enzymes of the electron transport chain and tricarboxylic acid cycle which 
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contain an iron-sulfur cluster at their active site (Lemire et al., 2008).  This effect on 
mitochondria has also been shown also in vivo in the heart following repeated pulmonary 
zinc exposure (Kodavanti et al., 2008).  We report here that following IT instillation, zinc 
accumulates in the heart with no indication of return to control levels up to 48 h after a single 
exposure; however it cannot be ascertained if 70Zn measured in the heart is replacing 
endogenous zinc pools.  Cardiomyocytes are very rich in mitochondria because of their high 
energy demand (Gustafsson and Gottlieb, 2008), and this demand may cause the myocardium 
to be a target of pulmonary zinc exposure.  Furthermore, in cardiomyocytes ion channel 
expression and functioning are necessary for proper cardiac conductance, and are changed 
with zinc exposure (Graff et al., 2004).  An accumulation in cardiac zinc levels may lead to 
mitochondrial dysfunction and ion channel disruption, possibly explaining adverse cardiac 
effects from inhalation of zinc-rich PM.    
    Using ICP-MS to measure zinc yields total zinc content of tissue, regardless whether it is 
protein bound or not.  In the plasma, zinc binds to many proteins, including α2-
macroglobulin and albumin (Sandstrom, 1997).  Bioavailability, and potentially the toxicity, 
of zinc may change depending on which protein it is bound to and further, which site on a 
specific protein it is bound to, as different sites have varying affinities.  The redox biology of 
zinc is complex.  It acts to protect cysteine and other disulfide groups on proteins from 
oxidation, and is released under oxidative conditions (Maret, 2007), making zinc available to 
modulate a variety of cellular signaling pathways.  Changes as small as in the picomolar 
range induce homeostatic responses in cells (Krezel et al., 2007).   
    The amount of exogenous zinc reaching the heart post IT was equal to 1% of the total zinc 
in the heart.  Ambient levels of zinc in the air have been measured as high as 27 µg/m3 
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(Harrison and Yin, 2000), whereas occupationally, people may be exposed to over 100 µg/m3 
zinc (Schroeder et al., 1987; Matczak and Gromiec, 2002).  It is estimated that in rats, 
following inhalation of 100 µg zinc / m3 for 6 h, 2 µg will be absorbed (Wallenborn et al., 
2008).  The dose used in the current study is roughly 25 times this amount.  If zinc 
accumulation in the heart is proportional to dose, this means breathing 100 µg/m3 for 6 h will 
lead to approximately a 0.04% increase in cardiac zinc levels which is above the range 
reported to induce changes (Krezel et al., 2007).  Accordingly, our studies have shown that 
cardiac effects do occur following inhalation exposure to 100 µg/m3 zinc (Wallenborn et al., 
2008), as described in more detail in the upcoming Chapter 4.  Furthermore, cardiac effects 
seen following pulmonary zinc exposure seem to be zinc specific, suggesting that they may 
be occurring as a direct effect of zinc on heart tissue (Gilmour et al., 2006b; Kodavanti et al., 
2008; Wallenborn et al., 2008).  Our report here that zinc is able to translocate from the lungs 
and directly reach the heart makes this speculation more plausible.  Exposure to 
environmentally relevant levels of zinc will not result in such high cardiac zinc 
concentrations and dietary zinc dominates as the source of endogenous pools; however, 
because pulmonary circulation passes the heart first, cardiac tissue may encounter much 
higher levels following inhalation of zinc rich PM than following ingestion of dietary zinc.  
Thus, although the concentration we have used in this study is high, because zinc is so tightly 
regulated, the amount of exogenous zinc reaching extrapulmonary organs following 
inhalation of environmental levels of zinc would most likely induce direct cardiac changes.   
    Zinc availability for absorption through the gut depends on many factors, including 
solubility, other nutrients eaten concomitantly, or underlying zinc status.  Absorption is 
inversely correlated with underlying zinc status, with estimates of 100% absorption reported 
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during zinc deficiency (Weigand and Kirchgessner, 1978).  In this study we used highly 
soluble zinc sulfate, with no other dietary modifiers.  The lack of other less soluble forms of 
zinc present, as well as the lack of potential inhibitors of zinc absorption in the diet most 
likely led to a relatively high zinc absorption rate through the gut.  Alternately, in the lungs, 
the acute phase response caused by pulmonary exposure to such relatively high amounts of 
zinc may have caused more 70Zn to translocate into the systemic circulation.  The doubled 
plasma level of 70Zn following IT than following gavage may be reflective of absorption 
differences; however, by 48 h post exposure, cardiac 70Zn accumulation following IT was 
four times than the accumulation following gavage, indicating greater cardiac exposure 
following IT than following gavage, regardless of different absorption rates.   
    We report in the current study increases in plasma and heart levels of 70Zn.  In the 
literature, there is concordance in cardiac responses to zinc following pulmonary exposure to 
zinc with in vitro exposure of cardiomyocytes to zinc (Gilmour et al., 2006b; Graff et al., 
2004).  Taken together, these findings indicate that following pulmonary exposure to zinc, 
this metal may be playing a direct role in cardiovascular injury.  However, we also observed 
an increase in endogenous zinc in the liver, a known hallmark of the acute phase response 
(Liuzzi et al., 2005).  A significant increase in hepatic metallothionein leads to redistribution 
of zinc pools, with the liver pulling zinc from other zinc pools in the body (Liuzzi et al., 
2005).  This redistribution of zinc pools leading to increased hepatic zinc levels may be a 
result of general systemic inflammation, as this has been reported following exposure to 
turpentine and LPS (Liuzzi et al., 2005).   
    Cellular mechanisms for trafficking zinc and copper, two essential metals, often overlap.  
Therefore, exposure to one often disturbs the homeostasis of another (Formigari et al., 2007).  
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Many studies investigating the relationship between zinc and copper note that increased 
levels of one lead to decreased levels of another, a product of direct competition for metal 
binding sites between the two (Ferenci, 1998).  This does not seem to be the case following 
IT instillation of zinc.  IT instillation, but not gavage, of zinc induced increases in lung, 
plasma, spleen and liver copper levels, likely as a result of an acute phase response rather 
than zinc replacing copper.  This relationship has been previously noted in vitro where zinc 
exposure increased the copper uptake of fibroblast cells (Santon et al., 2008).  Pulmonary 
zinc exposure may induce MT expression more rapidly than zinc via gavage, and this may 
lead to a more rapid increase in tissue copper levels.  IT of zinc induced a decrease in kidney 
copper levels, a response different from that of other tissue types measured.  From our results 
we are unable to ascertain the mechanism of this discordance; however one possible 
explanation for the decrease in kidney copper is that as part of the acute phase response, the 
liver is pulling not only zinc, but copper from other pools, including the kidney.  A slight but 
significant decrease in cardiac copper levels was observed 1 h post exposure via both IT 
instillation and oral gavage (data not shown).  A heightened zinc to copper ratio has been 
suggested to be the etiology of many disease states (Klevay, 1975), and furthermore, copper 
deficiency has been shown to induce changes in the heart, and in particular the cardiac 
mitochondria (Klaahsen et al., 2007).  However, by 4 h post exposure, copper levels had 
returned to control levels.  This pattern indicates that with respect to PM-induced 
cardiotoxicity, a temporary disturbance in copper homeostasis may not be playing as large of 
a role as the potential exogenous zinc accumulation in the heart.   
    Pulmonary exposure to zinc, as well as to PM that is rich in zinc, has been shown to induce 
adverse cardiac effects (Kodavanti et al., 2008); however zinc is essential and nontoxic when 
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taken orally.  Using a stable isotope of zinc to trace exogenous zinc, we have shown here that 
IT instilled 70Zn is rapidly translocated into systemic circulation, reaching extrapulmonary 
organs.  The kinetics of zinc differs between routes of exposure, suggesting that this may be a 
mediator of differential toxicity of zinc.  Ratios of isotopic zinc indicate that pulmonary 
delivered zinc disturbs endogenous zinc homeostasis in the liver.  Exogenous 70Zn collects in 
the heart more readily following IT than following oral gavage.  Furthermore, IT instillation 
of zinc induced changes in extrapulmonary copper homeostasis.  This is the first study to 
demonstrate that zinc delivered through the lung not only reaches, but accumulates in the 
heart, making it possible to exert direct effects.  Whether this translocation is dose dependent 
cannot be determined from the results presented here; although it is possible that a lower 
dose of zinc would lead to lower levels of lung injury, less changes in the blood/air barrier, 
and less translocation.  This, as well as other issues related to the relationship between dose 
and translocation ability, are further discussed in Chapter 5.  With regards to the results 
presented in Chapter 3, in the context of zinc rich PM, these results are perhaps indicative 
that the soluble zinc content may be partly responsible for cardiovascular effects.   
 
 
 
 
 
 
 
CHAPTER 4.  SUBCHRONIC INHALATION OF ZINC SULFATE INDUCES 
CARDIAC CHANGES IN HEALTHY RATS 
 
4.1 Introduction 
    Epidemiological studies show a clear link between increased cardiovascular health effects 
and exposure to particulate matter (PM) (Dockery, 2001); however, the mechanistic 
relationship between the two is poorly understood.  The PM issue is particularly complex, as 
ambient PM varies greatly in size, concentration, and composition.  Environmental exposures 
are usually over a lifetime at varying, and generally low concentrations, making comparable 
toxicology studies in animal models difficult.  Because of this complexity, it is a challenge to 
elucidate what specific characteristics of PM are mediating its toxicity.  Several different 
hypotheses about which individual components may be mediating toxicity of PM have been 
proposed.  As discussed in Chapter 2, the amount and variety of metals the PM contains 
differs with source and geographic location, and this characteristic remains a leading 
candidate thought to play a role in PM-induced injury (Costa and Dreher, 1997; Adamson et 
al., 2000).   
    Metals are present in respirable ambient PM and are primarily derived from anthropogenic 
combustion sources (Birmili et al., 2006).  Because of this, areas along roadsides (Schauer et 
al., 2006) or urban industrial areas (Dye et al., 2001) are rich in metals.  Residual oil fly 
ashes (ROFA) are particle samples that are generally rich in metals, and have been used in 
many previous studies investigating mechanisms of PM-induced injury (Kodavanti et al., 
1998 and 2003; Wichers et al., 2004).  We have shown that a single intratracheal (IT) 
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instillation of a ROFA sample containing moderate amounts of transition metals elicited not 
only pulmonary effects, but cardiac effects as well (Wichers et al., 2004; Wallenborn et al., 
2007b).  With regards to specific metal content, this ROFA contained the most amount of 
water soluble zinc, a metal also commonly abundant in the water soluble fraction of ambient 
PM (Adamson et al., 2000; Birmili et al., 2006).  The amount of zinc as one potential 
mediator of PM-induced toxicity has been suggested (Kodavanti et al., 2008), and several 
studies, both in vivo (Gavett et al., 1997; Kodavanti et al., 2003) and in vitro (Samet et al., 
1998), support this assertion.  As reported in Chapter 3, following pulmonary exposure, 
water soluble zinc is able to directly reach the heart, making it possible that zinc exerts direct 
effects on the heart. 
    Zinc is an essential element commonly found in ambient PM.  Evidence suggests that a 
significant portion of zinc likely exists in water soluble form (Birmili et al., 2006).  When 
intratracheally instilled at the same concentrations found in the water soluble fraction of a 
particle collected in Ottawa, Canada, zinc was the most abundant and only metal which 
caused lung injury (Adamson et al., 2000).  Inhalation of ROFA similar in composition to the 
Ottawa PM, containing high amounts of water soluble zinc, caused cardiac injury in healthy 
Wistar Kyoto rats (Kodavanti et al., 2003).  A single IT instillation of zinc sulfate (ZnSO4) 
caused changes in expression of genes reflective of alterations in mitochondrial function, ion 
channels, and cell signaling, in the hearts of healthy Wistar Kyoto rats (Gilmour et al., 
2006b).  Furthering this work, we have shown that repeated weekly IT instillations caused 
cardiac mitochondrial DNA damage, and cardiac gene expression changes distinct from 
changes seen following exposure in the same manner to soluble metal free Mount St Helen’s 
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ash (Kodavanti et al., 2008).  Results in Chapter 3 make a direct zinc effect on the heart 
plausible.   
    Most in vivo studies investigating the effects of pulmonary zinc exposure are designed as 
acute exposures to high concentrations of zinc.  Toxicology studies addressing the effects of 
a “real world” situation, i.e., subchronic or chronic exposures to concentrations of metals, 
and more specifically, zinc, which are environmentally relevant and found in industrial 
polluted settings are rare; however longer term inhalation studies have demonstrated cardiac 
and systemic effects following exposure to high concentrations of a combustion source PM 
rich in zinc (Kodavanti et al., 2002, 2003).   
    Zinc is an essential cofactor and structural element in a wide variety of cellular processes, 
estimated to be required for normal functioning of over 1000 proteins, including many 
different enzymes and transcription factors (Maret and Krezel, 2007).  Because of zinc’s 
critical role, any change in cellular zinc status or buffering capacity will have a wide variety 
of downstream effects, with the potential to be harmful, or possibly cytoprotective.  Zinc 
status within a cell has been shown to be affected by oxidative stress (Maret and Krezel, 
2007), as well as nitric oxide signaling (St Croix et al., 2005).  Zinc exposure has been shown 
to affect activity of a variety of enzymes (Maret et al., 1999), kinase/phosphatase signaling 
(Samet et al., 2003), and mitochondrial function (Ye et al., 2001; Dineley et al., 2005).  We 
have seen such pleiotrophic effects in previous cardiac microarray data following pulmonary 
zinc exposure (Kodavanti et al., 2008).  In this study we aimed to better define zinc exposure 
in the context of cardiovascular effects of environmentally relevant PM exposures.    
    Zinc is an essential element, and so ingestion has beneficial effects.  Here we wanted to 
focus on the potential toxic effects of inhalation of zinc, and so we chose nose only 
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inhalation exposure (versus whole body inhalation exposure) to limit preening and ingestion 
of zinc.  We hypothesized that a 16 week inhalation exposure to soluble ZnSO4 would cause 
increases in not only lung injury parameters, but changes in systemic markers as well.  We 
further hypothesized that changes seen in this study may not exactly reflect changes seen in 
earlier studies involving IT instillation of a high concentration of zinc, owing to differences 
in mechanism of injury between high and low concentrations, and also exposure durations.  
We chose exposure to filtered air or 10, 30 or 100 µg/m3 of water soluble ZnSO4.  Total zinc 
(soluble plus insoluble) has been measured similar to these concentrations in urban industrial 
environments and occupational settings (Schroeder et al., 1987; Matczak and Gromiec, 
2002).  Total zinc levels in an ambient setting have been reported as high as 27 µg/m3 
(Harrison and Yin, 2000).  We presume that depending on source, the solubility of zinc may 
vary in different ambient PM samples, but in many instances a large proportion will be in 
water soluble form (Adamson et al., 2000).  Our present results show that subchronic 
inhalation exposure to relatively low concentrations of ZnSO4 elicits minimal lung injury, as 
measured by bronchoalveolar lavage fluid markers of injury.  Furthermore, we observed 
small but significant changes in enzyme activities and metal binding protein levels in the 
heart, as well as in the cardiac gene expression profile, with no apparent pathological 
changes.  These changes are reflective of a distinctive effect of zinc on the myocardium, and 
support the notion that if zinc exists in a relatively high concentration, as may be found in 
highly polluted settings or occupational settings, PM associated zinc is possibly one of the 
factors mediating PM-induced cardiovascular injury.   
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4.2 Materials and Methods 
Animals.    Healthy male Wistar Kyoto (WKY) rats, 12 weeks old, were purchased from 
Charles River Laboratories Inc., Raleigh, NC.  Animals were double housed in polycarbonate 
cages with beta chip bedding and acclimatized for at least one week in an AAALAC-
approved animal facility (21 ± 1ºC, 50 ± 5% relative humidity, 12:12 h light/dark cycle) prior 
to the experimental period. All animals received standard Purina rat chow (Brentwood, MO) 
and water ad libitum, except during exposures.   
 
Nose only inhalation exposure.  Rats were randomly assigned to four groups (n = 12 per 
group) according to body weight, and exposed by nose-only inhalation (Ledbetter et al., 
1998) to either filtered air or aerosolized ZnSO4 (10, 30 or 100 µg zinc/m3) for 5 h/day, 3 
days/week for 16 weeks.  The aerosol, consisting of dried particles of ZnSO4, was generated 
by aerosolizing solutions of ZnSO4 heptahydrate (Sigma Aldrich Chemicals), mixed at 
different starting concentrations with a TSI Model 3076 atomizer operating at 30 PSI 
(Thermo Systems International, Shoreview, MN).  The output was mixed with dry air and 
directed to the exposure chamber (air flow of 98-105 liters/minute).  Chamber concentration 
data was determined by gravimetric analysis, with Inductively Coupled Plasma-Optical 
Emission Spectroscopy (ICP-OES) to determine zinc concentration.  Temperature and 
relative humidity were monitored and collected using a Rotronics Model I 200 thermo-
hygrometer connected to a PC (Windows XP Professional), running DasyTec’s DasyLAB 
Data Acquisition Software, version 8.0 (Amherst, NH), and reduced using Microsoft Excel 
(version 2003).  ZnSO4 particle size and distribution was determined using a Sub-Micrometer 
Particle Sizer (Thermo Systems International, Shoreview, MN). 
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Necropsy, bronchoalveolar lavage, blood collection.  Of the 12 rats per exposure group, 6 
were used for plasma/serum analysis and cardiac RNA isolation, and 6 were used for 
isolation of cardiac mitochondria.  Lung and heart pathology analysis, as well as 
bronchoalveolar lavage fluid (BALF) analysis, was performed for all rats.  Necropsies 
occurred 48 h after the last exposure.  At the designated time point, rats were weighed and 
anesthetized with an overdose of sodium pentobarbital (50-100 mg/kg, intraperitoneally). For 
analysis of plasma and serum, blood was collected through abdominal aortic puncture 
directly into vacuutainers containing EDTA or citrate as an anticoagulant (for fibrinogen 
analysis).  The heart was quickly excised and cut longitudinally in half.  One half was used 
for cardiac pathology (below).  A piece of left ventricle was removed from the remaining 
tissue, quick frozen in liquid nitrogen, and used for RNA isolation.  The left lung was tied 
off, and the right lung was lavaged using a volume of Ca++/Mg++ free phosphate buffered 
saline (pH 7.4) equal to 35 mL/kg body weight (representing total lung capacity) X 0.6 (right 
lung representing 60% of total lung capacity).  Three washes were performed with the same 
buffer aliquot.  BALF was saved in 15 mL sterile tubes on ice.   
 
Cell differential and bronchoalveolar lavage fluid (BALF) analysis.    Aliquots of BALF 
were used to determine total cell counts with a Z1 Coulter Counter (Coulter, Inc., Miami, 
FL).  A second aliquot was centrifuged (Shandon 3 Cytospin, Shandon, Pittsburg, PA) to 
prepare cell differential slides.  Slides were dried at room temperature and stained with 
Leukostat (Fisher Scientific Co., Pittsburg, PA).  Macrophages, neutrophils, eosinophils and 
lymphocytes were counted using light microscopy.  At least 200 cells were counted on each 
slide.  The remaining BALF was centrifuged at 1500 x g to remove cells, and the supernatant 
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fluid was analyzed for markers of lung injury.  Total protein (µg/mL BALF) was analyzed 
using Coomassie Plus Protein Assay Kit (Pierce Rockford IL). BALF albumin (µg/mL 
BALF) was analyzed using a commercially available kit (Diasorin, Stillwater, MN).  Lactate 
dehydrogenase (LDH) activity (U/L BALF) was determined using kit TR2001 from Thermo 
Trace Ltd (Melbourne, Australia). N-acetyl glucosaminidase (NAG) activity (U/L BALF) 
was measured using a kit and standards from Roche Diagnostics (Indianapolis IN).  γ-
glutamyl transferase (GGT) activity (U/L BALF) was measured using a kit from Thermo 
Trace Ltd (Melbourne, Australia).  These assays were modified and adapted for use on the 
Konelab clinical chemistry analyzer (Thermo Clinical Labsystems, Espoo, Finland). 
 
Preparation of cytosolic and mitochondrial fractions from heart.  For the 6 rats designated 
for cardiac mitochondrial isolation, the heart was quickly excised and cut longitudinally in 
half.  One portion was used for cardiac pathology (below) and the other half for isolation of 
mitochondrial and cytosolic fractions.  The right ventricle was removed, and the left ventricle 
was quickly weighed and minced with scissors in ice cold homogenization buffer containing 
210 mM mannitol, 5.0 mM MOPS, 70 mM sucrose and 1.0 mM EDTA, at pH 7.4.  Tissues 
were immediately homogenized in 10 mL fresh buffer using a glass Dounce homogenizer 
with a Teflon pestle.  Homogenates were centrifuged at 150 x g at 4ºC for 15 minutes to 
remove cellular debris.  The supernatant was transferred to another tube and centrifuged at 
13,500 x g at 4ºC for 20 minutes.  This supernatant was used as the cytosolic fraction, and 
was aliquoted and quick frozen at -80ºC until further analysis.  The pellet was resuspended in 
10 mL homogenization buffer with added protease inhibitor cocktail (Calbiochem Catalog 
#593134, San Diego, CA) at a 1:200 dilution.  The tubes were centrifuged at 13,500 x g at 
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4ºC for 20 minutes.  The supernatant was removed, and the pellet resuspended in 1 mL of the 
homogenization buffer with added protease inhibitors.  This was used as the mitochondrial 
fraction, and was aliquoted and quick frozen at -80ºC until further analysis.   
Cytosolic and mitochondrial fraction analyses.  Glutamate dehydrogenase (GDH) activity in 
both fractions was assessed to determine mitochondrial yield and contamination in the 
cytosolic fraction (Maianski et al., 2004) using a measurement of rate of oxidation of NADH.  
The reaction is: 2-oxoglutarate + NADH + NH4+ ↔ L(+)-Glutamate + NAD+ + H20.  2-
oxoglutarate and NH4+ are added as substrates, and NADH as coenzyme.  Aconitase activity, 
based on the formation of NADPH from NADP+, was measured in both fractions using the 
Bioxytech Aconitase-340 Assay (Oxis International Inc., Foster City, CA).  Citrate is 
converted to isocitrate (catalyzed by aconitase), which then undergoes oxidative 
decarboxylation (catalyzed by isocitrate dehydrogenase) and becomes α-ketoglutarate.  
Concomitantly during this last reaction, NADP+ is reduced to NADPH.  NADPH formation 
is measured spectrophotometrically at 340nm absorbance, and is proportional to aconitase 
activity.  Aconitase activity is presented in units, where one unit with convert 1 µmol of 
citrate to isocitrate at 25ºC, pH 7.4.  Ferritin levels were measured in both fractions using the 
K-Assay Ferritin from the Kamiya Biomedical Company (Seattle, WA).  This is an antibody 
based assay using latex beads coated in ferritin antibody.  When these antibodies recognize 
ferritin, the particles agglomerate, and this is detected as an absorbance change, which is 
proportional to the amount of ferritin in the sample.  A standard curve is used to determine 
the quantity of ferritin present.  Superoxide dismutase (SOD) activity was measured in both 
fractions using a kit from RANSOD (Randox Laboratories, Oceanside, CA).  SOD catalyzes 
the reaction of superoxide radicals to oxygen and hydrogen peroxide.  In this assay, xanthine 
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and xanthine oxidase are used to form superoxide radicals, which react with 2-(4-
iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium (INT) to form a red dye.  SOD activity is 
measured by the degree to which this reaction is inhibited (a decrease in red dye is indicative 
of a decrease in superoxide radical concentration, and presumably, an increase in SOD 
activity).  Glutathione peroxidase activity was measured indirectly by a coupled reaction with 
glutathione reductase, as the oxidation of NADPH by glutathione reductase during the 
oxidation of glutathione (GSH) to GSSG (Jaskot et al., 1983).  Isocitrate dehydrogenase 
(ICDH) activity was assessed in both fractions by measuring reduced NADPH following the 
ICDH catalyzed oxidative decarboxylation of L-isocitrate to 2-oxoglutarate, similar to the 
method described in the aconitase assay section above.  Succinate dehydrogenase (SDH) was 
measured according to the methods described by Trounce et al. (1996).  Glutathione 
transferase (GTR) activity was measured as the amount of amount of GSH conjugate of the 
GTR substrate 1-chloro-2, 4-dinitrobenzene, described further by Jaskot et al. (1983).  These 
assays were all modified and adapted for use on the Konelab clinical chemistry analyzer 
(Thermo Clinical Labsystems, Espoo, Finland).   
 
Lung and heart pathology.  For all twelve rats, the left lung was inflated with 10% formalin 
and placed in a vial of 10% formalin.  The heart was cut longitudinally to obtain 
representative portions of the right and left ventricles, and then placed into a vial of 10% 
formalin.  After fixation, the tissues were embedded in paraffin, cut into 5 µm thick sections, 
stained with hematoxylin and eosin (H&E) and examined under a light microscope.   
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Target RNA preparation and analysis of microarray data.  Target RNA from the left 
ventricle was isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA) and further 
purified using the RNeasy MinElute Cleanup Kit (Qiagen, Valencia, CA).  RNA integrity 
was assessed by the RNA 6000 LabChip® kit using a 2100 Bioanalyzer (Agilent 
Technologies, Palo Alto, CA).  15 µg RNA was converted into cDNA using a T7 promoter-
tailed oligo-dT primer.  A second strand cDNA synthesis was then carried out.  This double 
stranded cDNA was used as the template in an in vitro transcription (IVT) reaction, catalyzed 
by T7 polymerase and containing biotinylated CTP and UTP.  The biotinylated 
complementary RNA (cRNA) was purified from the reaction mixture, and fragmented to 
facilitate the hybridization step.  cRNA was produced using the Affymetrix “one-way” 
labeling kit (cat# 900493).  Total cRNA was then quantified using a Nano-Drop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE) and evaluated for quality 
after fragmentation on a 2100 Bioanalyzer.  The fragmented cRNA was added to a 
hybridization solution containing biotinylated control oligonucleotides and hybridized 
overnight at 45ºC to the Affymetrix RAE230A microarray chip in an Affymetrix Model 640 
GeneChip hybridization oven.  There were 6 animals per group and global gene expression in 
each animal was assayed on separate chips.  The chip was then washed using an Affymetrix 
450 fluidics station as recommended by the manufacturer to remove unhybridized cRNA.  
The bound cRNA was fluorescently labeled using phycoerythrin conjugated streptavidin 
(SAPE) and scanned using the Affymetrix Model 3000 scanner.  Intensities of fluorescent 
emissions were captured, and raw data (Affymetrix .cel files) obtained using Affymetrix 
GeneChip Operating Software (version 1.4).  This software also provided summary reports 
by which array QA metrics were evaluated including average background, average signal, 
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and 3’/5’ expression ratios for spike-in controls, β-actin, and GAPDH.  Labeling of RNA, 
hybridization to chips and washing of chips were carried out according to the manufacturer's 
recommendations. 
    The data (.cel files) were analyzed and statistically filtered using Rosetta Resolver® 
version 6.0 software (Rosetta Inpharmatics, Kirkland, WA).  Statistically significant changes 
in gene expression levels were identified using one-way ANOVA, p-value of ≤ 0.01.  
Differentially expressed genes between treatment and control groups, were also determined 
using a Bayesian T-test with the threshold for significance set at p ≤ 0.05 on MAS5.0 
normalized files. Comparison of the two statistical methods yielded 70 common genes 
changed.    
    A detailed description of the microarray data discussed here is available through Gene 
Expression Omnibus at the National Center for Biotechnology Information at 
http://www.ncbi.nlm.nih.gov/geo/ (Edgar et al., 2002), as accession number GSE11091.  
 
Statistical analysis.  BALF markers and cardiac enzyme activity data were analyzed by one 
way analysis of variance (ANOVA), with exposure as a factor, using SigmaStat software, 
version 3.5 (Systat Software, Inc., Point Richmond, CA).  In some cases, a student’s t-test 
was used to test for differences between air and high dose ZnSO4.  Significance was reached 
at a level of p ≤ 0.05.  Statistical analysis of microarray data is described in the previous 
section.   
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4.3 Results 
4.3.1. Nose only inhalation exposure  
    Exposures took place for 16 weeks in September – December of 2006, for 5 consecutive 
hours a day, three consecutive days per week, with four days in between exposures.  Due to 
scheduling conflicts, the days in between exposure periods occasionally varied, but 
exposures always took place three consecutive days in a row.  Target zinc concentrations for 
the low, medium and high levels were 10, 30 and 100 µg/m3, respectively.  The actual 
average zinc concentration in each of the chambers for 16 wks was 0.11 ± 0.1 (air), 9.0 ± 2.1 
(low), 35.0 ± 8.1 (medium), and 123.2 ± 29.6 (high) µg/m3.  Relative humidity (%RH) for 
each of these chambers was 37 ± 5.5 (air), 36 ± 4.6 (low), 37 ± 4.5 (medium), and 36.1 ± 4.3 
(high).  Temperature was 77.3 ± 1.5 (air), 77.0 ± 1.6 (low), 76.8 ± 1.7 (medium), and 76.5 ± 
1.6 (high) ºF.  Values for each are given in average ± standard deviation.  Particle size for 
each chamber, reported as number median diameter by electrical mobility (in nm) was air = 
102.7, geometric standard deviation (GSD) = 1.8, low = 30.8, GSD = 1.6, medium = 35.0, 
GSD = 1.7, and high = 43.6, GSD = 1.8.  Particle size for each chamber, reported in mass 
median diameter, measured by electrical mobility (in nm) was air = 277.7, geometric 
standard deviation (GSD) = 1.5, low = 89.2, GSD = 1.9, medium = 111.4, GSD = 1.9, and 
high = 177.7, GSD = 1.9.  It should be noted that following the first two weeks of exposure, 
measured zinc concentrations in the chambers were lower than expected and lower than the 
target levels.  In animal-free chambers, this drop in zinc concentration did not occur, so it 
was attributed to respiratory uptake by the rats.  Starting concentrations were raised in order 
to reach target levels of zinc concentrations.  Figure 4.1 depicts the nose only chambers and 
tubes used to expose rats to zinc sulfate.   
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4.3.2. Pathology and blood analyses 
    No exposure related pulmonary or cardiac pathological changes were noted following 16 
weeks exposure to up to 100 µg/m3 aerosolized ZnSO4.  Some abnormalities were noted; 
however these changes were not related to zinc exposure, and are typical of WKY rats of this 
age (Figure 4.2).  No alveolar type 2 cell hyperplasia was noted.  Figure 4.2 depicts 
representative images from control (A) and high dose (B) rats.  A minimal amount of cardiac 
mononuclear infiltration was noted, however infiltration of mononuclear cells was evident 
across all exposure groups and this degree of infiltration and pathology is typical of this rat 
strain and age.  Figure 4.2 depicts cardiac tissue from control (C) and high dose animals (D).  
Furthermore, no significant changes in plasma (Figure 4.3) or serum (Figure 4.4) markers 
were observed.   
 
4.3.3. Pulmonary injury and inflammation  
    Nose-only inhalation exposure to ZnSO4 was not associated with any changes in total 
lavageable cells, macrophages, or neutrophils (Figure 4.5), most likely due to the low level of 
exposure, or possibly development of tolerance over time.  A trend toward increase in BALF 
levels of protein was noted, although this change was not statistically significant (Figure 
4.6A).  The small increase in BALF protein is suggestive of a small increase in lung 
permeability associated with inhalation of ZnSO4; however the lack of change of other BALF 
parameters indicates that this effect is small (Figure 4.6).   
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4.3.4. Cardiac mitochondrial and cytosolic changes following pulmonary zinc exposure 
    Cardiac mitochondrial and cytosolic fractions were isolated by differential centrifugation 
for each exposure group.  A small but significant increase in cardiac mitochondrial ferritin 
levels was elicited by pulmonary zinc exposure (Figure 4.7 A).  A small but significant 
exposure related decrease in mitochondrial succinate dehydrogenase activity, an enzyme 
associated with the electron transport chain as well as the tricarboxylic acid cycle, was also 
noted (Figure 4.7 B), possibly indicating a small degree of mitochondrial dysfunction.  
However, no changes were noted in other tricarboxylic acid cycle enzymes measured in the 
mitochondrial fraction, including aconitase (Figure 4.7 C), indicating a modest mitochondrial 
impairment.  No changes were seen in activities of isocitrate dehydrogenase (ICDH) or 
glutamate dehydrogenase (GDH) (Figure 4.7).   
    Activity of glutathione peroxidase, an antioxidant enzyme, was slightly, but significantly, 
decreased in the cardiac cytosol (Figure 4.8).  This is reflective of earlier studies following 
pulmonary exposure to metal laden PM (Wallenborn et al., 2007b).  In the cytosolic fraction 
we observed no changes in activities of aconitase, GDH, glutathione transferase (GTR), 
superoxide dismutase (SOD), or level of ferritin (Figure 4.8).  
 
4.3.5. Gene expression analysis             
    Based on previous microarray results (Gilmour et al., 2006b; Kodavanti et al., 2008), we 
postulated that exposure to zinc would elicit changes reflective of dysregulation of many 
diverse physiological processes.  Indeed, we observed that subchronic exposure to 100, but 
not 10 or 30, µg/m3 of ZnSO4 elicited changes in expression of cardiac genes involved in cell 
signaling events, ion channels regulation, and coagulation.  Relative to our previous studies 
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(Gilmour et al., 2006a, 2006b; Kodavanti et al., 2008), this exposure was to a relatively low 
concentration of zinc, and therefore, as expected, few changes were seen.  A false discovery 
rate is a statistical tool that would be used in this case to avoid attributing gene expression 
changes to zinc exposure when they may be due to background changes.  However, because 
the exposures were to such low concentrations of zinc, and we were performing gene array 
analysis in heart tissue, no false discovery rate was applied to avoid missing smaller changes 
in gene expression.  Figure 4.9 depicts a Venn diagram of the three doses of zinc versus air 
control, and the number of unique and common genes changed.  Little overlap is seen 
between the three exposure groups, suggesting that noted changes were primarily seen only 
at the highest zinc concentration, 100 µg/m3.  Because we did not apply a false discovery 
rate, in order to ascertain that the gene expression changes we observed could be attributed to 
zinc inhalation exposure, we used two different tools to analyze expression changes (Rosetta 
Resolver and MAS5.0), and pooled the results.  We found 70 similar genes changed between 
air and high dose (p ≤ 0.05).  Genes changed were in categories in line with known zinc 
mechanisms and effects, such as cellular growth, coagulation, and phosphatase/kinase 
homeostasis (Figure 4.9).   
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Figure 4.1  
 
 
 
 
Figure 4.1.  Nose-only inhalation set-up used to expose rats to filtered air or or zinc (10, 30 
or 100 µg/m3) for 5 hours / day, 3 days / week for 16 weeks.  Rats were acclimatized to nose 
only tubes for one week before the beginning of exposures.  During exposures, rats were 
placed into nose only tubes (left column), which were placed into inhalation chambers (right 
column), one chamber per exposure concentration (four chambers total).  Tubes and 
chambers were cleaned between each day of exposure. 
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Figure 4.2 
      
      
 
 
 
 
 
 
 
Figure 4.2.  Hematoxylin and eosin (H&E) staining of heart and lung showing no zinc 
exposure related abnormalities.  Intact alveoli near a bronchus from a control (A) or high 
dose animal (B) are shown.  Minimal mononuclear cell infiltration in both heart and lungs 
was seen across all exposure groups.  Control (C) and high dose (D) cardiac tissue is shown.    
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Figure 4.3  
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Figure 4.3.  Plasma levels of angiotensin converting enzyme, fibrinogen, or total plasma 
protein following subchronic inhalation of zinc (10, 30 or 100 µg/m3) in WKY rats, 
measured 48h after the end of the last exposure.  Each bar represents the mean ± SEM for 6 
animals. 
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Figure 4.4  
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Figure 4.4. Serum levels of total cholesterol, low density lipoprotein, high density 
lipoprotein, glucose, triglycerides, or total serum protein following subchronic inhalation of 
zinc (10, 30 or 100 µg/m3) in WKY rats, measured 48h after the end of the last exposure.  
Each bar represents the mean ± SEM for 6 animals. * indicate significantly different from air 
control (p ≤ 0.05).   
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Figure 4.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.  Pulmonary inflammatory response to subchronic inhalation of air or zinc (10, 30 
or 100 µg/m3) as determined by analysis of bronchoalveolar lavage fluid (BALF) cells in 
WKY rats 48 h after the end of the last exposure.  Each bar represents the mean ± SEM for 
12 animals.   
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Figure 4.6 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6.  Pulmonary injury response to subchronic inhalation of air or zinc (10, 30 or 100 
µg/m3) as determined by analysis of bronchoalveolar lavage fluid (BALF) levels of protein, 
albumin, and activities of n-acetyl glucosaminidase (NAG), lactate dehydrogenase (LDH), 
and γ-glutamyl transferase (GGT) in WKY rats 48 h after the end of the last exposure.  Each 
bar represents the mean ± SEM for 12 animals.   
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Figure 4.7 
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Figure 4.7. Mitochondrial ferritin levels, succinate dehydrogenase activity, aconitase activity, 
isocitrate dehydrogenase activity, glutamate dehydrogenase activity following subchronic 
inhalation of air or zinc (10, 30 or 100 µg/m3) in WKY rats 48 h after the end of the last 
exposure.  Each bar represents the mean ± SEM for 6 animals.  * indicate significantly 
different from air control (p ≤ 0.05).   
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Figure 4.8  
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Figure 4.8. Cytosolic glutathione peroxidase activity, aconitase activity, ferritin levels, 
isocitrate dehydrogenase activity, glutathione transferase activity, and superoxide dismutase 
activity following subchronic inhalation of air or zinc (10, 30 or 100 µg/m3) in WKY rats 48 
h after the end of the last exposure.  Each bar represents the mean ± SEM for 6 animals.  * 
indicate significantly different from air control (p ≤ 0.05).   
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Figure 4.9 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9.  Venn diagram showing common and unique genes changed according to 
exposure concentration.  Gene lists used in developing this diagram were generated using 
Rosetta Resolver 6.0 and were normalized to air control values.  For these genes, significance 
was reached at p ≤ 0.01 using one way analysis of variance.   
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Figure 4.10 
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Figure 4.10.  Heat map showing gene expression changes as fold change from air control.  
Red and green colors indicate increases and decreases, respectively (expressed as the log of 
the ratio of exposed to control values).  Changes in gene expression listed are the pooled 
results of two independent statistical analyses, using Rosetta Resolver one-way ANOVA (p ≤ 
0.01) and Bayesian t-test with threshold of significance at p ≤ 0.05 on MAS5.0 normalized 
files.   
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4.4. Discussion 
    Ambient PM-associated metals, especially those in the water soluble fraction, have been 
proposed to mediate PM-induced pulmonary and cardiovascular injury (Costa and Dreher, 
1997; Kodavanti et al., 1998; Kodavanti et al., 2008).  Zinc is one of the most common water 
soluble metals found in ambient PM (Birmili et al., 2006), especially in industrial areas and 
near roadways (Dye et al., 2001; Schauer et al., 2006), and has been shown to mediate lung 
injury (Adamson et al., 2000).  At high concentrations, soluble zinc has also been shown to 
induce cardiac effects (Gilmour et al., 2006b; Kodavanti et al., 2008).  In order to more 
clearly define the cardiovascular effects of pulmonary exposure to environmentally relevant 
levels of zinc, we exposed healthy male WKY rats to relatively low concentrations of 
aerosolized ZnSO4 for 16 weeks.  We demonstrate here that this exposure regimen causes 
small changes in cardiac gene expression, activities of enzymes involved in mitochondrial 
respiration and levels of the iron binding protein ferritin in the absence of cardiac pathology, 
and without causing substantial lung injury or inflammation.   
    In investigating the mechanisms of ambient PM-induced cardiovascular injury, the 
question of whether soluble components of PM have a direct adverse effect on the 
cardiovascular system or if this effect is secondary to the pulmonary inflammatory response 
remains to be answered.  Despite the lack of significant lung injury, our study shows 
concomitant molecular cardiac changes, implying a direct effect of inhaled zinc on 
extrapulmonary systems, even at low concentrations.  This is consistent with our previous 
findings that a single IT instillation of zinc sulfate results in increased circulating zinc 
concentrations (Gilmour et al., 2006a).  Likewise, translocation of metals following 
pulmonary exposure to ambient and ROFA PM has been reported (Mani et al., 2006; 
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Wallenborn et al., 2007a).  Taken together, these observations provide a plausible 
explanation for the cardiac effect seen in the current study.  Epidemiological studies have 
linked PM-induced systemic health effects to the concentration of metals, and specifically 
zinc, in ambient air (Burnett et al., 2000).  Pulmonary zinc exposure induces hematological 
changes in healthy rats (Gilmour et al, 2006a).  Direct exposure to free zinc caused changes 
in contractile force and heart rate in isolated guinea pig hearts (Kalfakakou et al., 1993), and 
decreased the left ventricular developed pressure in isolated rat hearts (Bagate et al., 2006).  
In vitro exposure to zinc has been shown to elicit many different molecular changes, 
including disruption of kinase/phosphatase balance, mitochondrial enzyme activities, and 
changes in ion channel expression, in several cell types (Ye et al., 2001; Samet et al. 2003), 
including rat cardiomyocytes (Graff et al., 2004).  Although several characteristics of PM 
may be playing a role in its toxicity, in areas where zinc is found in high abundance as the 
most common soluble metal, the amount of zinc may be important in the causation of PM-
induced cardiovascular injury.    
    Numerous studies have employed IT instillation exposure as a means to investigate 
mechanisms of PM-induced injury.  While this is a well accepted method for mechanistic or 
initial screening studies, it remains that environmental, and most occupational exposures, 
usually take place at a much lower concentration for a longer period of time.  Using IT 
instillation as a means of exposure also raises the question of relevancy, i.e., whether or not 
the mechanisms of injury following a single acute exposure to a high concentration are 
similar to those following chronic exposures to a lower concentration.  This issue has been 
addressed with regards to lung deposition and lung damage following metal-rich ROFA 
exposure.  Exposure to the same amount of PM via IT instillation and nose-only inhalation 
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elicited similar lung deposition patterns, as well as BALF markers of lung injury, whereas 
these two exposure regimens caused different lung pathology scores.  By 48 h post exposure, 
lung pathology from IT instillation was less severe than from inhalation of ROFA (Costa et 
al., 2006).  Both qualitative and temporal differences exist between effects of IT instillation 
and inhalation.  Because of this, and because earlier studies employ such high zinc 
concentrations, we wanted to determine the cardiovascular effects of exposure to soluble zinc 
at environmentally relevant concentrations.  Further, because of the low concentration of zinc 
used, we speculated that by 48 h after the last exposure, effects seen would be due to the 
more chronic impact on the heart.  Our primary focus for this study was cardiovascular 
effects, and studies addressing differences in cardiovascular response between IT instillation 
and inhalation are lacking.  We have previously shown that a single IT instillation of 2 µmol 
/ kg body weight induces changes in expression of cardiac genes involved in processes such 
as cell signaling, ion channels, calcium homeostasis, growth, and mitochondrial respiration 
(Gilmour et al., 2006b).  With the current study, we demonstrate changes in cardiac 
expression of genes in several of these same categories, albeit to a lesser extent.  
Concordance in category of response in subchronic inhalation, single and multiple IT 
instillation, and in vitro zinc exposure validates the use of several exposure methods to 
investigate PM induced cardiovascular toxicity.       
    We chose exposure concentrations to be concordant with ones measured in environmental 
and occupational settings (Schroeder et al., 1987; Matczak and Gromiec, 2002).  The 
deposited dose of zinc was calculated for a rat to be 2.05 µg per rat per day, or 6.15 µg per 
rat per week.  Breathing frequency was assumed to be 102 breaths/min, tidal volume 2.1 mL, 
and deposition fraction 0.32 (Kodavanti et al., 2008).  Because of the small aerosol particle 
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size (30-43 nm), deposition fraction may be greater than 0.32.  However, because particles 
were dried ZnSO4, and therefore very hygroscopic, they may grow to have diameters of 3-4 
times this size.  This would put them in the 0.1 µm range, and so the deposition fraction may 
actually be less than our estimate of 0.32.  We have previously reported cardiac effects of 
pulmonary zinc exposure following a single IT instillation of 2 µmol / kg body weight 
(Gilmour et al., 2006a, 2006b), which is equal to 43 µg per rat.  We have also reported 
cardiac effects of zinc following one instillation per week of 11.1 µg per rat, for 16 weeks 
(Kodavanti et al., 2008).  Cardiac effects observed here are subtle; however this is expected, 
as the dose of zinc was half of the lowest dose we have previously used.  Moreover, in the 
present study, zinc was inhaled over a relatively long period of time rather than via one 
single weekly instillation of the entire dose (Kodavanti et al., 2008).  One aim of this study 
was to more accurately mirror “real world” conditions.  Occupational exposures to 
concentrations of zinc utilized in this study may occur for 8 h a day over decades (Matczak 
and Gromiec, 2002).  Ambient exposure occurs continually, in some locations to 
concentrations near our middle dose (Schroeder et al., 1987; Harrison and Yin, 2000).  
Although it is not known how much of the total zinc reported in these studies is in soluble 
form, available evidence suggests that zinc may be more soluble than other metals such as 
aluminum and iron (Adamson et al., 2000; Wallenborn et al., 2007a).  Therefore, our 
experimental conditions, especially the lower concentrations, may represent exposure to less 
of the soluble zinc than an individual would experience in a “real world” situation.  Changes 
seen may be amplified when exposures occur for a longer period of time.   
    Subchronic exposure to ZnSO4 at a relatively low concentration did not cause Type II 
alveolar cell hyperplasia, a reported lung effect specific to zinc exposure (Gilmour et al., 
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2006a).  Increases in lung injury and inflammation were minimal, evidenced by slight trends 
towards increase in BALF markers of injury and inflammation.  A tolerance in BALF 
neutrophil influx has been observed in mice following 5 days exposure to ZnO 
(Wesselkamper et al., 2001).  Unlike previous studies reporting cardiac pathology following 
exposure to zinc containing particles (Kodavanti et al., 2003), we observed no changes in 
heart pathological score.  However, in spite of the absence of cardiac pathology, small but 
significant changes were observed in the activities of cardiac enzymes associated with 
mitochondrial function.  Succinate dehydrogenase (SDH) is a mitochondrial membrane 
bound enzyme involved in electron transport, as well as the tricarboxylic acid cycle.  Here 
we observed a slight but significant decrease in its activity, suggestive of mitochondrial 
dysfunction.  Zinc induced inhibition of SDH has been recently reported (Lemire et al., 
2007).  Cellular trafficking of zinc is carried out by many different metal transport proteins, 
many of which contain zinc reactive thiol groups or iron sulfur clusters.  Increased oxidative 
stress causes zinc release from sulfur ligands of metallothionein, and therefore modulation of 
cell signaling pathways reliant on zinc (Maret, 2006).  Many enzymes of the tricarboxylic 
acid cycle also contain these groups, including SDH, aconitase, and cytochrome C oxidase, 
which makes them potential targets of zinc induced inhibition (Gazaryan et al., 2002; Lemire 
et al., 2007).  We have previously reported zinc induced decreases in aconitase and 
cytochrome C oxidase activities (Gottipolu et al., 2008; Kodavanti et al., 2008).  Zinc has 
also been reported to cause decreased thioredoxin reductase activity, prior to mitochondrial 
permeability transition (Gazaryan et al., 2007).  Decreased mitochondrial activity, and 
therefore ATP production, in the heart may be responsible for the reported zinc induced 
adverse cardiovascular effects.   
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    In addition to cardiac SDH inhibition, subchronic inhalation of ZnSO4 caused an increase 
in cardiac mitochondrial ferritin, suggesting an exposure related dysfunction of iron 
homeostasis.  This has been previously reported following a single IT instillation of zinc 
containing PM (Wallenborn et al., 2007b).  Zinc is able to bind to ferritin (Langlois 
d’Estaintot et al., 2004), and therefore may be displacing iron, leading to excess free iron in 
the cell.  Zinc is required for the proper function of thousands of catalysts, structural 
stabilizers, and/or regulatory cofactors, while iron has many roles in cellular processes, 
especially in the mitochondria in heme synthesis and iron sulfur cluster containing enzymes.  
Levels of these metals are tightly regulated by proteins such as ferritin.  Overlap in binding 
ability makes it possible for exposure to one to lead to changes in another (Gilmour et al., 
2006b).  Changes in normal levels of any essential metals may have both physiological and 
toxic consequences.     
    Gene array analysis was performed to provide a better picture of cardiac zinc effects, and 
to compare to earlier studies (Gilmour et al., 2006b; Kodavanti et al., 2008).  Because rats 
were exposed to such a low concentration of zinc, effects were few; however the pooling of 
analyses from two programs ensures that the results are significant and real for the high zinc 
exposure group.  Zinc containing proteins are involved in a wide variety of cellular 
processes, and this is mirrored in the categories of response.  Several genes in the Wnt 
pathway, including frizzled 1 (Fzd1), endoplasmic reticulum transmembrane protein dri 42 
(Ppap2b), and bone morphogenic protein (Bmp) receptor were affected.  The Wnt pathway is 
involved in cardiac development and growth (Klaus et al., 2007).  Bmpr2, a cytokine receptor 
in the TGF-β family, has been implicated in cellular growth pathways in several cell types 
(Morrell, 2006).  We also observed changes in several genes involved in cell structure.  
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Recent studies have suggested zinc is able to induce changes in TNF-α production and 
cytoskeleton components in the absence of its ability to produce reactive oxygen species 
(Wilson et al., 2007).  We observed small decreases in expression of several phosphatases, 
which are known to be inhibited by zinc exposure at the translational level in many cell types 
(Samet et al., 2003).  That we saw these changes at the transcriptional level may be reflective 
of the long term nature of the exposure.  These effects may lead to changes in cellular 
signaling pathways critical to normal cardiomyocyte functioning and growth.  For example, 
we observed a down regulation of protein phosphatase 3, the alpha subunit of calcineurin.  
Calcineurin expression changes may affect ion channel expression, namely calcium channels.  
Bradykinin receptor b2, which is also involved in calcium homeostasis, was also changed.  
Zinc is known to affect calcium signaling (Maret, 2007).  Dysregulation of calcium channels 
and calcium homeostasis in the heart may lead to physiological effects such as arrhythmias.  
Overall, in comparison to our earlier studies involving cardiac gene expression responses to 
zinc, there were a smaller number of genes changed, and furthermore, in contrast to previous 
studies (Kodavanti et al., 2008), more genes were downregulated than upregulated.  These 
differences may be reflective of the dose, duration, and degree of tolerance to zinc exposure.   
    Multiple IT instillations of zinc induced downregulation of cardiac phosphatase 
expression, potentially reflecting a response to zinc that is specific to more chronic exposure 
(Kodavanti et al., 2008).  In other cell types, an increase in kinase activity has been observed 
following zinc exposure (Wu et al., 1999).  In a human monocytic cell line, zinc increased 
protein kinase C (PKC) activity (Kojima et al., 2007), and furthermore, in an isolated 
perfused heart, intracellular zinc has been shown to have a protective role against 
ischemia/reperfusion injury by stabilizing PKC (Karagulova et al., 2007).  Subchronic 
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inhalation of zinc induced changes in both phosphatases and kinases.  Thus, in many cases 
there is a commonality in response, in that zinc induces changes in normal cellular signaling, 
namely in pathways reliant on phosphatase/kinase activities.  Recognizing these differences 
is important in defining the exact mechanism of not just zinc exposure, but zinc exposure in 
the context of ambient PM induced cardiovascular disease.   
    We have shown here that subchronic inhalation of ZnSO4 at environmentally relevant 
levels induces minimal lung injury as determined by pathology and BALF markers of injury 
and inflammation.  In contrast with previous exposures to zinc containing PM (Kodavanti et 
al., 2003, 2008), no cardiac pathology was seen; however, small but significant changes in 
cardiac mitochondrial SDH activity and ferritin levels, as well as cytosolic GPx changes 
indicate subtle mitochondrial specific effects.  In addition, cardiac gene expression changes 
were induced, further supporting that pulmonary zinc exposure, even at environmentally 
relevant concentrations, induces cardiac effects.  Changes were small; however may have 
significant biological and clinical relevance, especially for individuals with pre-existing 
cardiopulmonary impairments.  These results suggest that chemical speciation of PM may be 
important in injury causation, and may therefore need to be taken into account when defining 
PM regulations.   
 
 
 
 
 
CHAPTER 5.  OVERALL CONCLUSIONS AND SIGNIFICANCE 
    Taken together, these studies have shown that pulmonary exposure to zinc does in fact 
cause both pulmonary and cardiac effects that are distinct from effects of other metals, and 
that these effects are likely caused by direct movement of zinc outside of the lungs into 
systemic circulation.  Further, our observation of cardiac changes following inhalation of 
lower levels of zinc demonstrates that zinc effects on the heart are not a function of the high 
dose used in most animal toxicology studies.  This highlights the idea that mechanistic 
insights gained from IT studies are relevant to environmental exposures, as cardiac changes 
we saw following inhalation of lower levels of zinc were similar to ones seen following IT of 
zinc in previous studies.  This study supports the use of intratracheal instillation as a means 
to study mechanisms of PM-induced effects.   
    To fully define mechanisms of PM-induced cardiovascular injury, it is necessary to 
identify if any specific characteristic or constituent of PM is mediating effects.  PM 
characteristics vary greatly depending on location, meteorological conditions, surrounding 
point and mobile sources, and time of year.  PM is a nonhomogenous mixture of different 
chemicals, gases, metals, and particles of all different sizes.  Identification of specific 
characteristics that mediate toxicity will eventually aid in writing more specific regulations.  
The EPA currently regulates PM on a size basis only; however accumulating research is 
showing that the composition of PM is an important factor in determining PM toxicity.  In 
time, it may be that composition will come into play when writing regulations.
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    Earlier studies from our lab proved that PM associated metals do in fact translocate 
directly from the lungs into the systemic circulation, and via the plasma, reaches the liver and 
heart (Wallenborn et al., 2007a).  Specifically, we showed increases in plasma, heart, and 
liver levels of vanadium and nickel following a single IT instillation of a metal rich ROFA 
sample.  Because these metals are found in control tissue in such low amounts, we could 
ascertain that our detection of these metals outside of the lung was the result of their direct 
translocation.  We also observed increases in zinc outside of the lung; however we were 
unable to be sure that this was due to exogenous zinc reaching these organs, or changes in 
endogenous zinc homeostasis.  In a subset of these rats, we observed changes in 
mitochondrial and cytosolic enzymes in the heart (Wallenborn et al., 2007b).  Zinc is a 
known inhibitor of iron sulfur cluster containing enzymes, and so it is possible that these 
effects were the result of direct exposure of the heart to exogenous zinc.  Nickel has also 
been suggested to inhibit iron sulfur cluster containing enzymes; however through a separate 
mechanism than that of zinc.  As nickel was present in the ROFA used in these studies, this 
may have been what was occurring as well.  However, in a public health setting, although 
nickel is present in relatively high amounts in some areas, or around specific industries, zinc 
is more common in ambient PM, and so provides more of a concern than exposure to nickel.  
Therefore, the remainder of this project aimed to address the mechanism of cardiotoxicity 
following pulmonary zinc exposure.   
    These results implied that cardiac effects may be due to a direct effect of metals on the 
heart; however because effects were seen following exposure to a particle sample that was 
rich in vanadium, nickel, iron and zinc, it was unclear which individual metal may have been 
mediating toxicity.  Other studies from our lab indicated that zinc may be a potential 
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mediator of toxicity.  In 2003, it was shown that inhalation of an emission PM caused 
pathology changes in the hearts of healthy WKY rats.  As zinc was the only water soluble 
metal present in this PM, it was hypothesized that this was the causative factor (Kodavanti et 
al., 2003).  Other groups had also speculated that zinc may be a mediator of PM-induced 
injury (Adamson et al., 2000; Wu et al., 1999; Wichers et al., 2004).  This focus on zinc is 
especially relevant in a public health setting, as zinc is usually one of the most common 
metals found in ambient air, due to traffic and industrial operations.  As an extension of all of 
these studies, we decided to compare pulmonary and cardiac toxicological potencies of a 
panel of PM associated metals.  We saw that zinc does in fact cause distinct effects, both 
pulmonary and cardiovascular.  Our results suggest that each individual metal exerts effects 
via distinct mechanism of action.  However, a limitation of the study described in Chapter 2 
is that we did not include combinations of metals.  As PM exposure in environmental settings 
is rarely to a single metal, effects are most likely modulated by co-exposures.  For example, 
delayed nickel effects are blunted by co-exposure to iron, and immediate vanadium effects 
are enhanced by nickel co-exposure (Campen et al., 2002 and 2003).  This group further 
hypothesized that this is likely due to separate mechanisms of action of these metals.  In the 
case of iron and vanadium, iron may be inducing chelating proteins in the lung, diminishing 
the immediate potential of vanadium to redox cycle.  On the other hand, in the case of nickel 
and vanadium, nickel interferes with DNA damage repair, and so therefore could potentiate 
injury due to vanadium exposure.  Immediate pulmonary effects of copper (at 4 h post a 
single IT instillation) and relatively later effects of zinc (at 24 h post a single IT instillation) 
have been reported previously (Gottipolu et al., 2008).  In this study, the degree of response 
from exposure to zinc or copper or zinc and copper was dependent on the endpoint measured 
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and the time.  For example, copper exposure seems to be driving the immediate increases in 
NAG and GGT activity in the BALF, whereas zinc seems to be driving the later increase in 
BALF protein levels.  A faster clearance of copper than zinc from the lungs has been 
reported (Hirano et al., 1989; 1993), which may be explaining this difference in timing of 
response.  Zinc and copper may be interacting in different manners with different metal 
binding or oxidant response proteins to produce different effects, both in timing and degree 
of response.   
    Metallothionein is a metal binding protein which may be mediating differential effects of 
exposure to each of these metals.  Transcriptional activation of metallothionein involves the 
binding of a zinc finger transcription factor (MTF-1) to a DNA motif called a metal response 
element.  Metallothionein activation may be due to direct metal exposure; however 
metallothionein is also known to be induced by oxidizing agents such as hydrogen peroxide 
(Giedroc et al., 1998).  In the case of metal-metal interactions, it has been shown that zinc 
preferentially induces metallothionein; however once induced, the protein binds more readily 
to copper (Santon et al., 2008).  Exposure to each metal alone (zinc, copper, iron) induced 
metallothionein, and furthermore, these authors also report a decrease in iron accumulation 
with concomitant zinc exposure, suggesting that competition for a binding site may be the 
explanation for this (Santon et al., 2008).  Described in Chapter 2, the earliest time point that 
we measured lung metallothionein expression was 4 h post IT.  At any time point, only nickel 
and copper, but not zinc, significantly induced metallothionein expression in the lung.  Our 4 
h time point may have been too late to see any significant zinc induced changes in 
metallothionein mRNA levels.  Different potential to induce and bind to metallothionein may 
be a cause for each of these specific metals to cause distinct effects, and furthermore, 
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metallothionein induction and binding may be playing a role in metal-metal interactions 
during co-exposures.  The number of possible variations of combinations of metals and doses 
and time points is daunting, but this complexity highlights the importance of investigating 
not only toxic effects, but mechanisms of toxicity.  If mechanisms of toxicity are known, it 
may be possible to predict whether another metal may have a similar effect based on shared 
characteristics or biological pathways.   
    Even though nickel proved to be the most potent metal on an equimolar basis, we decided 
to turn our focus towards zinc, based on previous studies, and also based on air monitoring 
data.  Zinc is usually much more common in ambient air than nickel, and therefore presents 
more of a public health concern.  We had previously seen changes in extrapulmonary zinc 
levels, and so we decided to make use of a stable isotope of zinc to ensure that exogenous 
zinc is able to reach extrapulmonary organs and further, to monitor its kinetics to attempt and 
relate this to its biological effects.  Since ingestion of this same amount of zinc is nontoxic, 
we also compared kinetics of zinc following exposure via these two routes.  A limitation to 
the work described in Chapter 3 is the dose.  The concentration of zinc given is relatively 
high, even in terms of IT studies.  Pulmonary inflammation was not measured; however 
based on previous IT studies using even lower zinc concentrations, was definitely induced.  
Damage to lung epithelium most likely led to an increase in lung permeability, and 
subsequently, an increased rate of absorption.  This degree of pulmonary inflammation would 
not be present following inhalation exposure to lower levels of zinc (as described in Chapter 
4), and therefore one would expect less zinc translocation.  However, as zinc seemed to 
accumulate in the heart following pulmonary, but not oral, exposure, it is possible that long 
term exposure to zinc would cause cardiac zinc levels to continue to rise past the 48 hour 
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time point we measured in Chapter 3.  This cardiac accumulation is probably a result of 
differences in the ability to proactively regulate the amount of zinc absorbed.  The gut has a 
much more sophisticated manner of sensing underlying zinc status, and so therefore, we 
regulate zinc absorption accordingly (more zinc is absorbed during zinc deficiency).  This is 
in contrast with the lungs, which are a closed system, meaning clearance must occur via the 
mucociliary escalator, via the lymphatic system, or via direct translocation into the systemic 
circulation.  Furthermore, the lungs are not equipped with as sophisticated zinc transport 
system as is the gut, so more passive absorption may be occurring.  It is likely that zinc 
accumulation in the heart is due to the replacement of endogenous zinc present in zinc 
binding proteins, therefore making it biologically inert.  It is important to remember here that 
following gavage of zinc, cardiac 70Zn levels were increased but then reached a plateau, with 
no apparent accumulation.  This indicates that either continual exposure of the heart to zinc is 
not occurring, or continual replacement of endogenous zinc with exogenous zinc is not 
occurring.  Either way, this difference in kinetics may be involved in differences in toxicity 
with respect to route of exposure.  The importance of the zinc:copper ratio in the heart in 
regards to adverse cardiovascular events has been considered (Klevay, 1975).  This author 
speculated that an increase in this ratio would lead to numerous adverse effects, such as 
ischemic heart disease and hypercholesterolemia.  Klevay was trying to highlight the 
importance of knowledge of the detrimental effects of dietary copper deficiency (which 
would cause the zinc:copper ratio to increase); however, in our case, this may be important, 
as an accumulation of zinc in the heart following pulmonary exposure would also lead to an 
increase in the zinc:copper ratio.  Interestingly, we did observe a decrease in copper levels in 
the heart following zinc exposure, both via IT and gavage.  The greater increase in zinc at 1 h 
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following IT compared to following gavage taken with the copper decrease would lead to a 
greater increase in zinc:copper ratio, and perhaps adverse cardiac effects.  The exact 
mechanism by which a decrease in copper may cause harm is unclear.  Copper deficiency has 
been shown to affect the nitric oxide signaling pathway, important in both the heart and 
vasodilatory response.  Although we did not measure zinc or copper in vessels in any of our 
studies, impaired vasodilation has been shown to be induced by a zinc rich PM (Tamagawa et 
al., 2008), so therefore a change in the zinc:copper ratio may be partly responsible for this.  
This may also be important in the association between atherosclerosis and PM exposure.   
    A caveat to the study design of the experiment presented in Chapter 3 is that the rats were 
not fasted.  Underlying zinc status can greatly vary from subject to subject, and this will in 
turn influence absorption through the gut.  If the rats had been fasted, it is likely that more Zn 
would have been absorbed, and differences in extrapulmonary organs between these two 
routes would not have been as strikingly different.  However, as mentioned before, there was 
a difference in not only the amount of Zn reaching the heart, but the time course as well.  
Therefore, even if more equal amounts of Zn were to be absorbed, it is probable that there 
would still be differences in kinetics, and this still is perhaps mediating differences in 
toxicity.   
    The experiments conducted and described in the Chapters 2 and 3 utilized IT instillation as 
a means of pulmonary exposure.  The reasoning behind this choice is based on the specific 
hypotheses being tested in these two aims.  In Chapter 2, we wanted to compare the relative 
potencies of a panel of different metals commonly associated with PM and further, that have 
been speculated to be mediating PM toxicity.  Because a major goal of this study was 
dependent on the delivery of constant amounts of metal to each rat, IT instillation was used 
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as a means of exposure.  Similarly, for the 70Zn kinetics study, we wanted to compare 
kinetics via two routes of exposure (pulmonary versus ingestion) so therefore, the delivery of 
an exact known amount of 70Zn via each of these two routes was appropriate.  We were not 
hoping in either of these studies to mimic environmental exposures to zinc, but rather we 
were aiming to screen through other potential mediators of toxicity and show that zinc 
delivered to the lungs does have the ability to reach the systemic circulation and the heart.  IT 
instillation has a long history of utilization in the pulmonary toxicology literature, and is 
accepted as a means of exposure.  Until recently, studies comparing IT versus inhalation used 
incomparable doses, exposure times, or scenarios.  In 2000, Driscoll et al. evaluated much of 
the literature regarding this issue, and concluded that although slight differences in lung 
distribution (for example, more even alveolar distribution following inhalation than IT 
instillation, whereas IT instillation completely bypasses the upper respiratory tract) and 
clearance (in most studies clearance is slower following IT instillation than inhalation) may 
exist, IT instillation should still be an accepted means of exposure.  They also highlight other 
issues that should be taken into account when utilizing IT as a means of exposure, including 
the size and shape of substance, the solubility of substance, and the vehicle used.  They also 
highlight situations in which IT instillation should be avoided, including particle deposition 
studies, acute lung clearance studies, and studies in which the substance may react with the 
vehicle (Driscoll et al., 2000).  In 2000, a study was carried out comparing lung distribution, 
airway physiology, BALF markers of lung injury and inflammation, and lung histopathology 
following exposure to equal amounts of a particular ROFA that has been well characterized, 
both chemically and biologically (Costa et al., 2006).  These authors found similar patterns of 
BALF levels of protein and LDH activity.  This is of particular significance in the context of 
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the overall hypothesis of the experiments described in the preceeding chapters of this 
dissertation, as changes in permeability of the blood/air barrier may influence the ability of 
soluble PM components (particularly zinc), to translocate outside of the lungs.  That they 
found similar lung injury markers following IT versus inhalation validates our use of IT 
instillation to monitor cardiovascular effects and translocation.  A major difference between 
the two routes of exposure that was reported was the degree and timing of pathological 
changes in the lungs.  IT instillation seemed to cause a more acute effect, with signs of repair 
evident by 48 h post exposure, whereas inhalation exposure seemed to cause more delayed 
changes, and also more severe alveolar lesions, perhaps due to more particles being able to 
penetrate deeper into the lungs following inhalation compared to IT instillation.  (Costa et al., 
2006).  Since then, the similar lung distribution patterns between inhalation and estimated 
dose (which may be used to guide IT instilled dose) have been validated (Wichers et al., 
2006).     
    The study described in Chapter 4 establishes the environmental relevance of PM 
associated zinc.  Although the effects we observed in the heart were small, the fact that we 
saw any, especially without any significant increases in lung injury markers, is important.  
These exposures took place for 16 weeks, 3 days a week for 5 hours a day, whereas 
environmental exposures occur continuously over a lifetime.  Thus, it is likely that the effects 
we observed would be enhanced, and more so in populations with pre-existing cardiovascular 
complications.  For instance, individuals with an underlying cardiovascular condition may 
have an increased baseline oxidative stress level, and additionally, altered baseline 
antioxidant enzyme activity.  This has been shown by our lab in spontaneously hypertensive 
rats versus normotensive controls (Wallenborn et al., 2007b).  This may lead to a decreased 
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ability of these diseased populations to respond to toxic insults.  Additionally, zinc may cause 
changes in ion channel activity or expression, and so individuals with underlying arrhythmias 
or irregular heartbeats may be at increased risk of pulmonary exposure to soluble zinc.  This 
study also substantiates the use of intratracheal instillation as a means of investigating 
mechanisms of toxicity of PM.   
    Chapter 2 describes cardiac effects following IT of 1µmol/kg zinc (roughly 20µg/rat).  
Chapter 4 describes cardiac effects following inhalation of 10 to 100µg/m3 of zinc.  When 
deposition fraction, breathing frequency, and duration of exposure are taken into account, 
this is roughly equal to 2µg zinc per rat.  With the experiments described in Chapter 3, we 
showed that zinc does reach the systemic circulation and accumulates in the heart following 
pulmonary IT of 50µg zinc per rat.  However, this study utilized a high dose of zinc, even 
compared to earlier IT studies (Gilmour et al., 2006a and 2006b).  The exact mechanism of 
zinc translocation from the lungs into the systemic circulation is unclear, but may involve 
active transport or a more passive mechanism.  One would think that an increased 
permeability in the blood/air barrier would increase the amount of zinc that is able to 
translocate directly into the plasma, especially if a more passive solubilization is driving zinc 
translocation.  This issue is further discussed in detail in the upcoming Appendix 2; where we 
measured lung and plasma levels of 70Zn following a single IT instillation of a dose of 
0.2µmol/kg body weight (~0.6µg per rat), which was less than one tenth of the concentration 
used in the original study, and less than half of the lowest dose our lab has ever used 
(Gottipolu et al., 2008).  Briefly, we saw that 70Zn had a longer residence time in the lung 
following exposure to a lower dose.  Interestingly, at 1 h post IT, we also found a higher 
percentage of the instilled 70Zn in the plasma following exposure to the lower dose, 
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suggesting that a higher amount of lung injury may not lead to more translocation.  However 
it is unclear from these studies whether a higher baseline level of lung injury would lead to 
greater translocation rates.  An additional approach would be to expose rats to ozone, 
followed closely in time by exposure to 70Zn.  Pre-exposure to ozone increases the 
permeability of the lung to horseradish peroxidase (Miller et al., 1986).  Alternately, 
comparison of translocation rates in different diseased rat strains with different underlying 
levels of lung injury would also be interesting, although issues involved with the diseased 
state, other than underlying lung permeability, may influence translocation (increased 
mucous levels, impaired lung clearance mechanisms).  We have previously reported 
translocation of metals other than zinc, including vanadium and iron, in healthy WKY rats 
(Wallenborn et al., 2007a).  In this study we also observed translocation of these metals in 
stroke prone spontaneously hypertensive rats (SHRSP), and it appeared that less metal was 
reaching outside of the lungs of SHRSP compared to WKY despite a higher level of baseline 
lung injury in SHRSP (unpublished data).  However, this should not discount that increased 
lung permeability may lead to increased translocation rates, as SHRSP most likely have more 
mucous, and possibly impaired lung clearance mechanisms compared to healthy WKY rats.  
Other possible approaches to address this issue are discussed in Appendix 2.   
    The three aims presented in this dissertation all utilize the water soluble form of zinc (or 
metals, as is the case in Chapter 2).  We have chosen this in order to focus on better defining 
one specific potential mechanism of PM-induced cardiotoxicity, the direct translocation of 
water soluble metals (including zinc) to the heart.  However, in reality, although zinc is found 
in a water soluble form in ambient air, it also exists in less water soluble forms, such as zinc 
oxide (ZnO).  Because it is less soluble, and therefore will not solubilize as quickly or easily 
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into lung lining fluid, one would expect less translocation to occur.  An interesting 
experiment to confirm this hypothesis would be to compare extrapulmonary levels of 70Zn 
following IT instillation of 70ZnSO4 and 70ZnO.  The use of 70Zn would be the only way to 
ascertain that more zinc has the ability to translocate when it is found in a soluble form 
compared to an insoluble form.  Clearance and toxicity of instilled ZnO has been reported; 
however over a much longer period of time than any of the work presented here (up to 21 
days) and further, at higher concentrations than the concentrations described in the 
preceeding chapters (20-1000 µg per rat, whereas the highest concentration used in this 
dissertation was 70 µg per rat) (Hirano et al., 1989).  These authors reported no changes in 
extrapulmonary zinc levels; however even if they had seen changes, they would not have 
been able to delineate between exogenous zinc reaching outside of the lungs or changes in 
endogenous zinc pools.  These authors also did not measure any cardiovascular endpoints.  
More recently, a study was carried out reporting zinc IT instillation-induced systemic 
changes in circulating leukocytes and peripheral oxygen saturation.  Furthermore, these 
authors report very immediate (within minutes) increases in heart rate and electrocardiogram 
trace following instillation of zinc (LaGier et al., 2008).  This study describes pulmonary, 
systemic, and cardiac effects of pulmonary zinc exposure; however they used equal amounts 
of ZnO and ZnSO4 so one is unable to determine if effects of exposure to either form 
individually are distinct.  In vitro exposure to ZnO causes increases in inflammatory markers 
in vascular endothelial cells (Gojova et al., 2007); however for this to happen in vitro, ZnO 
would have to reach outside of the lungs.  With regards to toxic effects of pulmonary zinc 
exposure, it is possible that the less water soluble ZnO may be influencing the pulmonary 
effects while the more water soluble ZnSO4 may be influencing the cardiovascular effects.   
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    The term “particulate matter” encompasses a wide range of chemicals, particles, liquid 
droplets, aerosols, metals, and condensed vapors, among other diverse characteristics.  Not 
only is PM nonhomogenous across locations, its composition changes greatly and rapidly 
with time.  These factors, in addition to susceptibility of subpopulations (pre-existing 
cardiovascular disease, pre-existing respiratory disease, elderly, pregnant, children, etc.) 
complicate assessment of health risks of PM exposure.  EPA periodically revises the 
standards for PM, and the current studies are aimed at providing evidential support for the 
existence of cardiovascular health effects of zinc associated PM exposure, and to provide 
biological plausibility to associations in epidemiological literature.  While human data is 
crucial to setting appropriate PM standards, investigation of possible modes of toxicity of PM 
are needed to assess and establish causality.  In his 1965 essay now used as a guide to assess 
causality, Hill mentions biological plausibility as one measure of assuming a causal 
relationship.  In the context of PM and cardiac effects, we suggest here a possible pathway of 
zinc inhalation-induced cardiac effects, i.e., the direct translocation of water soluble zinc 
from the lungs to the heart, causing direct effects such as mitochondrial respiration 
inhibition, ion channel interference, and dysregulation of normal signaling pathways.   
    Recognition that increases in PM lead to decreases in respiratory and cardiovascular health 
was first established following two episodes of spikes in PM.  One was in Donora, 
Pennsylvania, in 1948 following a temperature inversion over a valley where a steel and zinc 
smelter was located.  The other, the London Smog of 1953, is one of the most well known 
PM episodes, and has acted as a catalyst for PM health effects research.  Since these two 
episodes, much work has been done to establish that PM exposure is associated with adverse 
health effects.  In 1993 Dockery et al published their findings on the Harvard Six Cities 
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study, focusing on PM and mortality in six US cities with varying levels of air pollution 
(Steubenville, OH, Watertown, MA, Harriman, TN, St. Louis, MO, Portage, WI and Topeka, 
KS).  These authors correlated a reduction in probability of survival when living in more 
polluted air (Dockery et al., 1993).  This was a landmark epidemiological study, as it was the 
first to show this correlation even after correcting for other important potentially confounding 
factors such as smoking, body mass index, and socioeconomic status.  The association 
between air pollution and adverse health outcomes is now very well recognized.  In the more 
recent past, investigators have attempted to link specific PM components or characteristics to 
health effects.  Studies investigating the potential contribution of the specific metal content 
have been overviewed in the introduction and discussion sections of Chapters 2, 3, and 4.  If 
an increase in PM causes an increase in the incidence of adverse health effects, it is assumed 
that a decrease in PM will cause a decrease in adverse health effects.  However, there are 
fewer studies investigating whether reductions in PM may lead to improvements in 
cardiovascular health.  One occasion where this was possible occurred in the late 1980s in 
Utah.  A labor dispute caused a steel mill to close in 1987.  PM levels in the surrounding 
valley correlated with the operation of the mill:  levels were relatively high in 1986 and 1988, 
and were low during 1987.  Epidemiology studies have since investigated the link between 
this reduction in PM in Utah, and have suggested that alleviation of a variety of health effects 
during 1987, including alleviation of respiratory symptoms, respiratory and cardiovascular 
morbidity and mortality (Pope, 1996), and even pre-term births (Parker et al., 2008), were 
due to the reduction in PM during this year.  Adverse lung development effects have been 
shown to be reduced when children relocate to areas with lower PM than higher PM (Avol et 
al., 2001).  Likewise, during the 1996 Atlanta Olympics, a minimization of traffic was 
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correlated with a decrease in hospital visits for acute asthma events in youth, compared to the 
4 weeks prior to and following the Olympics (Friedman et al., 2001).  And finally, a 1990 
ban on coal in Dublin resulted in a reduction of all non-trauma death rates, respiratory deaths, 
and cardiovascular deaths within 6 years (Clancy et al., 2001).  Since the advent of the EPA 
and the Clean Air Act in 1970, the US had made strides in improving air quality, and so more 
recently, an investigation was carried out showing that at numerous sites across the US, not 
only was life expectancy decreased with increased PM, but from 1980-2000, a reduction in 
PM could be correlated with an increase in life expectancy (Pope et al., 2009).  Although 
intervention studies are limited, ones that exist are all in agreement that cleaner air leads to a 
longer life expectancy and fewer adverse health outcomes.   
    Future directions of this work have been hinted at in these concluding paragraphs.  
Exploring toxicity of combinations of metals may be worth pursuing.  It would be useful as 
well to further explore the individual mechanism of toxicity of each metal.  We chose to 
further investigate zinc because of the public health relevance, meaning that zinc is usually 
the most common metal in ambient air (aside from iron, which we have shown to be 
minimally toxic).  In studying the kinetics of zinc following exposure, it may be of interest in 
future studies to measure cardiac markers that seem to be zinc-specific (mitochondrial 
effects, zinc transporter transcript or protein levels) following IT or gavage to correlate injury 
with kinetics.  Using ICP-MS to measure 70Zn does not delineate protein bound Zn from free 
Zn so therefore, it is currently unclear whether it may be the actual amount of zinc reaching 
the heart or the form that it reaches the heart in which causes harm.  Measuring zinc-specific 
markers in the heart would begin to resolve this issue.  Another possible future direction is 
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the use of 70Zn to monitor translocation following inhalation.  This would further define the 
role of pulmonary inflammation in the ability of a metal to translocate.   
    Untangling the PM issue is difficult.  The integration of human epidemiological studies, 
human clinical studies, in vivo animal toxicology studies, and in vitro toxicology studies is 
needed to make proper scientific judgment in setting PM standards that are not only 
protecting public health, but are achievable.  Although the research presented here represents 
a minor piece of this puzzle, we hope that it may be used in making PM standards more 
scientifically based.   
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APPENDIX 1:  ZINC PERFUSION IN AN ISOLATED HEART 
Introduction 
    The overarching aim of this project was to determine whether zinc present in PM is 
causing distinct pulmonary and cardiac effects, and whether zinc has a direct effect on the 
heart.  Our hypothesis was that following pulmonary exposure, soluble zinc directly moves 
through the pulmonary vasculature into systemic circulation, directly exposing the heart, and 
having direct, zinc-specific effects.  In order to further establish if cardiac effects seen 
following pulmonary exposure to zinc are due to the direct action of zinc on cardiac cells, the 
use of the Langendorff isolated heart perfusion system was considered.  A small pilot study 
was conducted, presented below.   
 
Background 
    Previous results from our lab indicated that following IT of 2 µmol/kg body weight zinc, 
plasma zinc levels were raised from ~1.5 µg Zn/g plasma to ~2.0 µg Zn/g plasma (Gilmour 
et al., 2006b).  This 0.5 µg/g increase is equivalent to ~7 µmol Zn.  The Langendorff isolated 
heart perfusion system has been used primarily to study effects of pharmacological agents on 
physiological parameters such as heart rate and contractility.  Additionally, it can be used to 
measure ability of the heart to recover from ischemic insult.  A small number of studies have 
investigated the effects of direct addition of zinc to the perfusion buffer.  Addition of zinc to 
perfusion buffer (up to 30 µmol zinc) caused drops in heart rate and tension to be greater 
(Kalfakakou et al., 1993).  Increases in arrhythmias following addition zinc to perfusion 
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buffer were noted as well (Evangelou et al., 1993).  Further, Bagate et al showed a decrease 
in heart rate and left ventricular developed pressure was induced by addition of 10 µmol zinc 
directly to perfusion buffer (2006).   
    The aim of this pilot study was to investigate whether we could replicate biochemical 
effects seen in the heart following pulmonary IT of zinc in hearts directly perfused with zinc.  
This would further support that cardiac effects of zinc are the result of zinc directly reaching 
the heart from the lungs following pulmonary zinc exposure.  We have previously seen 
inhibition of cardiac aconitase following pulmonary zinc exposure, so we chose to measure 
this.  We also chose to measure phosphorylation of extracellular signal regulated kinase 
(ERK) because this has been shown to be increased following zinc exposure in lung cells 
(Kim et al., 2006), so we hypothesized that this may be a marker of direct zinc exposure in 
the heart as well.  For the pilot study, we chose to perfuse hearts with 50µmol zinc so that 
effects could be well characterized.  Our plan was to repeat these perfusions with 7µmol zinc 
in the buffer (the amount raised in the plasma following pulmonary IT of 2 µmol/kg body 
weight) to compare cardiac effects in vivo.  We saw no significant changes in either endpoint 
we measured, indicating that either A) the Langendorff perfusion of a working heart may not 
be an accurate model for studying direct effects of soluble PM components on the heart, or 
B) cardiac effects seen following pulmonary exposure to soluble zinc may not be the result of 
a direct effect of zinc on the heart.   
 
Materials and Methods 
Animals.  Healthy male 13 week old Wistar Kyoto (WKY) rats were purchased from Charles 
River Laboratories Inc., Raleigh, NC.  Animals were double housed in polycarbonate cages 
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with beta chips bedding and acclimatized for 1 week in an AAALAC-approved animal 
facility (21 ± 1ºC, 50% ± 5% relative humidity, 12/12 hour light/dark cycle) prior to and 
during the experimental period.  All animals received standard Purina rat chow (Brentwood, 
MO) and water ad libitum.  The protocol for animal use in this study was approved by the 
Institutional Animal Care and Use Committee (NHEERL, USEPA).   
 
Perfusions.  Rats were anesthetized with an overdose of sodium pentobarbital (50-100 
mg/kg, intraperitoneally). Following deep anesthesia, the abdominal cavity was opened and 
1000 units of heparin/0.1 ml saline/rat was injected in posterior vena cava.  One minute later 
heart was quickly excised, washed in cold buffer and attached via aorta to a catheter with 
flowing perfusate.  A water filled balloon was inserted in the left ventricle via left atrium 
through which left ventricular pressure and heart rate are monitored using a transducer signal 
to the program Chart 5, version 5.5.1 from ADI Instruments.  The heart was kept submerged 
in the perfusate at 37ºC using a circulating water bath.  Two hearts were run simultaneously, 
one perfused with 10 µmol zinc and one perfused with Kreb’s buffer with no additional 
agents as a control.  Kreb’s buffer contained 120 mM NaCl, 11.1 glucose, 25mM NaHCO3, 
470 mM KCl, 120 mM MgSO4, 120 mM KH2PO4, and 1.36 mM CaCl2.  Buffer was bubbled 
with 95% O2 and 5% CO2 throughout the perfusion.  All perfusions lasted 70 minutes, except 
animal #4 (a saline control).  Following 20 minutes of perfusion, the heart of animal #4 
exhibited a much slowed heart rate compared to previous results and the time-matched zinc, 
so perfusion was stopped and the heart was processed for analysis (below).  For zinc hearts, 
10 minutes of baseline data was collected before zinc was added directly to the perfusion 
buffer.  Perfusion with zinc lasted 60 minutes.  Following 70 total minutes of perfusion, 
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hearts were removed and immediately processed for isolation of mitochondria and cytosol, or 
Western blotting.   
 
Preparation and aconitase analysis of cytosolic and mitochondrial fractions.  Following 
perfusion, the heart was quickly removed from the apparatus and the right ventricle removed.  
A portion of the left ventricle was cut for Western blot analysis (below) and remaining was 
used for isolation of mitochondrial and cytosolic fractions.  The remaining left ventricle was 
minced with scissors in ice cold homogenization buffer containing 210 mM mannitol, 5.0 
mM MOPS, 70 mM sucrose and 1.0 mM EDTA, at pH 7.4.  Tissues were immediately 
homogenized in 10 mL fresh buffer using a glass Dounce homogenizer with a Teflon pestle.  
Homogenates were centrifuged at 150 x g at 4ºC for 15 minutes to remove cellular debris.  
The supernatant was transferred to another tube and centrifuged at 13,500 x g at 4ºC for 20 
minutes.  This supernatant was used as the cytosolic fraction, and was aliquoted and quick 
frozen at -80ºC until further analysis.  The pellet was resuspended in 10 mL homogenization 
buffer with added protease inhibitor cocktail (Calbiochem Catalog #593134, San Diego, CA) 
at a 1:200 dilution.  The tubes were centrifuged at 13,500 x g at 4ºC for 20 minutes.  The 
supernatant was removed, and the pellet resuspended in 1 mL of the homogenization buffer 
with added protease inhibitors.  This was used as the mitochondrial fraction, and was 
aliquoted and quick frozen at -80ºC until analysis.  Aconitase activity, based on the formation 
of NADPH from NADP+, was measured in both fractions using the Bioxytech Aconitase-340 
Assay (Oxis International Inc., Foster City, CA).  Citrate is converted to isocitrate (catalyzed 
by aconitase), which then undergoes oxidative decarboxylation (catalyzed by isocitrate 
dehydrogenase) and becomes α-ketoglutarate.  Concomitantly during this last reaction, 
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NADP+ is reduced to NADPH.  NADPH formation is measured spectrophotometrically at 
340nm absorbance, and is proportional to aconitase activity.  Aconitase activity is presented 
in units, where one unit with convert 1 µmol of citrate to isocitrate at 25ºC, pH 7.4. 
 
Western blotting.  Portions of heart to be used for Western blot analysis were weighed, and 
homogenized in Tissue Protein Extraction Reagent, with added protease inhibitor cocktail 
(1:200 dilution, Calbiochem Catalog #593134, San Diego, CA), phosphatase inhibitor 
cocktails I and II (Calbiochem, San Diego, CA), 500µM phenylmethylsulphonyl fluoride 
(PMSF, serine protease inhibitor), and 1mM Na3VO4 (as a phosphatase inhibitor).  Samples 
were normalized to contain 5 µg protein/µl, then mixed with sample buffer containing 
sodium dodecyl sulfate, Pierce tracking dye, DTT and tris hydrochloride (Pierce Biotech, 
Product #39000).  Samples were then heated at 95ºC for 1 minute, and electrophoresed on 
pre-cast gradient gels, 8-16% (Invitrogen, Product #EC60452BOX) with pre-stained 
molecular weight markers (CruzMarker, Santa Cruz Biotech, SC-2035), in reducing 
conditions with running buffer containing SDS (Sigma).  Gels were then blotted onto PDF 
membranes (Invitrogen, Product #LC2005).  Blots were blocked at 4ºC for 2 hours in 
Blocking Buffer from Pierce (Product #37535) followed by incubation overnight with 
primary antibodies purchased from Santa Cruz Biotechnology for ERK (sc-94) and phospho-
ERK at Tyr 204 (sc-7383).  HRP-conjugated goat anti rabbit antibody was used for a 
secondary antibody (sc-2030).  Protein bands were detected using enhanced 
chemiluminescence detection solution (Pierce, product #1859674 and 1859675) and 
visualized using the FluorChem Imaging System (Alpha Innotech, San Leandro, CA).  
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Extracts from A549 (lung epithelial) cells treated with epidermal growth factor (EGR) were 
used as positive controls, and naïve A549 cells were used as a negative control.   
 
Results and Discussion 
Aconitase activity 
    Our previous results suggest that pulmonary zinc exposure may be inhibiting aconitase 
activity in the heart due to the direct translocation of zinc from the lungs into systemic 
circulation.  We therefore hypothesized that we would see a similar effects following direct 
zinc perfusion through a working heart.  In order to assess whether the Langendorff cardiac 
perfusion system could be used to investigate whether soluble PM components could be 
having direct effects on the heart, we added zinc directly to perfusion buffer and measured 
aconitase activity in the mitochondria and cytosol of hearts following 70 minutes of 
perfusion (60 minutes with zinc buffer).  We have previously noted inhibition of aconitase 
activity in mitochondria of heart of rats exposed via pulmonary IT to zinc.  Addition of 50 
µmol zinc to the perfusion buffer in a working heart model did not induce any significant 
changes in aconitase activity in either the mitochondrial or cytosolic fractions (Figure 5.1).   
    The most acute time point that we have previously observed cardiac aconitase activity 
inhibition was 4 h post pulmonary exposure (Gottipolu et al., 2008).  Although we have not 
measured this at a more acute time point, it is possible that it may take this long following 
pulmonary exposure for zinc to exert direct effects on the heart.  Another instance in which 
we observed inhibition of cardiac aconitase was following repeated instillations, over 16 
weeks (Kodavanti et al., 2008).  Ex vivo perfusion of hearts via the Langendorff system can 
only be carried out for up to 3-4 hours, which may be too short of a time to see zinc effects 
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on the heart, and a limitation of this model in the context of studying direct PM effects on the 
heart.   
 
ERK phosphorylation 
    In vitro experiments have indicated that zinc acts as a phosphatase inhibitor, and zinc 
exposure induces increases in phosphorylation of different proteins, including extracellular 
signal regulated kinase (ERK) (Kim et al., 2006).  We hypothesized that direct addition of 
zinc to perfusion buffer would induce increases in ERK phosphorylation in an ex vivo 
cardiac perfusion system as well.  Perfusion of 50 µmol zinc did not induce an increase in the 
amount of phosphorylated ERK, as measured by Western blot analysis (Figure 5.2).   
    Not only were we unable to detect any increase in phosphorylated ERK, we were unable to 
detect any phosphorylated ERK at all in any sample.  Our detection of both ERK and 
phospho-ERK in both positive and negative controls assured us that the antibody and our 
Western blotting protocol are working.  Although tissue homogenizations were carried out in 
the presence of numerous protease and phosphatase inhibitors, it is possible that aberrant 
phosphatase activity led to the de-phosphorylation of all ERK in the cells.  Another 
possibility is that both groups (saline and zinc perfused) exhibited no ERK phosphorylation 
at tyrosine 204.  MAP kinase phosphatase 1 (MPK-1) is a dual specificity MAPK 
phosphatase with the ability to dephosphorylate both threonine and tyrosine residues, and has 
been implicated in cardiac hypertrophy (Weng et al., 2007).  Furthermore, in vitro, 
phosphorylation of tyrosine 204 has been measured in cardiomyocytes (Torsoni et al., 2005).  
The process of perfusion may have caused de-phosphorylation, as we did not include heart 
homogenates that were not perfused.  However, Torsoni et al. (2005) implicated that 
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mechanical stretch in cardiomyocytes induces increases in ERK tyrosine phosphorylation (at 
tyrosine 204), so it would seem that perfusion would induce increased protein tyrosine 
phosphorylation as well.  Future studies, including measuring levels of phospho-ERK in non-
perfused hearts, would be necessary to explore the role of cardiac protein tyrosine 
phosphorylation.   
    Overall, in our hands, the Langendorff working heart perfusion system did not prove to be 
a good model of direct effects of soluble Zn on the heart.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  143 
Figure 5.1 
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Figure 5.1.  Aconitase activity in the cardiac mitochondria or cardiac cytosol following 70 
minutes perfusion with Krebs buffer or Krebs buffer with the addition of 50µmol zinc.   
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Figure 5.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2.  Protein levels of phosphorylated ERK and total ERK following 70 minutes 
perfusion with Krebs buffer or Krebs buffer with the addition of 50µmol zinc.  A549 cells 
treated with EGF were used as a positive control, and A549 cells untreated were used as a 
negative control.   
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APPENDIX 2:  DOSE DEPENDENCE OF 70ZINC TRANSLOCATION, EXCRETION 
OF 70ZINC 
 
Introduction 
    The three specific aims described in the preceding chapters were all designed to better 
define the role of zinc in PM-induced cardiovascular toxicity.  The overarching hypothesis 
was that zinc translocates directly from the lungs into the systemic circulation, whereby it has 
a direct effect on extrapulmonary organs.  With the experiments described in Chapter 3, we 
showed that zinc does reach the systemic circulation and accumulates in the heart following 
pulmonary IT of 50µg zinc per rat.  However, this study utilized a high dose of zinc, even 
compared to earlier IT studies (Gilmour et al., 2006a and 2006b).  Chapter 2 describes 
cardiac effects following IT of 1µmol/kg zinc (roughly 20µg/rat), and Chapter 4 describes 
cardiac effects following inhalation of 10 to 100µg/m3 of zinc.  When deposition fraction, 
breathing frequency, and duration of exposure are taken into account, this is roughly equal to 
2µg zinc per rat.   
    We did not measure pulmonary injury when carrying out zinc translocation experiments; 
however as evidenced by pulmonary injury following exposure to less than half of the 
concentration of zinc that we measured in experiments described in Chapter 2, a large 
amount of pulmonary injury was induced.  This pulmonary injury probably leads to changes 
in the permeability of the blood/air barrier.  Whether or not the rate of zinc translocation 
from the lungs is influenced by the presence of pulmonary injury is unclear from our 
experiments described thus far, because we only used one high dose of zinc.  Zinc 
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translocation from the lungs into the systemic circulation may occur passively or through 
active zinc transport.  It is unclear from the current literature which of these may be 
occurring, but the fact that we were unable to measure changes in lung levels of ZnT-1 
mRNA following direct lung exposure to zinc is suggestive of other translocation 
mechanisms.  If this is the case, one would think that changes in lung permeability (i.e., 
increased lung injury) would affect the rate of zinc translocation.   
    Our hypothesis for this follow-up study was that exposure to a lower concentration of zinc 
will lead to a longer residence time in the lung for zinc, as well as less translocation into the 
systemic circulation due to less vascular leakage.  The lowest concentration used in any of 
our previous studies utilizing IT as a means of exposure was 0.5µmol Zn/kg (Gottipolu et al., 
2008).  For this purpose, we wanted to minimize pulmonary injury but still be able to detect 
70Zn outside of the lung.  We chose to expose rats to 0.2µmol 70Zn/kg body weight.  We 
collected lungs and plasma to investigate lung clearance and residence time, and plasma to 
investigate translocation rates.   
    Furthermore, because the amount of zinc eliminated in feces or urine probably differs 
greatly between the two routes of exposure (pulmonary IT versus oral gavage), we measured 
70Zn in the urine and feces of rats exposed to 0.7µmol 70Zn/rat, via either IT or gavage, to 
mimic the original study concentration and design.  Our hypothesis was that more 70Zn 
would be excreted following gavage than pulmonary IT, and therefore, 70Zn levels in the 
urine and feces of rats gavaged with 70Zn would be higher than rats receiving 70Zn via IT.   
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Materials and Methods 
Animals.  Healthy male 13 week old Wistar Kyoto (WKY) rats were purchased from Charles 
River Laboratories Inc., Raleigh, NC.  Animals to be used for lung and plasma collection 
were double housed in polycarbonate cages with beta chips bedding and acclimatized for 1 
week in an AAALAC-approved animal facility (21 ± 1ºC, 50% ± 5% relative humidity, 
12/12 hour light/dark cycle) prior to and during the experimental period.  Animals to be used 
for feces and urine collection were single housed in metabolic cages in an AAALAC-
approved animal facility (21 ± 1ºC, 50% ± 5% relative humidity, 12/12 hour light/dark cycle) 
prior to and during the experimental period.  All animals received standard Purina rat chow 
(Brentwood, MO) and water ad libitum.  The protocol for animal use in this study was 
approved by the Institutional Animal Care and Use Committee (NHEERL, USEPA).   
 
Zinc sulfate.  The same 70ZnSO4 used for the original study was used to prepare the dosing 
solutions for this appendix.  Two separate solutions were prepared, for the first part, 0.2µmol 
70Zn / ml, and for the second, 2.4µmol 70Zn / ml.   
Study design.  As outlined in the introduction, there were two parts to this appendix.  For the 
first part, rats were randomly assigned to different groups (n = 6 for zinc exposed per time 
point and n = 2 for saline exposed per time point) (Table 6.1).  For the feces and urine 
collection, rats were randomly assigned to different groups (n = 6 for zinc IT, n = 6 for zinc 
gavage, n = 1 for saline IT, and n = 1 for saline gavage) (Table 6.2).   
 
Intratracheal instillations.  Enriched ZnSO4 was weighed and suspended in sterile saline at a 
concentration of 0.2 or 2.4 µmoles 70Zn / ml.  Solutions were shaken overnight prior to IT 
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instillation or oral gavage.  Rats were anesthetized under light halothane and single IT 
instillations or oral gavages were given at a volume of 1 ml/kg (Costa et al., 1986).  Control 
rats received 1 ml/kg of the sterile saline.   
 
Necropsy and tissue collection.  At 1, 4, 24 or 48 h post exposure, rats were weighed and 
anesthetized with sodium pentobarbital (50-100 mg/kg, ip).  Blood was collected through 
abdominal aortic puncture directly into a vaccutainer containing sodium heparin and 
centrifuged at 3000 X g at 4ºC for 10 min.  An aliquot of this plasma was stored at -80ºC.  
The accessory lobe of the right lung was removed, blotted with gauze, quick frozen in liquid 
nitrogen, and stored at -80ºC until analysis.   For animals housed in metabolic cages, at 1, 4, 
24 or 48 h post exposure, feces and urine was collected and weighed, and saved at -80°C 
until analysis.   
 
Sample preparation.  Samples were prepared and analyzed in the same manner as the 
original study (see Chapter 3 Materials and Methods).  For feces and urine analysis, samples 
were homogenized and a small fraction was used for analysis.   
 
Statistical analysis.  A two way analysis of variance (ANOVA) test was performed, with 
time and exposure as factors, separately for IT groups and gavage groups.  One way ANOVA 
tests were performed to determine statistically significant differences between routes of 
exposure (IT versus gavage) and exposure (zinc versus saline), using Sigma Stat software, 
version 3.5 (Systat Software, Inc., Point Richmond, CA).  Pairwise comparisons were made 
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using the Holm-Sidak method.  Statistical significance was stated when a minimum p-value 
of 0.05 or less was reached.   
 
Results / Discussion 
Lung and plasma zinc levels   
    
70Zn was detected in both the lungs and plasma of rats receiving 70Zn via pulmonary IT 
(Figure 6.1).  Residence times of 70Zn in the lung were calculated by dividing the absolute 
number at 4, 24 and 48 h post IT by the value in the lung at 1 h.  This comparison is shown in 
Figure 6.2.  At 24 and 48 h post IT, a higher percentage 70Zn remained in the lungs of 
animals given the lower dose, relative to original amount, suggesting a longer relative 
residence time of 70Zn at lower doses.  This may be due to a faster clearance rate at higher 
doses, or a faster rate of absorption into the systemic circulation, or both.  It is important to 
remember that Figure 6.1 depicts percentages of 70Zn in the lung at each time point relative 
to the amount found in the lung at 1 h, for each concentration separately.  There is a much 
higher absolute amount of 70Zn in the lungs of rats instilled with a higher amount of 70Zn.  
For example, at 48 h post IT of 0.2µmol/kg, there was ~285ng exogenous 70Zn in the lungs, 
whereas at 48 h post IT of 2.4µmol/kg, there was ~4300ng exogenous 70Zn still in the lungs.   
    In order to better visualize translocation rates into plasma, we divided the amount of 70Zn 
found in the plasma at each time point by the amount found in the lung at 1 h (Figure 6.3).  
These graphs suggest that initially, a higher percentage of 70Zn is translocated into the plasma 
following pulmonary exposure to a lower concentration than exposure to a higher 
concentration.  Similar to Figure 6.2, it is important here to note that Figure 6.3 values are 
percentages relative to the amount found in the lung at 1 h in each concentration separately.  
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Absolute amounts of 70Zn found in the plasma are much higher following 2.4µmol/kg 70Zn 
than following exposure to 0.2µmol/kg 70Zn.  For example, at 1 h post IT, there is ~1000ng 
exogenous 70Zn in the plasma of rats exposed to 2.4µmol/kg, whereas at 1 h post IT, there is 
~63ng exogenous 70Zn in the plasma of rats exposed to 0.2µmol/kg.  In any case, taken 
together, these data illustrate differences in lung residence time which are dependent on 
concentration.  Furthermore, the fact that a higher percentage of 70Zn translocates into the 
plasma from the lungs following exposure to a lower concentration suggests that pulmonary 
inflammation may not lead to increased relative rates of zinc translocation.   
    Part of the inflammatory response of the lung is an induction of the metal binding protein, 
metallothionein (MT).  It is possible that at the higher concentration, more MT is present to 
bind zinc, making it less available for translocation.  Previous studies have suggested that 
increased lung injury (and therefore increased permeability of the blood/air barrier) lead to 
increases in translocation, by the measurement of movement of horseradish peroxidase from 
the lungs into systemic circulation (Miller et al., 1986).  This suggests that increased lung 
permeability may lead to increased translocation; however this may not occur with regards to 
permeability to essential metals such as zinc, as many metal binding proteins are available to 
complex zinc and perhaps reduce its availability to translocate.   
    Following IT of 2.4µmol Zn/kg, we observed increases in lung and plasma levels of Cu.  
Here, following pulmonary IT of 0.2µmol Zn/kg, we did not observe any zinc exposure 
related increases in lung or plasma Cu levels (Figure 6.4), suggesting that this observation 
may be due to the larger insult to the body, and possibly part of the acute phase response.  
The copper binding protein ceruloplasmin is a general acute phase protein, and increases in 
serum ceruloplasmin and copper are usually indicative of some insult to the body (not 
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necessarily specific to metal exposure) (Harvey and McArdle, 2008).  Our observation here 
of differences in copper levels in the lung and plasma between concentrations is probably 
reflective of differences in degree of pulmonary and systemic responses.  
 
70Zn excretion 
    To assess differences in zinc excretion with respect to route of exposure, we measured 
70Zn levels in urine and feces of animals exposed to 2.4µmol Zn/kg via either IT or oral 
gavage.  We were able to detect 70Zn in the urine and feces of all exposure groups (Figure 
6.5).  By multiplying the values given per gram of tissue by the total weight (in grams) 
collected at each time point, we were able to visualize the total amounts of 70Zn excreted 
(Figure 6.6).  In the urine, by 4 h post exposure, a relatively higher amount of 70Zn was being 
excreted by rats exposed to 70Zn.  By 48 h post exposure, the total amount of 70Zn excreted 
by rats gavaged with 70Zn was more than triple the amount excreted by rats receiving 70Zn 
via pulmonary IT.  This difference may explain differences in extrapulmonary 70Zn levels 
following exposure via these different routes.  When 70Zn was introduced into the lungs via 
IT, the major of excretion is via the mucociliary escalator or through absorption into the 
systemic circulation.  This is in contrast with oral gavage of 70Zn, because when given orally, 
70Zn has the chance to pass through the gut without being absorbed and be excreted directly.   
   Levels of 70Zn in the feces were also assessed.  When comparing on a per gram basis 
(Figure 6.5), in general, more 70Zn was found in the feces of rats exposed to 70Zn via gavage.  
With the exception of 24 h post gavage of 70Zn, the total amounts of zinc excreted via feces 
were higher in saline exposed rats, due to higher amounts of feces collected at all time points 
from saline exposed animals.  It appears that 70Zn was excreted in the highest amount 24 h 
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following gavage of 70Zn.  This is consistent with our hypothesis that more 70Zn would be 
excreted from rats receiving 70Zn via gavage than via pulmonary IT.  At 24 h post gavage, 
the total amount of 70Zn excreted was ~30,000ng, or 30µg (Figure 6.6).  This is equal to over 
half of the total dose of 70Zn given, suggesting that only about half of the dose given via 
gavage was absorbed in to the systemic circulation.  This is in contrast with the situation 
following pulmonary IT, where most of the 70Zn was probably absorbed.  This difference in 
absorption partly explains our results in Chapter 3, where we observed significantly higher 
amounts of 70Zn in all extrapulmonary organs following IT than following gavage.  However, 
with regards to cardiac levels of zinc, we found differences in not only the absolute amounts 
of 70Zn reaching the heart between routes of exposure, but differences in kinetics as well.  
Regardless of absorption rates, 70Zn accumulates in the heart following pulmonary exposure 
but not oral gavage, and this suggests that the heart is a preferential target following 
pulmonary zinc exposure but not oral zinc exposure.   
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*The number in each cell represents total number of rats/group. 
Table 6.1.  Low dose 70Zn kinetics experimental design.  Table shows exposure groups, time 
course, and group sizes.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Strain/Time kill Exposure groups*
WKY 70ZnSO
4
IT,
0.2µmol/kg
Saline, IT
1 hour 6 2
4 hour 6 2
24 hour 6 2
48 hour 6 2
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*The number in each cell represents total number of rats/group. 
TABLE 6.2.  70Zn excretion experimental design. Table shows exposure groups, time course, 
and group sizes.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
70ZnSO
4
IT,
0.7
µmol/rat
Saline, IT 70ZnSO
4
gavage,
0.7 µmol/rat
Saline, 
gavage
1 hour 6 1 6 1
4 hours 6 6
24 hours 6 6
48 hours 6 6
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Figure 6.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1. Levels of 70Zn in lungs or plasma at 1, 4, 24 and 48 h following a single 
intratracheal instillation of 0.2µmol/kg body weight 70ZnSO4 in rats.  All values represent 
mean ± standard error of the mean (n = 2 for control groups and n = 6 for 70Zn groups).  (*) 
indicate significantly different from saline control within the same time point. 
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Figure 6.2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.2.  Residence times of 70Zn in the lung at 1, 4, 24 or 48 h following a single 
intratracheal instillation of 70ZnSO4, at either 2.4µmol/kg or 0.2µmol/kg body weight.  
Percentages were calculated by dividing the absolute number at 4, 24 and 48 h post exposure 
by the value in the lung at 1 h.   
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Figure 6.3.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.  Translocation of 70Zn from the lungs into the plasma following a single 
intratracheal instillation of 70ZnSO4, at either 2.4µmol/kg or 0.2µmol/kg body weight.  
Percentages were calculated by dividing the amount of 70Zn found in the plasma at each time 
point by the amount found in the lung at 1 h. 
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Figure 6.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4.  Levels of copper in the lungs and plasma at 1, 4, 24 and 48 h following a single 
intratracheal instillation of 0.2µmol/kg body weight 70ZnSO4 in rats.  All values represent 
mean ± standard error of the mean (n = 2 for control groups and n = 6 for 70Zn groups).  
 
 
 
 
 
 
 
Cu, lungs
0
500
1000
1500
2000
2500
3000
1 hour 4 hours 24 hours 48 hours
Time Post IT
n
g 
C
u
 
/ g IT Zinc
IT Saline
Cu, plasma
0
500
1000
1500
2000
1 hour 4 hours 24 hours 48 hours
Time Post IT
n
g 
C
u
 
/ g IT Zinc
IT Saline
  159 
Figure 6.5. 
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Figure 6.5.  Urine and feces levels of 70Zn, expressed per gram, at 1, 4, 24 and 48 h following 
a single intratracheal instillation or oral gavage of 2.4µmol/kg body weight 70ZnSO4 in rats.  
All values represent mean ± standard error of the mean (n = 1 for control groups and n = 6 
for 70Zn groups).   
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Figure 6.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6.  Total levels of 70Zn in urine and feces at 1, 4, 24 and 48 h following a single 
intratracheal instillation or oral gavage of 2.4µmol/kg body weight 70ZnSO4 in rats.  Values 
were obtained by multiplying the amount of 70Zn measured per gram by the total amount 
collected at each time point.  All values represent mean ± standard error of the mean (n = 1 
for control groups and n = 6 for 70Zn groups).   
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